Pseudo [qlco]	5
nmol/mL [qnco]	5
Bone Specific Alkaline Phosphatase [lbpr]	5
Internal Carotid Artery Stenosis [dsyn]	5
Creatine [aapp, bacs]	5
Autoimmunity [patf]	5
fibres [phsu]	5
Proline [aapp, bacs]	5
Associated Pulmonary Arterial Hypertension [dsyn]	5
Meats [food]	5
Breast Reconstruction [topp]	5
Accountability [idcn]	5
Total Resection [topp]	5
reuptake [celf]	5
Imaging Tool [medd]	5
low fibrinogen [dsyn]	5
Telomere Shortening [comd]	5
Oral infection [dsyn]	5
Hepatitis B [dsyn]	5
heave [dsyn]	5
Anti-epileptic [phsu]	5
Gestational Diabetes [dsyn]	5
Peak pressure [qnco]	5
Texture [qlco]	5
Isoflurane [orch, phsu]	5
Echography [diap]	5
cognitive disorders [mobd]	5
Ottawa [popg]	5
Meningiomas [neop]	5
Congenital disease [cgab, dsyn]	5
Toxicology [bmod]	5
Fat metabolism [moft]	5
Cortex [bpoc]	5
Sedatives [phsu]	5
Activities, Physical [dora]	5
lipid transfer protein [aapp, bacs]	5
Broccoli [plnt]	5
Cancel [qlco]	5
Brains [bpoc]	5
Circumflex [spco]	5
Progestogen hormone therapy [topp]	5
Civilization [acty]	5
Metabolic Processes [orgf]	5
benefiting [qnco]	5
Knowledge Translation [resa]	5
Radical nephrectomy [topp]	5
Increased blood viscosity [fndg]	5
Mediastinal Hodgkin Lymphoma [neop]	5
Psychologic [ftcn]	5
Alternate days [tmco]	5
Rare Diseases [dsyn]	5
t-all [neop]	5
Prolonged QTc interval [patf]	5
Anabolic steroids [phsu, strd]	5
Balloon Dilatation [topp]	5
Review Group [prog]	5
intracranial tumors [neop]	5
Laxatives [phsu]	5
Abdominal Circumference [clna]	5
Microangiopathy [dsyn]	5
Breast Conservation Treatment [topp]	5
Clinical Practice Guideline [inpr]	5
Triangle [cnce]	5
Factor VII, Activated [aapp, enzy, phsu]	5
Mental status [fndg]	5
gene product [aapp, bacs]	5
Isoenzymes [aapp, enzy]	5
Arterial occlusive disease [dsyn]	5
Medicaid Program [gora]	5
Professor [prog]	5
Chronic disorder [dsyn]	5
Quote [mnob]	5
Ventral [spco]	5
calcium supplementation [topp]	5
Tobacco Consumption [inbe]	5
neurodevelopment [ortf]	5
SAT [gngm]	5
Logistic Models [inpr, qnco]	5
lecture [inpr]	5
Pages [idcn]	5
Dermis [tisu]	5
Vitamin D intake [fndg]	5
Venous occlusion [patf]	5
Seasons [tmco]	5
Ovarian dysfunction [dsyn]	5
rivaroxaban [orch, phsu]	5
Amoxicillin [antb, orch]	5
Disabilities [fndg]	5
Coagulation Factor [aapp, bacs, phsu]	5
Cerebral Stroke [dsyn]	5
Estrogen Receptor Status [clna]	5
NR [geoa]	5
per year [tmco]	5
Task Forces [gora]	5
crises [fndg]	5
genotoxicity [comd]	5
Isradipine [orch, phsu]	5
Pulmonary infections [dsyn]	5
Guide wire [medd]	5
Neutrophil count [lbpr]	5
Secondary hypertension [dsyn]	5
nuclear magnetic resonance [diap]	5
Probes [medd]	5
Chemoprotective [qlco]	5
Lower leg [blor]	5
Laryngeal Cancer [neop]	5
hawthorn [plnt]	5
Disopyramide [orch, phsu]	5
PPAR [aapp, rcpt]	5
Knowledge Base [inpr]	5
LIPO [neop]	5
Cancer Cell Growth [neop]	5
Nitrous Oxide [bacs, inch, phsu]	5
Anti-Sense Oligonucleotides [bacs, irda, nnon]	5
Monitors [medd]	5
Factors, Economic [qnco]	5
polar [qnco]	5
Intra-arterial infusion [topp]	5
Burn [inpo]	5
Valencia [fish]	5
Electrocardiography, Ambulatory [diap]	5
omit [idcn]	5
Ventilator [medd]	5
Ophthalmology [bmod]	5
Ribavirin [nnon, phsu]	5
Acute pulmonary embolism NOS [patf]	5
Prostaglandin Production [phsf]	5
Judgments [menp]	5
DSM-IV [inpr]	5
BC [qnco]	5
Therapeutic procedure [topp]	5
Lignan [orch]	5
nmol/mg [qnco]	5
Ritonavir [orch, phsu]	5
Drug toxicity [inpo]	5
educators [prog]	5
Methanol [hops, orch, phsu]	5
Floor [mnob]	5
Tachypnea [sosy]	5
CELLULAR THERAPY [topp]	5
Qualification [qlco]	5
Naftidrofuryl [orch, phsu]	5
quality research [resa]	5
breast cancer prevention [topp]	5
Nutritional Assessment [diap]	5
FRY [gngm]	5
Androgen Suppression [topp]	5
conformal radiation therapy [topp]	5
Eating patterns [inbe]	5
Case Studies [inpr]	5
Employee [prog]	5
recanalized [ftcn]	5
active ingredient [qlco]	5
Hemiparesis [dsyn]	5
Apo A-II [aapp, bacs]	5
Epistaxis [patf]	5
Salts [chvs]	5
Sibling [famg]	5
Black race [popg]	5
Stoma [anst]	5
Public Health Practice [hlca]	5
Medical Surveillance [hlca]	5
Middle Cerebral Arteries [bpoc]	5
normal angiogram [fndg]	5
Pilot Projects [resa]	5
Interviewers [prog]	5
Blood Plasma [bdsu]	5
Reproductive Health [bmod]	5
public healthcare [inpr]	5
glucose monitoring [hlca]	5
centuries [phsu, vita]	5
stage I breast cancer [neop]	5
Europe, Eastern [geoa]	5
lime [inch, phsu]	5
Frozen [npop]	5
Apoprotein(a) [aapp, bacs]	5
FA [dsyn]	5
Cytoprotection [phsf]	5
Cannulation [topp]	5
Sigmoidoscopy [diap]	5
Orthopedic [bmod]	5
Catheterizations [topp]	5
Viral Infections [dsyn]	5
Federation of Gynecology and Obstetrics [prog]	5
Flare [sosy]	5
Exogenous Factors [ftcn]	5
Protein intake [clna]	5
Spastic [sosy]	5
descriptions [idcn]	5
Hot Flash [sosy]	5
Bundle branches [bpoc]	5
Spur [bpoc]	5
Phyto [euka]	5
Fe+++ [elii]	5
platelet inhibitor [phsu]	5
Chemoprevention Study [resa]	5
Drops [bodm]	5
Joint Pain [sosy]	5
growth hormone levels [lbtr]	5
Proteolysis [moft]	5
nephrologists [prog]	5
TFPI [aapp, phsu]	5
Peripheral nerve [bpoc]	5
m/s [qnco]	5
Iceland [geoa]	5
Social isolation [socb]	5
Fenretinide [orch, phsu]	5
Generalizations [menp]	5
Family Caregivers [famg]	5
Mastication [ortf]	5
Diastolic arterial pressure [clna]	5
Normal anatomy [qlco]	5
cultural differences [qlco]	5
Fatty Acid Metabolism [moft]	5
Hits [fndg]	5
Transcriptome [nusq]	5
prevention program [inpr]	5
PPAR alpha [aapp, rcpt]	5
EORTC [hcro]	5
Tumor Mass [fndg]	5
Palliative Treatment [hlca]	5
Brugada Syndrome [dsyn]	5
Sucrose [bacs, carb, phsu]	5
sleep quality [fndg]	5
Functional assessment [diap]	5
Lipolysis [orgf]	5
Immortalized [mbrt]	5
Awakening [tmco]	5
Skull [bpoc]	5
Group E [clas]	5
Unresectable [clna]	5
drug combination [phsu]	5
Extranodal [spco]	5
Sight [orgf]	5
Worry [fndg]	5
Neodymium [elii]	5
Rheumatoid Factor [aapp, imft]	5
Clamping [topp]	5
age onset [qnco]	5
Nonprescription [phsu]	5
Para-aortic [spco]	5
Left ventricular structure [bpoc]	5
average heart rate [fndg]	5
treatment guideline [topp]	5
Tax [qnco]	5
Marfan Syndrome [dsyn]	5
Seminal [clna]	5
congenital diseases [cgab, dsyn]	5
Glycine [aapp, bacs, phsu]	5
Population Database [inpr]	5
Sodium Channel Blockers [phsu]	5
Semi-quantitative [qnco]	5
Ventricular extrasystoles [patf]	5
brain findings [fndg]	5
Defer [tmco]	5
sclerosing solution [phsu]	5
Health Care Reform [gora]	5
Ventricular myocardium [bpoc]	5
Refractory angina [dsyn]	5
Sahara [geoa]	5
Education, Continuing [edac]	5
work related [fndg]	5
overviews [inpr]	5
Embolic stroke [dsyn]	5
nutrition education [edac]	5
gabapentin [orch, phsu]	5
Bloating [sosy]	5
Integrative Medicine [bmod]	5
coronary artery diseases [dsyn]	5
Childhood Cancer Survivor Study [resa]	5
Cell Transplantation [topp]	5
Neuromuscular [qlco]	5
Colesevelam hydrochloride [orch, phsu]	5
Dried [qlco]	5
Respiratory syncytial virus infection [dsyn]	5
Atlanta [euka]	5
Invasiveness [qlco]	5
Phase III Clinical Trial [resa]	5
Breast Biopsy [diap]	5
Regional Blood Flow [ortf]	5
Good Clinical Practice [inpr]	5
Fisher [mamm]	5
Mathematical Model [inpr]	5
Volumes, Cardiac [orgf]	5
Image Feature [qlco]	5
tissue engineer [topp]	5
Pain intensity [clna]	5
Institutionalized [fndg]	5
free time [dora]	5
personal experience [inbe]	5
NYHA classification [inpr]	5
evaluable patients [podg]	5
Hemangiomas, Cavernous [neop]	5
Old myocardial infarction [dsyn]	5
P group [clna]	5
Ordinal [inpr]	5
Left ventricular end systolic volume [lbtr]	5
Health Level [qlco]	5
Endothelin receptor antagonist [phsu]	5
Aortic atherosclerosis [dsyn]	5
Cell Survival [celf]	5
Strictures [anab]	5
Tourniquet [medd]	5
legislative [inpr]	5
Dexrazoxane [orch, phsu]	5
Primary site [spco]	5
Center for Disease Control [hcro]	5
nordic [hcro]	5
Interventional procedure [diap, topp]	5
B-Cells [cell]	5
Mineralocorticoid [horm, phsu, strd]	5
Orientated [fndg]	5
damages [inpo]	5
days week [tmco]	5
Correspondence [inpr]	5
Discharge Planning [hlca]	5
rt-PA [aapp, enzy, phsu]	5
Unresolved Issue [idcn]	5
Nitric Oxide Donors [phsu]	5
Venous blood sample [bdsu]	5
Population Distribution [qnco]	5
Blood Screening [lbpr]	5
Vinblastine [bacs, orch, phsu]	5
NCCN [hcro]	5
Carers [prog]	5
Autoantibody [aapp, imft]	5
cleavage [celf]	5
Wrist [blor]	5
endovascular interventions [topp]	5
Vascular Cell Adhesion Molecule [aapp, imft]	5
Pulmonary artery hypertension [patf]	5
calcifications [ortf]	5
Profiles, Metabolic [npop]	5
corticosteroid therapy [topp]	5
Specialty Group [hcro]	5
Puerto Rico [geoa]	5
Arbitrary unit [qnco]	5
drug mechanism [patf]	5
Receptor Gene [gngm]	5
Entrapment [fndg]	5
co-treatment [hlca]	5
Companion [popg]	5
Frequencies, Allele [qnco]	5
Life Table Analysis [ocac]	5
Receptors, LDL [aapp, rcpt]	5
Arthralgia [sosy]	5
White blood cell [cell]	5
atheromatous [patf]	5
Increased lipid [fndg]	5
suspicious [idcn]	5
Openness [spco]	5
Cardiac pacing [topp]	5
Wegener Granulomatosis [dsyn]	5
Cell Adhesion [celf]	5
hole [fndg]	5
Television [mnob]	5
Grade II [qlco]	5
Family Health [fndg]	5
Platelet Function Tests [lbpr]	5
Mammographies [diap]	5
Tunisia [geoa]	5
Non-smoker [fndg]	5
Normal Ventricular Ejection Fraction [fndg]	5
Fire [phpr]	5
Estrone sulphate [horm, phsu, strd]	5
Biomaterials [bodm]	5
benchmarks [qnco]	5
high uric acid [fndg]	5
Aruba [geoa]	5
Health maintenance [hlca]	5
chemical properties [npop]	5
Diabetes Therapy [topp]	5
Cofactor [bacs]	5
White Adipose Tissue [tisu]	5
Hyperlipemia [dsyn]	5
Erection [ortf]	5
Autonomic dysfunction [patf]	5
parasitic [euka]	5
myocardial necrosis [dsyn]	5
Estrogens, Synthetic [orch, phsu]	5
Prostheses [medd]	5
Fits NOS [sosy]	5
Conjugate [imft]	5
Chronic congestive heart failure [dsyn]	5
IU/d [qnco]	5
Ventricular dilation [fndg]	5
beraprost [eico, horm, phsu]	5
STS [lipd, phsu]	5
Computers [mnob]	5
Detergent [chvf]	5
Small molecules [orch]	5
Coxibs [orch, phsu]	5
Engraftment [phsf]	5
Biological Agents [bacs, phsu]	5
Mammography - screening [topp]	5
renovascular [dsyn]	5
Acyl Coenzyme A [bacs, lipd, nnon]	5
Therapeutic Index [qnco]	5
Test, Rank-Sum [qnco]	5
Plasma insulin level [lbpr]	5
HIGH BLOOD GLUCOSE [dsyn]	5
Luteal Phase [ortf]	5
unite [bodm]	5
metastatic breast cancer [neop]	5
Juvenile [aggp]	5
c peptide levels [lbpr]	5
AES [gngm]	5
Surgical specimen [sbst]	5
Wheat [food]	5
Blood-Pool Scintigraphy [diap]	5
Communication skills [orga]	5
Beck depression inventory score [clna]	5
NAD(P)H oxidase [aapp, enzy]	5
Ticagrelor [nnon, phsu]	5
vaccinated [fndg]	5
Leisure Time [idcn]	5
Lipodystrophy [dsyn]	5
Aging, Premature [dsyn]	5
Ectasia [patf]	5
Deacetylase [aapp, enzy]	5
Committee, Advisory [gora]	5
Tomography, Spiral Computed [diap]	5
Survey Instrument [inpr]	5
alcohol ingestion [inbe]	5
System, Information [inpr]	5
Sildenafil citrate [orch, phsu]	5
urinary levels [ftcn]	5
trafficking [celf]	5
Immobilisation [topp]	5
Biofeedback [topp]	5
Nitrendipine [orch, phsu]	5
Auricular [ftcn]	5
Uncovered [ftcn]	5
Middle Cerebral Artery Occlusion [acab]	5
vascular grafts [medd]	5
ileal bypass [topp]	5
Right ventricular ejection fraction [clna]	5
Right Ventricular Dysplasia [cgab, dsyn]	5
Cholecystitis [dsyn]	5
Helicobacter pylori [bact]	5
Cervical Squamous Cell Carcinoma [neop]	5
Potentiation [topp]	5
hospital day [hcro, mnob]	5
Latino [popg]	5
Patient referral [hlca]	5
Wall motion index [clna]	5
Nephrectomy [topp]	5
Deceleration time [qnco]	5
subcortical [blor]	5
Botanicals [orch, phsu]	5
Skin lesion [dsyn]	5
Primary Lesion [dsyn]	5
high insulin [dsyn]	5
Epirubicin [orch, phsu]	5
Disease, Gastrointestinal [dsyn]	5
acute exacerbations [fndg]	5
Oxyhaemoglobin [aapp, bacs]	5
FM [gngm]	5
HEART, BASE [blor]	5
Inflammatory arthritis [dsyn]	5
Relative ratio [qnco]	5
Swine [mamm]	5
Tenth [qnco]	5
alcohol effects [dsyn]	5
PCO [dsyn]	5
Nuclear Medicine [bmod]	5
Neuroendocrine neoplasm [neop]	5
progestin replacement therapy [topp]	5
Relapsing [phpr]	5
archive [mnob]	5
Mammary Cancer [neop]	5
arterial calcification [patf]	5
Observed Incidence [qnco]	5
Obstetric [ftcn]	5
Cardioprotective Agent [phsu]	5
Cost Analyses [ocac]	5
Adenomas [neop]	5
Coronary artery spasm [dsyn]	5
Imputation [qnco]	5
protein i [aapp, bacs]	5
Lancet [medd]	5
Educational Status [fndg]	5
Angeliq [horm, phsu, strd]	5
G-Protein-Coupled Receptors [aapp, rcpt]	5
kg/day [qnco]	5
CALCIUM SUPPLEMENTS [phsu, vita]	5
acquiring [tmco]	5
Premature Infants [aggp]	5
Maximum Heart Rate [fndg]	5
Blood Vessel Tissue [tisu]	5
Androgen deficiency [dsyn]	5
desires [menp]	5
Picibanil [orch, phsu]	5
Circulating Endothelial Cells [lbpr]	5
Arterial oxygen saturation [lbpr]	5
Oriental [popg]	5
Seizure free [fndg]	5
Anti-Rheumatic Drugs [phsu]	5
sleep duration [fndg]	5
Fatty Acids, Monounsaturated [bacs, lipd]	5
Clot formation [lbpr]	5
Solvent [irda]	5
odd ratio [qnco]	5
Receptor Signaling [moft]	5
graduated [popg]	5
CDC [hcro]	5
Death Records [mnob]	5
Fibrin Degradation Products [aapp, bacs]	5
Respiratory distress [sosy]	5
herbal medicines [plnt]	5
Aspiration Pneumonia [dsyn]	5
high calcium [fndg]	5
performances [inbe]	5
Suture, NOS [topp]	5
Social status [qlco]	5
Neurotoxicity [inpo]	5
Second Primary Cancers [neop]	5
liposomal [lipd]	5
blinded study [resa]	5
Phospholipid Transfer Protein [aapp, bacs]	5
Diagonal [spco]	5
Cardiac intensive care unit [hcro]	5
Cross Linked [npop]	5
high sodium [fndg]	5
Whole food [food]	5
Extents [spco]	5
health care service [hlca]	5
Complete left bundle branch block [dsyn]	5
Inspiratory [orgf]	5
Epidemiology Research [resa]	5
Peritonitis [dsyn]	5
Debridement [topp]	5
Increased blood flow [fndg]	5
impairing [ftcn]	5
PANCREATIC CANCER [neop]	5
Colorado [geoa]	5
Lipid Peroxides [lipd]	5
Shape relationship [cnce]	5
Chorda [plnt]	5
Tomatoes [food]	5
Saving, Cost [qnco]	5
Induction Therapy [topp]	5
Subfamily [clas]	5
Protector [medd]	5
Editions [inpr]	5
Ebstein Anomaly [cgab]	5
ROC Analysis [qnco]	5
Panacea [euka]	5
IMT [neop]	5
nmol/mg{protein} [qnco]	5
gene mutations [genf]	5
Party [cnce]	5
verbs [inpr]	5
Nanomedicine [ocdi]	5
Linkage Disequilibrium [qnco]	5
Relaxed [acty]	5
Gap junction [bsoj]	5
Patient-Centered Care [hlca]	5
Erosion [acab]	5
Androgen Effects [phsf]	5
interviewing [acty]	5
Nuclear Cardiology [inpr]	5
hdl raising [fndg]	5
Dermatologist [prog]	5
Descriptors [inpr]	5
Lymphocyte Count [lbpr]	5
Major medical [idcn]	5
Doubtful [cnce]	5
cinacalcet [orch, phsu]	5
Signature [amas]	5
Holistic [prog]	5
Congestion [patf]	5
Bone disease [dsyn]	5
Leaf [plnt]	5
Resort [mnob, orgt]	5
Moricizine [orch, phsu]	5
Island [geoa]	5
Colonoscopies [diap]	5
Waiting List [inpr]	5
Ethylenediaminetetraacetic Acid [orch, phsu]	5
Practice Guideline [inpr]	5
TEMPLATE [medd]	5
Transpulmonary [spco]	5
Nutritional deficiencies [dsyn]	5
Cardiac infarction [dsyn]	5
Current age [tmco]	5
Dietary Protein [aapp]	5
Southwest [spco]	5
Axillary lymph node dissection [topp]	5
membership [inbe]	5
Subcategory [clas]	5
implanting [topp]	5
Prior Radiotherapy [fndg]	5
Microbubbles [medd]	5
Negated [ftcn]	5
Carotid bifurcation [blor]	5
thiobarbituric acid [orch]	5
Therapeutic Technique [topp]	5
sevelamer [orch, phsu]	5
Bisoprolol [orch, phsu]	5
serum creatine phosphokinase [lbpr]	5
Heart Failure, Right-Sided [dsyn]	5
Stockings, Elastic [medd]	5
surgical complications [fndg]	5
Sleep apnea syndrome [dsyn]	5
obsolete [idcn]	5
Basal Ganglia [bpoc]	5
Hormone Responsive [ftcn]	5
catechins [orch, phsu]	5
National Health Interview Survey [inpr]	5
Cardiovascular event risk [fndg]	5
conceived [ftcn]	5
Orthotopic [spco]	5
Cubic [spco]	5
Dihydropyridines [orch, phsu]	5
glutathione peroxidase activity [moft]	5
SECONDARY MALIGNANCY [fndg]	5
Tumor Response [idcn]	5
Scar Tissue [fndg]	5
SINGLE GROUP [resa]	5
Sex Distribution [qnco]	5
Simulator [medd]	5
Recovery Period [tmco]	5
Increased Platelet Aggregation [moft]	5
regulatory agency [orgt]	5
chart reviews [hlca]	5
Privacy [idcn]	5
Generic Substitution [hlca]	5
Coronary artery occlusion [dsyn]	5
oxide [inch]	5
risk indicator [qnco]	5
Personal risk factor [orga]	5
Models, Economic [inpr, qnco]	5
manual review [inpr]	5
penis [bpoc]	5
Tooth Loss [acab]	5
Embryologies [bmod]	5
Antithrombins [aapp, bacs, phsu]	5
Pain Control [topp]	5
Jaws [bpoc]	5
Aortic coarctation [cgab]	5
Hostility [menp]	5
Chronic thromboembolic pulmonary hypertension [dsyn]	5
Elastin [aapp]	5
Venous-lymphatic malformation [cgab]	5
Audio [inpr, mnob]	5
Drowsiness [fndg]	5
EX [idcn]	5
IMMUNO-DEFICIENCY [dsyn]	5
therapeutic aspects [ftcn]	5
g/g [qnco]	5
Primary Care Group [hcro]	5
Tmax [qnco]	5
Vulvovaginal atrophy [neop]	5
Machine Learning [mcha]	5
Patient Monitoring [hlca]	5
dabigatran [phsu]	5
quetiapine [orch, phsu]	5
childbirth [orgf]	5
Regional Lymph Node [bpoc]	5
Rheumatic Diseases [dsyn]	5
Fluctuating [tmco]	5
remind [topp]	5
Compatibility [qlco]	5
Apoptosis Pathway [celf]	5
Dietary Lipid [food]	5
Electrolytes [inch, phsu]	5
Ethnopharmacology [bmod]	5
solid tumor [neop]	5
Caesarean Section [topp]	5
NYHA Class I [fndg]	5
Dexmedetomidine [orch, phsu]	5
adalimumab [aapp, imft, phsu]	5
Heterozygote [orga]	5
Psychiatrists [prog]	5
Cancer Cause [bmod]	5
mAs [qnco]	5
Clients [popg]	5
radiated [ftcn]	5
Hypertension, Renovascular [dsyn]	5
Pons [bpoc]	5
Gap Junctions [bsoj]	5
Induced vasodilatation [topp]	5
condensation [mobd]	5
coagulation profile [lbpr]	5
primary ovarian insufficiency [dsyn]	5
good effect [fndg]	5
Meter [qnco]	5
Abnormal lipid profile [fndg]	5
Peroxide [inch]	5
Allele Frequency [qnco]	5
dictated [inpr]	5
Macroprolactinomas [neop]	5
Solitary [qnco]	5
Secondary disease [dsyn]	5
Hematoma, Subdural [patf]	5
Triacylglycerols [bacs, lipd]	5
Early complication [sosy]	5
Microsomal [qlco]	5
testosterone undecanoate [horm, phsu, strd]	5
Overdose [inpo]	5
Potential Subject [humn]	5
balloons [mnob]	5
Filters [mnob]	5
manpower [ftcn]	5
conjugated estrogens/medroxyprogesterone [topp]	5
Dietary Practices [inbe]	5
Intravenous Injections [ftcn]	5
configurations [spco]	5
Tyrosine Kinase Inhibitors [moft]	5
Seronegative [qlco]	5
continents [geoa]	5
committed [orch, phsu]	5
isoprenoid [orch]	5
Epidemiologic Study [resa]	5
sex therapy [topp]	5
LAS [gngm]	5
Phase III Study [resa]	5
Gastrointestinal Diseases [dsyn]	5
placebo therapy [topp]	5
SMOOTH MUSCLE ACTIN [gngm]	5
Forecasting [inpr]	5
Cachexia [sosy]	5
Large tumor [qlco]	5
phantom [mnob]	5
Niaspan [orch, phsu]	5
Digestive Tract [bdsy]	5
Circumflex artery [bpoc]	5
Slow disease progression [fndg]	5
oxidized low density lipoprotein [aapp, bacs]	5
Bronchial Epithelial Cell [cell]	5
faith [idcn]	5
anorectic [dsyn]	5
Submucosal [ftcn]	5
Synthetic graft [topp]	5
lining [spco]	5
Abnormal bleeding [patf]	5
DT [imft, phsu]	5
assessment program [ocac]	5
low dose oral contraceptive [phsu]	5
Isozyme [aapp, enzy]	5
fatty acid oxidation [moft]	5
Restriction fragment length polymorphism [clna]	5
Myocardial Reperfusion Injury [patf]	5
Thoughts [menp]	5
Growth retardation [patf]	5
Epileptic [dsyn]	5
Necrotising [ftcn]	5
wisdom [idcn]	5
Epidemiologic Research [resa]	5
long qt [fndg]	5
Tracer [irda]	5
large breast [fndg]	5
Dissociation [mobd]	5
Spontaneous Sustained Ventricular Tachycardia [dsyn]	5
Bromocriptin [orch, phsu]	5
Axillary Dissection [topp]	5
Elevated D-dimer [fndg]	5
Chronotherapy [topp]	5
Data Mining [mcha]	5
Plant-Derived Compounds [bacs, orch]	5
Kliogest [phsu, strd]	5
Ethics [idcn]	5
peroxisome proliferator activated receptor [aapp, rcpt]	5
Sterols [strd]	5
Clinical Services [hlca]	5
Molecular Imaging [diap]	5
Copies [mnob]	5
Anti-Hypertensives [phsu]	5
Hypothermia [fndg]	5
Low Back Pain [sosy]	5
Urogenital Tract [bdsy]	5
dislike [menp]	5
refractory period [celf]	5
Diabetes Mellitus, Insulin-Dependent [dsyn]	5
Plate [medd]	5
Gear [qlco]	5
Cross-section [spco]	5
troponins [aapp, bacs]	5
austrian [popg]	5
Pulmonary resection [topp]	5
Arterial blood [tisu]	5
Re-exploration [diap]	5
bigger [qnco]	5
Cellulitis [dsyn]	5
KT [qlco]	5
Decreased Libido [sosy]	5
Bradyarrhythmia [dsyn]	5
Deep vein [bpoc]	5
Coronary Sinus [bpoc]	5
Cuba [geoa]	5
Hydroxyindoleacetic Acid [orch]	5
check ups [fndg]	5
Polycystic [qlco]	5
Repression [menp]	5
Factor VIII Activity [lbpr]	5
Ejection time [orga]	5
Therapeutic Uses [biof]	5
Subcutaneous Tissue [tisu]	5
inferiority [socb]	5
Immunosuppressive drugs [clna]	5
Module [cnce]	5
Cardio-Renal Syndrome [dsyn]	5
Perioperative death [fndg]	5
Community acquired pneumonia [dsyn]	5
anticholinergic drugs [phsu]	5
medication prescription [inpr]	5
ventriculography [diap]	5
coumestan [orch]	5
Cyclooxygenases [aapp, enzy]	5
Idiopathic Pulmonary Fibrosis [dsyn]	5
Catchment Area [geoa]	5
localize [spco]	5
Underweight [fndg]	5
Athletic [dora]	5
Factor VIIa [aapp, enzy, phsu]	5
Health Related Behaviors [inbe]	5
graft loss [patf]	5
Bone Marrow Transplantation [topp]	5
Cellular membrane [celc]	5
Prior Treatment [clna]	5
Immigrants [popg]	5
Dilate [ftcn]	5
Preoperative Therapy [topp]	5
Coma [dsyn]	5
Sotradecol [lipd, phsu]	5
Catalonian [popg]	5
Pruritus [sosy]	5
Arsenic [elii, hops]	5
Private Practice [bmod]	5
Form, Dosage [bodm]	5
AC [aapp, enzy]	5
initial assessment [fndg]	5
Hypocalcaemia [patf]	5
hormonal therapies [topp]	5
ibutilide [orch, phsu]	5
Heart valve replacement [topp]	5
Dipping [fndg]	5
cultural factors [idcn]	5
Cytoplasmic [celc]	5
Dysmenorrhea [patf]	5
War [acty]	5
Embryology [bmod]	5
personality [mobd]	5
ulcerations [patf]	5
Colorectal polyps [neop]	5
{Spray} [qnco]	5
Nil [qnco]	5
Neurotransmitters [nsba]	5
Adipokine [aapp, bacs]	5
Temporal relationship [tmco]	5
Cellular Process [celf]	5
Haemoglobinuria [dsyn]	5
Projection [inpr]	5
Transient myocardial ischaemia [dsyn]	5
Geriatrician [prog]	5
Olmesartan medoxomil [orch, phsu]	5
Valsalva Maneuver [diap]	5
Heparin-induced thrombocytopenia [dsyn]	5
Health Expenditures [qnco]	5
Inflammatory changes [ftcn]	5
cancer registries [inpr]	5
shaping [spco]	5
Postoperative stroke [dsyn]	5
Abscesses [dsyn]	5
Liver Transplant [topp]	5
RFLP [clna]	5
Enhancer [nnon]	5
BMIPP [irda, lipd]	5
Serum estradiol level [lbpr]	5
Nutritional Therapy [topp]	5
Acute myeloid leukaemia [neop]	5
Detoxification [orgf]	5
Moderate Activity [dora]	5
Aberrant Crypt Foci [fndg]	5
Infratentorial [spco]	5
Radial Artery [bpoc]	5
Vegetable Protein [aapp, bacs]	5
transporter [aapp, bacs]	5
transformations [celf]	5
Body Image [menp]	5
Ionized [qlco]	5
Thromboembolic Event [dsyn]	5
windows [mnob]	5
stimulant [phsu]	5
Unstimulated [qlco]	5
parathyroid hormone level [lbpr]	5
Diabetic Kidney Disease [dsyn]	5
Milrinone [orch, phsu]	5
Fractures, Bone [inpo]	5
Crystalline [chvs]	5
Fasting blood glucose level [lbpr]	5
upper endoscopy [diap]	5
Angiodysplasia [dsyn]	5
Dry [npop]	5
Volumes, Heart [orgf]	5
Older child [aggp]	5
Low density lipoprotein subfraction [aapp, bacs, lipd]	5
Complement Activation [moft]	5
Cardioversion, external [topp]	5
Executed [acty]	5
ambition [menp]	5
Therapies, Biological [topp]	5
Phase II Study [resa]	5
disease characteristic [patf]	5
Legumes [plnt]	5
MUL [gngm]	5
Phase III Trial [resa]	5
Physics [ocdi]	5
Hypovolaemia [fndg]	5
Postoperative bleeding [patf]	5
Methyltestosterone [horm, phsu, strd]	5
Mirror [mnob]	5
Cellular Aging [celf]	5
Painless [ftcn]	5
Neurotransmitter [nsba]	5
regional cancer [neop]	5
der [comd]	5
Ps [gngm]	5
Ectatic [ftcn]	5
Animal protein [aapp, bacs]	5
Blood Serum [bdsu]	5
Coagulant [phsu]	5
kaempferol [orch]	5
Vacuum [npop]	5
SDS [gngm]	5
Skull Base [blor]	5
disease mortality [qnco]	5
Infertile [dsyn]	5
Interferon Gamma [aapp, imft, phsu]	5
American College of Surgeons [pros]	5
kPa [qnco]	5
lengthen [ftcn]	5
Probing depth [qnco]	5
prisma [orch, phsu]	5
disease management programs [topp]	5
Venous Insufficiency [dsyn]	5
Genome-Wide Association Study [mbrt]	5
drug studies [resa]	5
Peroxisome Proliferator-Activated Receptors [aapp, rcpt]	5
Chin [blor]	5
affluent [qlco]	5
Pre-condition [cnce]	5
liver steatosis [dsyn]	5
Magnesium Sulfate [inch, phsu]	5
Pregnancy Outcome [fndg]	5
vitro [qlco]	5
segregation [socb]	5
Aortic valve area [orga]	5
mobilize [topp]	5
Non-functional [ftcn]	5
New York City [geoa]	5
Trustees [prog]	5
Anterolateral [spco]	5
Reservoir [geoa]	5
Models, Binomial [inpr, qnco]	5
Plasma Volume [clna]	5
Immunologic [bmod]	5
Invitation [inpr]	5
pseudoaneurysms [patf]	5
Sustained VT [dsyn]	5
angiomas [neop]	5
travel [dora]	5
School, Medical [hcro, mnob]	5
patient registry [inpr]	5
Anniversary [evnt]	5
Pneumococcal Infections [dsyn]	5
Hernia [anab]	5
Hill [spco]	5
Tracheostomy [topp]	5
Metabolic Marker [bacs]	5
Fructosamine [carb]	5
arterial diseases [dsyn]	5
Concrete [mnob]	5
Ischaemic reperfusion injury [inpo]	5
Behavioral Intervention [topp]	5
Unsaturated [qnco]	5
Manipulating [orgf]	5
infectious endocarditis [dsyn]	5
Cell adhesion molecule [aapp, bacs]	5
educational programs [edac]	5
Biguanides [orch, phsu]	5
VASE [aapp]	5
Adriamycin [orch, phsu]	5
Epicatechin [orch, phsu]	5
publish [ocac]	5
Oral Disease [dsyn]	5
Biologics [bacs, phsu]	5
Greece [geoa]	5
intra-aortic balloon pump [topp]	5
Fill In [acty]	5
Specimen [sbst]	5
Variant angina [dsyn]	5
Cat [mamm]	5
Mediation [socb]	5
Analysis of Variance [qnco]	5
Cancer Cell [cell]	5
Diagnosis, Psychiatric [mobd]	5
fatty streak [patf]	5
Redo [tmco]	5
Dropouts [popg]	5
Health Care Organization [hcro]	5
Polyunsaturated fat [food]	5
ruling [qlco]	5
Mevalonate [bacs, orch]	5
charisma [bodm]	5
Cardiac Rupture [dsyn]	5
Protein Binding [moft]	5
vildagliptin [orch, phsu]	5
Backbone [bpoc]	5
millimeter [qnco]	5
DNA Binding [genf]	5
Aortic Aneurysm [dsyn]	5
Spasm [sosy]	5
Dysarthria [mobd]	5
Angiology [bmod]	5
Apolipoprotein E phenotype [lbtr]	5
lymphoblastic leukemia [neop]	5
Alternating [ftcn]	5
specialize [qlco]	5
research agenda [resa]	5
Cholesterol deposition [patf]	5
Traverse [cnce]	5
Circumflex coronary artery [bpoc]	5
Sterna [bpoc]	5
Anorexia [dsyn]	5
Bibliography [inpr, mnob]	5
convention [hcpp]	5
Coagulation Factor VII [aapp, bacs, phsu]	5
Stripping [topp]	5
Muscle Cells [cell]	5
Father [famg]	5
Emotional Well-being [clna]	5
Pulmonary Disease, Obstructive [dsyn]	5
Haemodynamic monitoring [diap, topp]	5
Otolaryngology [bmod]	5
drug free [qnco]	5
Quantitative Evaluation [qnco]	5
Intermediate density lipoprotein [aapp, bacs, lipd]	5
outcome prediction [hlca]	5
Placenta [emst]	5
Human gene [gngm]	5
Fats, Unsaturated [lipd]	5
cervical lesions [patf]	5
interrupt [qlco]	5
Research Base [orgt]	5
Pleural fluid [bdsu]	5
Mexican Americans [popg]	5
Insurance Status [idcn]	5
Free triiodothyronine [aapp, horm]	5
unknown etiology [fndg]	5
kJ [qnco]	5
Laboratory Research [resa]	5
Late period [fndg]	5
intercellular adhesion molecule [aapp, bacs]	5
Transesophageal [spco]	5
Diseases, Coronary [dsyn]	5
Grape [food]	5
skin damage [sosy]	5
Pain symptoms [sosy]	5
Producer [humn]	5
Sterol [strd]	5
True positive [qlco]	5
Magnitudes [qnco]	5
Life Table [inpr, qnco]	5
Iron stores [lbpr]	5
Somatostatin analog [aapp, horm, phsu]	5
Therapies, Combination Drug [topp]	5
Memory loss [mobd]	5
audience [popg]	5
high diastolic blood pressure [fndg]	5
Fat diet [topp]	5
Cerebral Hemorrhage [patf]	5
Urinary concentration [ortf]	5
ejection [phpr]	5
Homologous [gngm]	5
Aortic Aneurysms [dsyn]	5
Exit [spco]	5
PER [gngm]	5
Due to [ftcn]	5
Atrio-Ventricular Node [bpoc]	5
Increased lipoprotein [fndg]	5
Glomerulonephritis [dsyn]	5
Bruce protocol [topp]	5
simulating [bodm]	5
Risk Factor Assessment [inpr]	5
repeats [ftcn]	5
Pulmonary artery stenosis [anab]	5
Esophagectomy [topp]	5
donor organs [bpoc]	5
Transverse [spco]	5
Estrogen Receptor Antagonists [moft]	5
Free protein S [aapp, bacs]	5
Proptosis [dsyn]	5
Null Mouse [mamm]	5
Mini-mental state examination [diap]	5
human female [popg]	5
Work environment [spco]	5
Viagra [orch, phsu]	5
Portugal [geoa]	5
infliximab [aapp, imft, phsu]	5
Aura [fndg]	5
Drinking Water [sbst]	5
Unadjusted Mortality Rate [qnco]	5
Oropharyngeal [blor]	5
Culture medium [irda]	5
nitric oxide signaling [moft]	5
Dose Rate [qnco]	5
miRNA [bacs, nnon]	5
TX [idcn]	5
patient assessment [hlca]	5
Hypokinesia [sosy]	5
eating pattern [inbe]	5
Sirtuins [aapp, enzy]	5
Dry weight [orga]	5
health history [fndg]	5
Violence [mobd, socb]	5
Pulses [hlca]	5
Microscopy, Confocal [lbpr]	5
globe [bpoc]	5
Follicle [bpoc]	5
Myocardial degeneration [patf]	5
Capacity Building [hlca]	5
Localized Lesion [fndg]	5
Enjoyed [menp]	5
Vein thrombosis [patf]	5
organize [ftcn]	5
wait list [inpr]	5
Parkinsonia [plnt]	5
cangrelor [nnon, phsu]	5
Velocity Ratio [qnco]	5
System, Integrated Delivery [hcro]	5
pmol [qnco]	5
granulocyte [cell]	5
energies [npop]	5
RNA, Small Interfering [bacs, nnon]	5
Vena Cava, Inferior [bpoc]	5
Scaling [fndg]	5
Fee for Service [qnco]	5
AIN [neop]	5
Adult onset [fndg]	5
Coronary sclerosis [dsyn]	5
Reclassified [qlco]	5
Gel Electrophoresis [lbpr]	5
Empiric [qlco]	5
Multiple Myeloma [neop]	5
BIS [tmco]	5
Foam Cells [cell]	5
Pneumothorax [dsyn]	5
Cardiac disorder [dsyn]	5
Hair [bpoc]	5
Dutch Population [popg]	5
Sick Leave [idcn]	5
PR Interval [fndg]	5
Disseminate [spco]	5
Liposome [lipd]	5
Systematic Bias [idcn]	5
ale [food]	5
Nicotine Addiction [mobd]	5
Iron Chelator [phsu]	5
repairs [orgf]	5
Echocardiography, Contrast [diap]	5
Li+ [elii]	5
resting metabolic rate [orgf]	5
pro b [neop]	5
Very-Low-Density Lipoproteins [aapp, bacs, lipd]	5
Population Intervention [hlca]	5
Patient Care Team [hlca]	5
Vena Cava, Superior [bpoc]	5
hydroxyl group [inch]	5
Connective Tissue Disorders [dsyn]	5
New type [idcn]	5
Hemi [inpr]	5
Endoglin [aapp, imft]	5
Languages [lang]	5
dalcetrapib [orch, phsu]	5
Apolipoproteins B [aapp, bacs]	5
QD [tmco]	5
lvh [dsyn]	5
Sensor [medd]	5
Ranges, Normal [qnco]	5
Synonym [cnce]	5
Telephone Interview [resa]	5
topography [clas]	5
kg/min [cnce]	5
Telangiectasias [dsyn]	5
Dissatisfaction [menp]	5
angina attack [dsyn]	5
Olive [bpoc]	5
Chromium [elii, hops]	5
Lipid risk factors [qlco]	5
self-treatment [inbe]	5
Aseptic [qlco]	5
cholesterol lipoprotein [aapp, bacs, lipd]	5
Life Expectancies [grpa]	5
False Negative [lbtr]	5
generalist [prog]	5
Anti-Inflammatory Agents, Non-Steroidal [phsu]	5
TELE [gngm]	5
Genetic Condition [dsyn]	5
Hospital, City [hcro]	5
kinin [aapp, bacs]	5
Tricuspid Atresia [cgab]	5
practice research [resa]	5
ANTIMICROBIALS [phsu]	5
kexin [aapp, enzy]	5
Tagged [irda]	5
Lengthening [topp]	5
Level of Evidence [fndg]	5
Venous flow [lbtr]	5
Geographic Location [geoa]	5
Ascorbic Acid [orch, phsu, vita]	5
Malabsorption [dsyn]	5
Hydrogen Peroxide [inch, irda, phsu]	5
Osteoarthritis, Knee [dsyn]	5
geriatricians [prog]	5
Alar [hops, orch]	5
EU [orgt]	5
His [aapp, bacs, phsu]	5
Ethanolamine [orch]	5
atrial tachycardias [patf]	5
Fixation [topp]	5
HTX [gngm]	5
Ventricular Repolarization [ortf]	5
too early [idcn]	5
General terms [fndg]	5
metal chelation [moft]	5
Serological [ftcn]	5
special needs [ftcn]	5
Pilot Studies [resa]	5
Immunoassays [lbpr]	5
beagles [mamm]	5
Large Mass [fndg]	5
Intraoral [spco]	6
Electroencephalography [diap]	6
Not Responsive [fndg]	6
vardenafil [orch, phsu]	6
Radionuclide [elii]	6
Propeptide [aapp]	6
MS/MS [mbrt]	6
Cross-Reference [inpr]	6
Ablation Techniques [topp]	6
Proximal Left Anterior Descending Artery [bpoc]	6
molecular markers [clna]	6
Recovering [qlco]	6
Vasopressin [aapp, horm, phsu]	6
Left main coronary artery disease [dsyn]	6
Cardiac tomography [diap]	6
NYHA Class III [fndg]	6
Pd [elii]	6
SNPs [nusq]	6
Jugular vein [bpoc]	6
receptor expression [genf]	6
Disposal [acty]	6
Hypomagnesaemia [fndg]	6
Residual Disease [neop]	6
Normal body mass index [orga]	6
Monophasic [tmco]	6
Internal Mammary Artery [bpoc]	6
mediated response [menp]	6
Chromosome [celc]	6
Neurologic Disorders [dsyn]	6
Glasgow coma scale [inpr]	6
Androgen Effect [phsf]	6
forecast [inpr]	6
Denervation [topp]	6
Isis [euka]	6
Factor IX [aapp, bacs, phsu]	6
Antimineralocorticoid [bacs]	6
Elastic Modulus [qnco]	6
Comparison.study [clna]	6
Venous Angioma [neop]	6
Cognitive ability [menp]	6
Latex [bodm, orch]	6
Functional independence measure [inpr]	6
Tertiary Referral Center [hcro, mnob]	6
Albumin excretion rate [lbpr]	6
cancer recurrence [neop]	6
Continent [qlco]	6
Arizona [geoa]	6
retinoic acid receptor beta [aapp, rcpt]	6
Behavior Modification [topp]	6
Bicuspid aortic valve [cgab]	6
Fosinopril [opco, phsu]	6
Protease Inhibitors [bacs, phsu]	6
coil embolization [medd]	6
Plasma homocysteine level [lbpr]	6
Constrain [cnce]	6
disrupt [qlco]	6
Electrolyte [inch, phsu]	6
DNA Repair [genf]	6
Telemetry [diap]	6
Connective Tissue Diseases [dsyn]	6
Schools [mnob, orgt]	6
Triphasic [tmco]	6
Mechanics [npop]	6
Hypercalcaemia [dsyn]	6
Reporter [prog]	6
nitrotyrosine [aapp]	6
Lymphovascular Invasion [fndg]	6
purchasing [acty]	6
Drug Design [ocdi]	6
mIU/L [qnco]	6
Anesthetics [bmod]	6
Exposed Group [popg]	6
quitting [idcn]	6
gene delivery [genf]	6
Plasticity [npop]	6
Contrast Agents [irda]	6
dietary salt [food, inch]	6
Initiator [qlco]	6
micronized fenofibrate [orch, phsu]	6
Sternotomy [topp]	6
Antithrombin Activity [lbpr]	6
Subarachnoid [ftcn]	6
chocolate [plnt]	6
Experimental Finding [fndg]	6
Community Health Workers [prog]	6
Interferon [aapp, imft, phsu]	6
Transferring [acty]	6
kDa [qnco]	6
Geriatric Assessment [hlca]	6
hyperthyroid [dsyn]	6
Vague [qlco]	6
Pharynx [bpoc]	6
Sirolimus [antb, orch]	6
Hypertensive emergency [dsyn]	6
high-dose chemotherapy [topp]	6
Coronary spasm [dsyn]	6
Haemoptysis [sosy]	6
Middle East [geoa]	6
Hydration [fndg]	6
neurologists [prog]	6
Hb [aapp, bacs]	6
Minus [qlco]	6
Presenting complaint [fndg]	6
encoded [menp]	6
General status [fndg]	6
Spontaneous Regression [fndg]	6
Mononuclear cells [cell]	6
Bipolar Disorder [mobd]	6
Norethindrone [horm, phsu, strd]	6
Anaesthesiologist [prog]	6
Sternum [bpoc]	6
Greek [popg]	6
Tomato [food]	6
Home Care [hlca]	6
aboriginal [popg]	6
AR+ [fndg]	6
San Francisco [geoa]	6
Radiation Effect [biof]	6
blood clot [patf]	6
Necrotic [ortf]	6
diagnostic study [diap]	6
Geriatric medicine [bmod]	6
Training Program [edac]	6
Meningioma [neop]	6
PAVe [topp]	6
Biventricular Pacing [topp]	6
Embolisation procedure [topp]	6
genetic analysis [lbpr]	6
azimilide [orch, phsu]	6
Paraesthesia [sosy]	6
Fingers [blor]	6
Parenteral Nutrition [topp]	6
Metabolic Equivalents [diap]	6
Multi-organ failure [patf]	6
Curriculum [inpr]	6
Hyponatraemia [fndg]	6
Trazodone [orch, phsu]	6
Eye Diseases [dsyn]	6
g m [qnco]	6
Outdated [inpr]	6
Complex carbohydrate [carb]	6
target drug [medd]	6
Radiation Protection [phpr]	6
Taste [ortf]	6
irbesartan [orch, phsu]	6
Antiandrogens [phsu]	6
Clearing [idcn]	6
NMOLE [qnco]	6
Prior Hormone Therapy [clna]	6
outreach [shro]	6
Complementary Medicine [bmod]	6
Experimental Result [fndg]	6
HIV related [idcn]	6
Risperidone [orch, phsu]	6
comorbid condition [fndg]	6
Angiotensin Receptor Antagonists [phsu]	6
active ingredients [qlco]	6
PTS [gngm]	6
Platelet rich plasma [bdsu]	6
Collaborator [pros]	6
Complete Blood Count [lbpr]	6
Clofibrate [orch, phsu]	6
Bone remodeling [ortf]	6
Registered nurse [prog]	6
Adipose Tissue, Subcutaneous [tisu]	6
Feet [bpoc]	6
Sick Sinus Syndrome [dsyn]	6
Male predominance [fndg]	6
Bed rest [topp]	6
Mutated [comd]	6
Port-Wine Stain [cgab]	6
Electrical Stimulation [topp]	6
skill [inbe]	6
Behavioral therapy [topp]	6
nutritional supplements [food]	6
Bright [fndg]	6
XX [orga]	6
Aortic wall [bpoc]	6
Urinary Bladder [bpoc]	6
Hydrocephalus [dsyn]	6
bisphosphonate [opco, phsu]	6
Competence [qlco]	6
Treatment satisfaction [fndg]	6
Preparedness [fndg]	6
functional ability [dora]	6
Arteriola [bpoc]	6
Euros [qnco]	6
Balanced diet [topp]	6
Laboratory test [lbpr]	6
Capillary malformation [cgab]	6
Complication, Postoperative [patf]	6
Enoxaparin [carb, phsu]	6
TRAIL [gngm]	6
Momentum [npop]	6
Non-Target [qlco]	6
Doxazosin [orch, phsu]	6
Ordered [qlco]	6
Cytotoxic Agents [bacs, hops]	6
Contra-indicated [fndg]	6
days month [tmco]	6
milliliter [qnco]	6
Stroma [bpoc]	6
SSRI [phsu]	6
Dial [mnob]	6
Rigidity [sosy]	6
Handle [cnce]	6
Nova Scotia [geoa]	6
Bleeding episodes [fndg]	6
Endocrine system [bdsy]	6
Triglyceride Metabolism [moft]	6
ileum [bpoc]	6
Rapid progression [fndg]	6
Nodular [qlco]	6
Cutting, NOS [topp]	6
Gonadal Hormones [horm]	6
Wound Infection [patf]	6
Cholesterol, Dietary [strd]	6
Mitral valve disease [dsyn]	6
ATIII [aapp, phsu]	6
Drug abuse [mobd]	6
Transcend [bodm]	6
Magazines [inpr, mnob]	6
Dairy Products [food]	6
Swimming [dora]	6
sexual problem [dsyn]	6
Polytetrafluoroethylene [bodm, orch]	6
oxidative metabolism [celf]	6
Vascular impedance [orgf]	6
thiol [orch]	6
Translocation [comd]	6
appointment [idcn]	6
Health Sciences [bmod]	6
Radiologic finding [fndg]	6
Social Insurance [gora]	6
Blood Clots [acab]	6
Stains, Port-Wine [cgab]	6
BMD [clna]	6
Allowance [qnco]	6
major artery [bpoc]	6
fragments [ftcn]	6
Low hemoglobin [fndg]	6
Helical Tomotherapy [topp]	6
empower [menp]	6
Stable isotope [elii]	6
Second Line Therapy [topp]	6
Valves, Aortic [bpoc]	6
Receptors, Progesterone [aapp, rcpt]	6
Passage [spco]	6
Clinical Testing [resa]	6
Remuneration [qnco]	6
Clinical stage I [qlco]	6
Decreased HDL cholesterol [fndg]	6
MILD DYSFUNCTION [fndg]	6
Procainamide [orch, phsu]	6
growth hormone treatment [dsyn]	6
EuroSCORE [inpr]	6
drug dosage [qnco]	6
Circulatory system [bdsy]	6
Retirement [fndg]	6
Kingdom [clas]	6
Pharmacologic Actions [npop]	6
abdominal aortic aneurysm repair [topp]	6
Congenital Defects [cgab]	6
Hospital Administration [hlca]	6
collateral vessels [bpoc]	6
Lipidaemia [dsyn]	6
Education programmes [edac]	6
Tau [inpr]	6
Hydrogel [orch, phsu]	6
Non-Parametric Test [inpr]	6
Recurrent episode [tmco]	6
Salivary [spco]	6
Autophagy [celf]	6
Oliguria [sosy]	6
health states [fndg]	6
Left ventricular end diastolic volume [lbtr]	6
EL [gngm]	6
Estrogen Metabolism [moft]	6
radiotherapy breast [topp]	6
Health Literacy [edac]	6
Increased size [fndg]	6
Alopecia [fndg]	6
CP [fndg]	6
FDG [irda, orch]	6
preventive health care [topp]	6
Steno [mamm]	6
Leg pain [sosy]	6
Muscle, Heart [tisu]	6
Sensory [qlco]	6
SETTLE [neop]	6
Tumors, Germ Cell [neop]	6
endocrinologic [ftcn]	6
Plasma protein [aapp, bacs]	6
glutamate [aapp]	6
System, Data [inpr, mnob]	6
mindfulness [menp]	6
low cholesterol levels [fndg]	6
Massive bleeding [patf]	6
Oxygen supply [clna]	6
Both [spco]	6
Flag [ftcn]	6
Strain gauge plethysmography [diap]	6
Alarm [medd]	6
Multi-Specialty [inpr]	6
Focused attention [menp]	6
Drug Delivery System [medd]	6
blood cultures [lbpr]	6
Biological Markers [clna]	6
air force [orgt]	6
Creatine Phosphokinase [aapp, enzy]	6
Starch [bacs, carb, phsu]	6
pulmonary involvement [dsyn]	6
Testis [bpoc]	6
Parenteral Nutrition, Total [topp]	6
Adaptability [menp]	6
Low weight [fndg]	6
Stomach Cancer [neop]	6
low albumin [fndg]	6
PO [spco]	6
South Asians [popg]	6
Very Poor [inpr]	6
drug concentration [qnco]	6
Saturated fat intake [fndg]	6
Mind-Body Therapies [topp]	6
Hypolipidemic Agents [phsu]	6
pathogenicity [qlco]	6
Looks [orga]	6
ONYX [orch, phsu]	6
Video [mnob]	6
Gavage [topp]	6
normal lipid [fndg]	6
Diet Modification [topp]	6
Dental Procedures [hlca]	6
Body Temperature [orga]	6
Aortic Stenosis, Calcific [acab]	6
Ester [orch]	6
Mineralocorticoid Receptor [aapp, rcpt]	6
Constriction [topp]	6
Adverse reaction [fndg]	6
Thalassaemia intermedia [dsyn]	6
{NOS} [qlco]	6
Junctional [spco]	6
Season [tmco]	6
Behavioral Treatment [topp]	6
ET-A [aapp, rcpt]	6
Laparoscopic Surgery [topp]	6
hypolipemia [patf]	6
Symptom severity [fndg]	6
retarding [qlco]	6
Pathologic findings [fndg]	6
Immunocytochemistry [lbpr]	6
Notes [inpr]	6
Anti-Antibodies [aapp, imft]	6
Pericardial effusions [dsyn]	6
anastrozole [orch, phsu]	6
Past Medical History [fndg]	6
Plug [mnob]	6
Stone [bdsu]	6
fistulous [ftcn]	6
Chromogranin A [aapp, horm, irda]	6
Anti-diabetic Agent [phsu]	6
national institute health [hcro]	6
varenicline [orch, phsu]	6
Favorable Clinical Outcome [fndg]	6
Annotated [idcn]	6
Bulky Disease [fndg]	6
Circle [spco]	6
FFM [dsyn]	6
Poisoning [inpo]	6
Taught [qlco]	6
Respiratory Distress Syndrome, Acute [dsyn]	6
Ventricular Ablation [topp]	6
Reasoning [menp]	6
Unmarried [popg]	6
age difference [aggp]	6
Spinal Cord Stimulation [topp]	6
blood pressure monitoring [medd]	6
Polymers [bodm, chvs]	6
Sensitivities [fndg]	6
Intradural [ftcn]	6
Administrators [prog]	6
Pre-Procedure [tmco]	6
Adventitia [tisu]	6
Running [dora]	6
T wave [fndg]	6
courage [menp]	6
Psychological Well Being [fndg]	6
Vitality [fndg]	6
Spot [fish]	6
Phosphate Binder [phsu]	6
First Birth [tmco]	6
triple vessel disease [dsyn]	6
Common Tumor [neop]	6
Mace [food]	6
d dimers [aapp, bacs]	6
Fibrinolytic Agents [phsu]	6
Microscope [medd]	6
Watt [qnco]	6
Photodynamic Therapy [topp]	6
pediatric cancer [neop]	6
Rio [inpr]	6
Homozygote [orga]	6
carotid disease [dsyn]	6
glutaryl-coenzyme A [lipd, nnon]	6
Lipid accumulation [fndg]	6
Provocation [phpr]	6
Community acquired [qlco]	6
Lymphatics [bdsy]	6
Carcinoid [neop]	6
Upper Limb [bpoc]	6
Peer Review [hlca]	6
Veterans Administration [orgt]	6
Treatment Side Effects [patf]	6
isolates [sbst]	6
clinical reports [inpr]	6
Mexican American [popg]	6
anglo [popg]	6
chylomicron [aapp, bacs, lipd]	6
Granulocyte Colony-Stimulating Factor [aapp, imft]	6
Peripheral Neuropathy [dsyn]	6
Valvular Heart Diseases [dsyn]	6
Page [inpr]	6
Birth Defect [cgab]	6
Pericardial disease NOS [dsyn]	6
nateglinide [aapp, phsu]	6
hypofractionation [topp]	6
Protease Inhibitor [bacs, phsu]	6
Chelators [irda, phsu]	6
Cigarette smoke [hops]	6
natriuretic [phsu]	6
Health Care Quality [qlco]	6
LEFT MAIN CORONARY ARTERY [bpoc]	6
Left ventricular outflow tract [bpoc]	6
Peripheral blood cell [cell]	6
Happen [acty]	6
TAPE [medd]	6
Tilt [qlco]	6
Persistent pulmonary hypertension [dsyn]	6
Tobacco Cessation [inbe]	6
Prohormone [horm]	6
outcomes study [resa]	6
Serum Calcium Level [lbtr]	6
Consultants [prog]	6
Ion Channel [aapp, bacs]	6
social functioning [socb]	6
animal data [inpr]	6
low heart rate [patf]	6
Thyroid Function Tests [lbpr]	6
Residual Tumor [neop]	6
Transcriptional Regulation [genf]	6
skilled [inbe]	6
anabolic [phsu, strd]	6
Blood Transfusions [topp]	6
yoga [idcn]	6
tonic [phsu]	6
Operative Time [tmco]	6
Decay [acab]	6
smooth muscle cell migration [celf]	6
disrupting [qlco]	6
neck surgery [topp]	6
Tissue Distribution [qnco]	6
Percutaneous Coronary Revascularization [topp]	6
Aggression [mobd]	6
Turmeric [food]	6
Acids [chem]	6
Thoracoscopy [diap, topp]	6
Submission [ftcn]	6
advertisement [inpr]	6
Medicalization [socb]	6
Foreign [idcn]	6
Cholesterol screening [lbpr]	6
late stages [tmco]	6
personal health [fndg]	6
isoflavone soy [aapp, phsu]	6
Actin [aapp, bacs]	6
Door to needle time [fndg]	6
SsuE [moft]	6
Extensive Disease [dsyn]	6
Micelles [lipd]	6
low socioeconomic status [qnco]	6
Increased density [fndg]	6
Case Management [hlca]	6
Population Register [inpr, qnco]	6
VD [dsyn]	6
vigilant [menp]	6
Fermentation [moft]	6
coordinate [fndg]	6
Thr [aapp, bacs, phsu]	6
PATHOLOGICAL EXAMINATION [ftcn]	6
flushes [sosy]	6
Bare Metal Stent [medd]	6
Excessively [qlco]	6
Gonadal Dysgenesis [cgab, dsyn]	6
ng/L [qnco]	6
Chitosan [carb, phsu]	6
anacetrapib [orch, phsu]	6
High density lipoprotein subfraction [aapp, bacs, lipd]	6
Veteran [popg]	6
Large vessels [bpoc]	6
Aggressiveness [mobd]	6
pause [tmco]	6
Iron deficiency anaemia [dsyn]	6
Bypass graft [topp]	6
Albino [cgab]	6
Adsorption [lbpr]	6
Inversion [comd]	6
aggregating [qlco]	6
suspended [idcn]	6
Intracranial Aneurysms [dsyn]	6
Dextran [carb, phsu]	6
Enhanced Activity [qnco]	6
Inspired [orgf]	6
Cardiac activity [fndg]	6
Survey, Nutrition [resa]	6
anterior infarction [dsyn]	6
neuroendocrine tumours [neop]	6
Age-Months [orga]	6
blood components [topp]	6
Cereals [food]	6
sclerose [patf]	6
Functional analysis [hlca]	6
Exercise, Isometric [topp]	6
ventricular ectopy [patf]	6
babies [aggp]	6
Pulse Rate [clna]	6
Prescription Drugs [phsu]	6
electronic monitoring [medd]	6
Vascular abnormalities [fndg]	6
methylenetetrahydrofolate reductase gene [gngm]	6
Dietician [prog]	6
aortic calcification [dsyn]	6
Compression Garment [mnob]	6
Paclitaxel [orch, phsu]	6
Class III antiarrhythmic drug [phsu]	6
Blood Physiology [ortf]	6
synthase [aapp, enzy]	6
Blood chemistry [lbpr]	6
Compression Stockings [medd]	6
Dosage Forms [bodm]	6
Metabolomic [bmod]	6
Pneumonectomy [topp]	6
Pharmacy records [inpr]	6
Attribution [menp]	6
Aromatase [aapp, enzy]	6
Burns [inpo]	6
Public Sector [popg]	6
dependent patients [ftcn]	6
anti inflammatory drug [phsu]	6
Canine [mamm]	6
Reprint [inpr]	6
Reactants, Acute-Phase [aapp, bacs]	6
Drug Carriers [bodm]	6
LMWH [carb, phsu]	6
aldosterone levels [lbtr]	6
Behavioral change [inbe]	6
Miles [qnco]	6
Peptic ulcer disease [dsyn]	6
study trial [resa]	6
Self-Assessment [menp]	6
Microbiology [bmod]	6
Fish intake [fndg]	6
intracranial lesions [fndg]	6
High testosterone [fndg]	6
antigen levels [lbpr]	6
Os [blor]	6
Receptor Activation [celf]	6
Botanical [orch, phsu]	6
Fig [food]	6
Inferred [menp]	6
quality data [qlco]	6
Institutional Review Board Approval [rnlw]	6
Rheumatism [dsyn]	6
Complete heart block [dsyn]	6
Hypoglycemic Agents [phsu]	6
Raynaud Phenomenon [dsyn]	6
Secondary diagnosis [qlco]	6
Thalamus [bpoc]	6
RTOG [hcro]	6
MOPP [topp]	6
categorizing [acty]	6
credibility [qlco]	6
Georgia [geoa]	6
MULTIVITAMINS [orch, phsu, vita]	6
anti antibody [aapp, imft]	6
Cerebellum [bpoc]	6
chinese medicine [bmod]	6
Health checkup [fndg]	6
sexual functioning [orgf]	6
yeast [fngs]	6
Glycolysis [moft]	6
rigid [sosy]	6
Immunotherapy [topp]	6
phenyl [chvs]	6
knock out [inpo]	6
Revisions [tmco]	6
Flaxseed [plnt]	6
Anatomic Location [blor]	6
exposing [clna]	6
Blood Sugar [carb]	6
Analysis, Factor [qnco]	6
Sexually [bhvr]	6
Cell Cycle Arrest [celf]	6
disease still [dsyn]	6
tissue type [lbpr]	6
reproductive hormones [horm]	6
Image analysis [lbpr]	6
Titre [qnco]	6
Palliative Surgery [topp]	6
Hypertension education [hlca]	6
Idiopathic ventricular fibrillation [dsyn]	6
time delay [tmco]	6
Follicular [qlco]	6
Tie [mnob]	6
Xanthomas [dsyn]	6
Fostered [famg]	6
Whole blood viscosity [lbpr]	6
Antiviral [phsu]	6
Aerobic capacity [clna]	6
Lobectomy [topp]	6
Staphylococcus [bact]	6
Pigs [mamm]	6
Processed food [food]	6
Domestic [cnce]	6
Internal Consistency [qnco]	6
Urinary tract [bpoc]	6
serology [lbpr]	6
Glyceryl Trinitrate [orch, phsu]	6
Subspecies [cnce]	6
Normal cholesterol [fndg]	6
Cardia [blor]	6
Cancer Screening [diap]	6
Next Generation Sequencing [mbrt]	6
Use-Effectiveness [idcn]	6
Prophylactic Oophorectomy [topp]	6
Polypectomy [topp]	6
interrogation [gora]	6
Abnormal blood pressure [fndg]	6
chemical composition [npop]	6
Platelet Counts [lbpr]	6
Frail Elderly [aggp]	6
Cardinal [bird]	6
Human body [humn]	6
Metabolic acidosis [patf]	6
cardiac surgeons [prog]	6
Urea Nitrogen, Blood [lbpr]	6
Post-Mortem Examination [diap]	6
Inheritance [qnco]	6
macroangiopathy [dsyn]	6
Systemic blood pressure [fndg]	6
Mass Spectrometry [lbpr]	6
Stage IIA [clas]	6
Systolic arterial pressure [clna]	6
Row [idcn]	6
Gas Chromatography-Mass Spectrometry [lbpr]	6
dP/dt [clna]	6
Level I [inpr]	6
Arteriopathy [dsyn]	6
New medications [phsu]	6
evaluation study [inpr]	6
disease stage [diap]	6
Increased pressure [ftcn]	6
Itching [sosy]	6
HEART-VALVE, MECHANICAL [medd]	6
E-Mail [inpr]	6
Carcinogens [hops]	6
Brain Injury [inpo]	6
New episode [tmco]	6
Radiation Pneumonitis [inpo]	6
Histological finding [fndg]	6
Estrogen Receptor Modulators [phsu]	6
increasing insulin [dsyn]	6
Hospital Readmissions [hlca]	6
Industrial [ocac]	6
Medulloblastoma [neop]	6
Atrium [bpoc]	6
Conduction disorders [dsyn]	6
Inefficient [ftcn]	6
immunoreactivity [moft]	6
MAZE [topp]	6
bout [tmco]	6
Rash [dsyn]	6
Dublin [geoa]	6
Biliary [ftcn]	6
Genetic Disorders [dsyn]	6
Snoring [sosy]	6
Fluoxetine [orch, phsu]	6
deferasirox [orch, phsu]	6
g/kg body weight [qnco]	6
population risk [popg]	6
Hydralazine [orch, phsu]	6
factor VII coagulant activity [aapp, imft]	6
Anxiety depression [mobd]	6
epidural [bsoj]	6
Renal Artery Stenosis [dsyn]	6
Flow Rate [qnco]	6
Relax [acty]	6
breakthroughs [qlco]	6
Intravenous heparin [carb, phsu]	6
consulting [hlca]	6
Retrieval [hlca]	6
Treatment Factor [inpr]	6
Hungary [geoa]	6
native valve endocarditis [dsyn]	6
benign breast disease [dsyn]	6
femoro-popliteal [bpoc]	6
Clinical target volume [qnco]	6
Salpingo-oophorectomy [topp]	6
Model, Cardiovascular [inpr]	6
Hypertension, moderate [fndg]	6
Visual loss [dsyn]	6
collapse [patf]	6
Neurologic deficit [fndg]	6
Combined radiotherapy [topp]	6
Adjudication [gora]	6
Co-payment [qnco]	6
Sodium retention [dsyn]	6
Signaling Molecule [bacs]	6
Principal Component Analysis [qnco]	6
Drug interaction [moft]	6
Pathogenicity Factors [bacs, hops, orch]	6
Fibroblast [cell]	6
Hibernating myocardium [patf]	6
Renal injury [inpo]	6
Five-year Survival Rate [qnco]	6
VE [geoa]	6
Toxicological [ftcn]	6
STENT, CORONARY [medd]	6
Hydroxymethylglutaryl coenzyme A reductase [aapp, enzy]	6
Peripheral artery [bpoc]	6
Phrases [inpr]	6
Carnitine [aapp, phsu]	6
Koreans [popg]	6
Ambulatory ECG [diap]	6
Pathological Processes [patf]	6
Systems, Cardiovascular [bdsy]	6
dollar [qnco]	6
Haem [bacs, orch]	6
Arterial vessel [bpoc]	6
individual therapy [topp]	6
Weaning [orgf]	6
Left atrial appendage [bpoc]	6
Fibrin Glue [aapp, bodm, phsu]	6
Psyllium [bacs, orch, phsu]	6
Cognitive Behavioral Therapy [topp]	6
PGE [bacs, eico]	6
automatic defibrillator [medd]	6
Long-Term Care Facility [hcro]	6
T-Lymphocytes [cell]	6
Estradiol / Progesterone [phsu]	6
Computational [resa]	6
Android [mnob]	6
Lytic [patf]	6
descent [famg]	6
Electrons [qnco]	6
HMG-CoA [bacs, orch]	6
Euthyroidism [fndg]	6
Peripheral vascular resistance [phsf]	6
Budgets [inpr]	6
Dialysis Therapy [topp]	6
Platelet adhesion [celf]	6
paraoxonase activity [moft]	6
plasma creatinine [lbpr]	6
Physical findings [fndg]	6
Neonate [aggp]	6
medians [spco]	6
Anticoagulant Agents [phsu]	6
Study year [tmco]	6
Dementia, Vascular [dsyn]	6
Dilution [lbpr]	6
fibrosis, radiation-induced [inpo]	6
study trials [resa]	6
Intoxication [fndg]	6
Nitric Oxide, Endothelium-Derived [bacs, inch, phsu]	6
Dialysis Center [hcro]	6
Coat [mnob]	6
IMN [geoa]	6
Drug dose [qnco]	6
Entrance [spco]	6
Resistivity index [clna]	6
Somatostatin [aapp, horm, phsu]	6
Associated with [qlco]	6
anatomical structures [anst]	6
Anterior myocardium [bpoc]	6
Follicular Phase [tmco]	6
Widening [spco]	6
young adulthood [aggp]	6
remnant-like particle cholesterol [aapp, lipd]	6
Hepatitis C virus [virs]	6
markets [geoa]	6
Autopsies [diap]	6
Cell Culture [lbpr]	6
hearing loss [dsyn]	6
Ultrasound guidance [diap]	6
Organ system [bdsy]	6
Aminotransferase [aapp, enzy]	6
acute stress [sosy]	6
prophylactic use [inbe]	6
Metabolomics [bmod]	6
Renal Excretion [ortf]	6
SLE NOS [dsyn]	6
Muscle, Cardiac [tisu]	6
INR [lbpr]	6
Charges [qnco]	6
fight [socb]	6
Asthenia [sosy]	6
Oral hypoglycaemic [phsu]	6
Brain Abscess [dsyn]	6
chemotherapy regimens [topp]	6
Dexfenfluramine [orch, phsu]	6
elevated blood glucose [fndg]	6
Drug eluting stent [medd]	6
DEGRADED [phpr]	6
Calcium intake [clna]	6
Copolymer [chvs]	6
Lens [bpoc]	6
Extracorporeal Circulation [topp]	6
Information Systems [inpr]	6
Attachment [topp]	6
Respiratory rate [clna]	6
thienopyridine [orch, phsu]	6
public education [edac]	6
Saphenous vein graft [bpoc]	6
Akinetic [ftcn]	6
Occupational Exposure [inpo]	6
Anesthetic Agents [phsu]	6
criticisms [socb]	6
SESTAMIBI [orch, phsu]	6
Reperfusion Damage [inpo]	6
Colitis [dsyn]	6
Prophylactic drug therapy [topp]	6
Prophylactic treatment [topp]	6
Fetal echocardiography [diap]	6
Kava [plnt]	6
Actors [prog]	6
low body mass index [fndg]	6
Antipsychotic Drugs [phsu]	6
Estrogen+progestogen preparation [horm, phsu, strd]	6
Gentle [orch, phsu]	6
Second Line Treatment [topp]	6
Psychiatry [prog]	6
Anastomotic Leakage [patf]	6
Wisconsin [geoa]	6
Sinus Tachycardia [dsyn]	6
Sinus Node [bpoc]	6
Hospital acquired [qlco]	6
diagnostic catheterization [diap]	6
Palsy [fndg]	6
pfizer [hcro]	6
Fostering [dora]	6
Estrogens, Esterified [horm, phsu, strd]	6
Class I antiarrhythmic drug [phsu]	6
Referenced [cnce]	6
research results [fndg]	6
Subscale score [qnco]	6
pseudoaneurysm [patf]	6
Penicillin [antb, orch]	6
Probability Sample [qnco]	6
Pathologic stage [clna]	6
Factor XII [aapp, bacs]	6
analgesia [topp]	6
gestagen [horm, phsu, strd]	6
Atrophic [patf]	6
congenital cardiac defect [cgab]	6
Atresia [cgab]	6
Curettage [topp]	6
Red meat [food]	6
Non-small cell [qlco]	6
Medication compliance [fndg]	6
Macroscopic [qlco]	6
Ta [imft]	6
Atypical antipsychotic [phsu]	6
Etanercept [aapp, imft, phsu]	6
Telehealth [hlca]	6
Embedded [lbpr]	6
MDA [orch, phsu]	6
Diaphragm [bpoc]	6
Valvulopathy [dsyn]	6
Acute cardiovascular disease [dsyn]	6
information sources [fndg]	6
Arterial Intima [tisu]	6
chaga [phsu]	6
Phleboliths [acab]	6
Hypertension clinic [inpr]	6
Birth Defects [cgab]	6
Electrocardiographic Findings [fndg]	6
Electric [npop]	6
Worker [ocdi]	6
Varicose [spco]	6
Dental caries [dsyn]	6
Axilla [blor]	6
Industrialized Nations [qlco]	6
Jr [idcn]	6
Dopamine Agonist [phsu]	6
Electricity [npop]	6
xenografts [topp]	6
Flap [bpoc]	6
Anaerobic Threshold [qnco]	6
water retention [fndg]	6
Post-dose [tmco]	6
Electrodes [medd]	6
Generalization [menp]	6
Protons [elii]	6
kill [socb]	6
Coenzyme [bacs, orch]	6
measured blood pressure [topp]	6
new onset atrial fibrillation [dsyn]	6
vascular occlusion [acab, dsyn]	6
splenic [bpoc]	6
Foramen Ovale, Patent [cgab, dsyn]	6
Echocardiography, M-Mode [diap]	6
Grade IV [qlco]	6
Antidiabetics [phsu]	6
AVE [topp]	6
Spectrophotometry [lbpr]	6
breast cancer screening [topp]	6
Reciprocal [qlco]	6
Wasting [dsyn]	6
Mammals [mamm]	6
Change patterns [qlco]	6
Neurosurgeon [prog]	6
Isotretinoin [orch, phsu]	6
Qualitative Research [resa]	6
Gas Chromatography [lbpr]	6
burst [qlco]	6
osmotic [npop]	6
Cor pulmonale [dsyn]	6
Execution [gora]	6
Beverage [food]	6
Main diagnosis [qlco]	6
repetition [ftcn]	6
DISC [medd]	6
counseling patients [hlca]	6
Tricuspid annulus [bpoc]	6
grams [qnco]	6
medication history [inpr]	6
Internal Carotid Arteries [bpoc]	6
Diaphragmatic [bpoc]	6
manifesting [ftcn]	6
Lower respiratory tract infection [dsyn]	6
Supraventricular arrhythmia [patf]	6
Attributable Risk [qlco]	6
Medical Examination [hlca]	6
Neurobiology [bmod]	6
Retarded [qlco]	6
Adult disease [dsyn]	6
Voting [inbe]	6
Irritation [phpr]	6
Oe [qnco]	6
Risedronate [orch, phsu]	6
Missions [orgt]	6
very-low-density lipoprotein particle [celc]	6
Familial form [fndg]	6
Thai [popg]	6
Lung Tumor [neop]	6
Squamous [qlco]	6
Converge [acty]	6
Noise [phpr]	6
Humanism [idcn]	6
Behavioral Modification [topp]	6
Lasers [mnob]	6
dissected [ftcn]	6
pulmonary complications [patf]	6
Hospitals, General [hcro, mnob]	6
Skin Aging [ortf]	6
Nonseminoma [fndg]	6
Stage I Testicular Seminoma [neop]	6
imaging methods [ftcn]	6
NHANES III [inpr]	6
Biweekly [tmco]	6
Serum LDL cholesterol level [lbpr]	6
Bronchodilators [phsu]	6
Ergometries [hlca]	6
policy statement [inpr]	6
a t [topp]	6
Bone marrow cell [cell]	6
low ldl [fndg]	6
lung tumors [neop]	6
Theophylline [bacs, orch, phsu]	6
Van [mnob]	6
arithmetic [inpr]	6
Manufacturing [ocac]	6
hypothalamic [bpoc]	6
Eicosanoids [eico]	6
Medical department [hcro]	6
nurse practitioner [prog]	6
Direct Technique [topp]	6
Serum insulin level [lbpr]	6
Outlier [qnco]	6
Medication Therapy Management [hlca]	6
Health Resources [idcn]	6
Cumulative Exposure [phpr]	6
Cardiac markers [lbpr]	6
Immunocompromised [fndg]	6
contamination [hcpp]	6
nosology [inpr]	6
Poland [geoa]	6
Uncontrolled Study [resa]	6
Coumadin [orch, phsu]	6
Large family [famg]	6
Resectable [qlco]	6
Hospice [hcro, mnob]	6
Waveforms [npop]	6
Sinus bradycardia [patf]	6
Accreditation [gora]	6
Kilogram [qnco]	6
Fasting blood sugar [lbtr]	6
Medical Assistance [gora]	6
Inner city [geoa]	7
Uterine Arteries [bpoc]	7
Case Mix [qnco]	7
benign prostatic hyperplasia [patf]	7
Self Regulation [hcpp]	7
Ventricular Septal Defects [anab]	7
Drug Withdrawal [mobd]	7
aggregates [qlco]	7
monoclonal [fndg]	7
RESP [clna]	7
liver metastases [neop]	7
Blood Pressure Monitoring, Home [diap]	7
Testicular Germ Cell Tumor [neop]	7
troglitazone [orch, phsu]	7
Multidetector Computed Tomography [diap]	7
Trait [orga]	7
medical patients [podg]	7
Bony [ftcn]	7
Population Group [popg]	7
Ambiguity [qlco]	7
exertional [sosy]	7
gastrointestinal toxicity [fndg]	7
Morphine [orch, phsu]	7
nerves [tisu]	7
Transforming [patf]	7
Decisional conflict [fndg]	7
rapid diagnosis [diap]	7
Kaplan-Meier Survival Curves [qnco]	7
Skin reaction [clna]	7
Patient number [inpr]	7
Ligand Binding [moft]	7
associating [qlco]	7
Genetic Disorder [dsyn]	7
peaked [qnco]	7
Hypofractionated Radiotherapy [topp]	7
Books [inpr]	7
Energy Metabolism [phsf]	7
Nuclear Receptor [aapp, rcpt]	7
admitting [hlca]	7
Blood products [phsu]	7
turkish [popg]	7
WHO [qlco]	7
Rome [geoa]	7
Connective Tissue [tisu]	7
Malignant tumor [neop]	7
New England [geoa]	7
Cardiovascular angiography [diap]	7
CHF [dsyn]	7
Hyperlipidemias [dsyn]	7
Anti-Cancer Agents [orch, phsu]	7
Small bowel [bpoc]	7
Heart Valves [bpoc]	7
catabolic [ftcn]	7
Ketamine [orch, phsu]	7
repaglinide [orch, phsu]	7
Thyroid stimulating hormone level [lbpr]	7
perceived risk [qlco]	7
operative risk [idcn]	7
Food Component [chvf]	7
cruciferous vegetables [food]	7
psychosocial variables [qlco]	7
Corporation [orgt]	7
progesterone treatment [topp]	7
Optimism [menp]	7
Neurological status [fndg]	7
Reinforcement [menp]	7
Swiss [popg]	7
Gastrointestinal system [bdsy]	7
Arterial endothelium [tisu]	7
Generations [tmco]	7
TGF-beta [aapp, bacs]	7
publicity [qlco]	7
Dropout [popg]	7
relaxing [qlco]	7
Care Delivery [hlca]	7
Aneurysmal [spco]	7
Household income [fndg]	7
cytotoxicity [comd]	7
Emotional distress [mobd]	7
Disease, Rheumatic [dsyn]	7
Spouses [famg]	7
UND [gngm]	7
Blood glucose level [lbtr]	7
Eggs [food]	7
Quitting Smoking [inbe]	7
land [mnob]	7
Shortest [qnco]	7
Unidentified [qlco]	7
Medication Reconciliation [hlca]	7
Colorectal Carcinoma [neop]	7
Placebo Effect [idcn]	7
Divide [ftcn]	7
Ataxia [sosy]	7
Policy Making [gora]	7
Ophthalmic Artery [bpoc]	7
Tachycardias, Supraventricular [dsyn]	7
Telangiectasia [dsyn]	7
MISUSE [fndg]	7
Neurodegeneration [comd]	7
Developmental Process [ortf]	7
Renal Cell Carcinoma [neop]	7
Population Surveillance [resa]	7
Acute-Phase Protein [aapp, bacs]	7
NAD+ [bacs, nnon, phsu]	7
Checking [acty]	7
Subarachnoid Hemorrhage, Aneurysmal [patf]	7
Malignant Neoplasms [neop]	7
venous disease [dsyn]	7
cardiac problems [fndg]	7
landscape [spco]	7
Concurrent Chemoradiotherapy [topp]	7
forget [mobd]	7
Trace Elements [bacs, elii]	7
Dentistry [bmod]	7
new technology [inpr]	7
Intubation, Endotracheal [topp]	7
tadalafil [orch, phsu]	7
Histopathologic Examination [bmod]	7
patient care plan [hlca]	7
Mucosa [tisu]	7
Nicotine replacement therapy [topp]	7
debates [acty]	7
Animal Study [anim]	7
Immunosuppressive Agents [imft, phsu]	7
letrozole [orch, phsu]	7
diet renal disease [topp]	7
Asleep [fndg]	7
educating patients [edac]	7
Oral Contraceptives, Low-Dose [phsu]	7
Total lipids [fndg]	7
Drug Evaluation [resa]	7
brain function [ortf]	7
Cardioprotective Agents [phsu]	7
cooperative study [resa]	7
perinatal [tmco]	7
experimental research [resa]	7
reoperations [topp]	7
Dentist [prog]	7
Tailored Intervention [hlca]	7
TBARs [irda, orch]	7
Serum albumin level [lbpr]	7
diabetologists [prog]	7
Skin Cancer [neop]	7
ppm [qnco]	7
Urinary symptoms [sosy]	7
dermatologists [prog]	7
Specialized Center [hcro]	7
kidney dysfunction [patf]	7
Adjusted Life Years [tmco]	7
Film [mnob]	7
Mitogen [aapp, bacs]	7
disulfide [chvs]	7
At-Risk Population [popg]	7
Non-Insulin Dependent Diabetes [dsyn]	7
Netherlands [geoa]	7
cardiac patient [podg]	7
Chlortalidone [orch, phsu]	7
cent [qnco]	7
Health Costs [qnco]	7
Medicine, Traditional [bmod]	7
Anticancer Drugs [hlca]	7
Receiver [medd]	7
Oncologic [bmod]	7
PV [neop]	7
cooling [npop]	7
appealing [gora]	7
Nasopharyngeal carcinoma [neop]	7
Immunosuppressive therapy [topp]	7
Regional lymph nodes [bpoc]	7
void [orgf]	7
Nomogram [inpr]	7
Divorced [fndg]	7
prosthetic valves [medd]	7
Siderosis [dsyn]	7
Bilateral salpingo-oophorectomy [topp]	7
Skinfold Thickness [diap]	7
Denominator [qnco]	7
Enlisted [idcn]	7
Regressions, Logistic [resa]	7
Regional center [mnob]	7
Heparin therapy [topp]	7
Inquiry [acty]	7
TNM [hops, irda, orch]	7
replacements [topp]	7
given treatment [topp]	7
Low Cardiac Output Syndrome [patf]	7
FC [acty]	7
Services, Clinical Pharmacy [hcro]	7
high potassium [fndg]	7
Low birth weight [podg]	7
respects [socb]	7
weeks gestation [fndg]	7
Very Severe [qlco]	7
myographs [medd]	7
Soluble fiber [food]	7
nephrotoxicity [inpo]	7
Ecologies [ocdi]	7
regulations [rnlw]	7
Sustained ventricular fibrillation [dsyn]	7
Argentina [geoa]	7
exemestane [phsu, strd]	7
Coronary Calcium Score [qnco]	7
Cell Line [cell]	7
Prior Surgery [fndg]	7
Hydrocortisone [horm, phsu, strd]	7
Nasopharyngeal [bpoc]	7
Iliac Arteries [bpoc]	7
Septic Shock [patf]	7
Congress [orgt]	7
Myocardial cell [cell]	7
Competency [qlco]	7
Clinic Visits [hlca]	7
NHANES [resa]	7
Streptococcus pneumoniae [bact]	7
Polypeptide [aapp]	7
Central region [geoa]	7
Midgut [emst]	7
Unique Identifier [inpr]	7
Menopausal state [phsf]	7
Study Site [hcro]	7
Mann-Whitney U Test [qnco]	7
Decision Aid [inpr]	7
Western medicine [bmod]	7
Multiplicity [qnco]	7
RP [gngm]	7
biocompatibility [moft]	7
Atheromatous Plaques [patf]	7
scheduling [qlco]	7
Luteinising hormone [aapp, horm, phsu]	7
Fatty streaks [patf]	7
protective factors [biof]	7
Placebos [topp]	7
Necropsy [diap]	7
Sensibilities [qlco]	7
Full Time [fndg]	7
Neuronal [imft]	7
Tobacco Dependence [mobd]	7
Endovascular Procedures [diap, topp]	7
Cardiac assessment [hlca]	7
peroxidation [phpr]	7
Geriatrics [bmod]	7
nebivolol [orch, phsu]	7
Visit, Clinic [hlca]	7
Bile Acid Binding Resin [phsu]	7
Age Categories [aggp]	7
Immunoblotting [lbpr]	7
Serum oestradiol level [lbpr]	7
Inflation [qnco]	7
acute mi [dsyn]	7
Eighth [qnco]	7
Instruction [edac]	7
mU/kg/day [qnco]	7
Micro-organism [orgm]	7
liraglutide [aapp, horm, phsu]	7
Bedtime [tmco]	7
Red blood cell [cell]	7
Ventricular tachycardia, polymorphic [dsyn]	7
Not used [ftcn]	7
Incretin [aapp, horm, phsu]	7
Deposit [ftcn]	7
Diode laser [medd]	7
transduction [orgf]	7
Advising [acty]	7
Sheets [spco]	7
Sleep-Disordered Breathing [dsyn]	7
Delayed Diagnosis [qlco]	7
encouragement [socb]	7
White Coat Hypertension [dsyn]	7
feelings [menp]	7
Community Trial [resa]	7
physical symptoms [sosy]	7
Hypertension risk [fndg]	7
australians [fndg]	7
Malaysian [popg]	7
Oldest Old [aggp]	7
Patient needs [ftcn]	7
Refusal [orch, phsu]	7
Postpartum Period [tmco]	7
Cyclooxygenase II Inhibitor [orch, phsu]	7
Dihydropyridine Calcium Channel Blocker [phsu]	7
Colorectal Adenoma [neop]	7
droloxifene [orch, phsu]	7
Tobacco Smoking [inbe]	7
chronobiology [bmod]	7
mononuclear cell [cell]	7
Central Laboratory [orgt]	7
Toxins [bacs, hops]	7
Interfered [qlco]	7
Incentive [qlco]	7
Sociology [ocdi]	7
LN [neop]	7
Upright [spco]	7
Cataracts [anab]	7
albumin levels [lbtr]	7
trap [medd]	7
Tertiary Referral Hospital [hcro, mnob]	7
Milk [bdsu]	7
Asbestos [hops, inch]	7
Cobalt [elii]	7
Cation [chvs]	7
Clipping [topp]	7
neurosurgeons [prog]	7
Obstetrics [bmod]	7
Connective tissue disease [dsyn]	7
Sclerotherapies [topp]	7
Thyroid disorders [dsyn]	7
Age Cohort [popg]	7
Health Services Research [resa]	7
Hepatitis C [dsyn]	7
poor diet [fndg]	7
Descending aorta [bpoc]	7
Cardiac drugs [phsu]	7
arch [blor]	7
Rich food [food]	7
Leucocytosis [patf]	7
Probing [diap]	7
Sitting diastolic blood pressure [fndg]	7
Cardiology service [topp]	7
Chronic venous insufficiency [dsyn]	7
Competent [qlco]	7
Apple [plnt]	7
Community Hospital [hcro, mnob]	7
Large vessel [bpoc]	7
Aglycone [orch, phsu]	7
J-shaped [spco]	7
DNA Synthesis [genf]	7
molecular pathway [moft]	7
Smooth muscle cell [cell]	7
Flush [sosy]	7
syndrome x [dsyn]	7
Transmitted [patf]	7
idoxifene [orch, phsu]	7
American Indian [popg]	7
RF [aapp, imft]	7
effusions [patf]	7
triphenylethylene [orch, phsu]	7
wounds [qlco]	7
Lobar [qlco]	7
catalase activity [moft]	7
Vulva [bpoc]	7
Irritability [fndg]	7
LDL Precipitation [topp]	7
Radio-Opaque [bodm]	7
Increased serum cholesterol [fndg]	7
mimetics [bmod]	7
cellular component [celc]	7
In Vitro Model [resa]	7
Exon [bacs, nnon]	7
Impaired Renal Function [dsyn]	7
Lower (action) [acty]	7
short stay [inpr]	7
Functional Foods [food]	7
Thickened [fndg]	7
Baseline weight [orga]	7
Perivascular [spco]	7
Tertiary Prevention [topp]	7
Americas [geoa]	7
Estimator [prog]	7
Psychotropic Drugs [phsu]	7
Work-Site [spco]	7
Womens Health [bmod]	7
Angiotensin II receptor antagonist [phsu]	7
not eligible [inpr]	7
Pulmonary Capillary Wedge Pressure [clna]	7
Clinical Trials, Phase III [resa]	7
Daily Activity [dora]	7
Furosemide [orch, phsu]	7
Enema [topp]	7
alternate day [tmco]	7
Monitoring, Ambulatory Electrocardiographic [diap]	7
Workshops [edac]	7
conjugates [imft]	7
efficacy treatment [qlco]	7
risk perception [qlco]	7
high creatinine [fndg]	7
factor V Leiden [aapp]	7
Liver Failure [dsyn]	7
Military [prog]	7
Heart Defect, Congenital [cgab]	7
Exercises [dora]	7
glycation [phpr]	7
Length of Stay [tmco]	7
Exercise Therapy [topp]	7
Receptors, Steroid [aapp, rcpt]	7
marine [prog]	7
Machine [mnob]	7
kilograms [qnco]	7
Health Care Access [qlco]	7
Health Technology [hlca]	7
coagulation disorders [dsyn]	7
Behavioral changes [inbe]	7
Pancreatic beta Cells [cell]	7
moderate drinking [inbe]	7
Preventive action [qlco]	7
Nonalcoholic steatohepatitis [dsyn]	7
poor nutrition [dsyn]	7
Psychosocial Factor [qlco]	7
Assertion [qlco]	7
Histopathologic [bmod]	7
intraabdominal [blor]	7
Isoprostane [bacs, eico]	7
Training Programs [edac]	7
contralateral breast cancer [neop]	7
Malignant cells [cell]	7
Protein Kinase C [aapp, enzy]	7
Sphere [spco]	7
Fenfluramine [orch, phsu]	7
Postthrombotic Syndrome [patf]	7
Background Radiation [npop]	7
Bifurcation [topp]	7
calcific [qlco]	7
mild moderate [qlco]	7
Acute ST segment elevation myocardial infarction [dsyn]	7
Stem Cell Transplantation [topp]	7
chambers [medd]	7
cancer risks [qnco]	7
Replicate [ftcn]	7
clinical examinations [hlca]	7
Proxies [grup]	7
Diastolic flow [ortf]	7
NYHA Class III/IV [fndg]	7
organizing [ftcn]	7
Insurance Coverage [idcn]	7
Acute Rejection [fndg]	7
Refuse [eehu]	7
Spotting [patf]	7
INAPPROPRIATE SHOCK [phpr]	7
Central venous pressure [clna]	7
Apnea [patf]	7
Genetic Markers [genf]	7
Cell Membranes [celc]	7
Deploy [acty]	7
SGA [fndg]	7
Respiratory syncytial virus [virs]	7
disease rates [qnco]	7
Israeli [popg]	7
Low-Fat Diets [topp]	7
fsh levels [lbtr]	7
Vitamin level [lbpr]	7
Recurrence free survival [fndg]	7
Impending [tmco]	7
Disabled [podg]	7
Health Care Team [hlca]	7
Equal To [qlco]	7
Seasonal [tmco]	7
remember [menp]	7
Emergency Medicine [bmod]	7
effort angina [sosy]	7
Neoplasm [neop]	7
lipid modification [moft]	7
Immunomodulation [orgf]	7
Cost Containment [gora]	7
unscheduled [idcn]	7
Toremifene [orch, phsu]	7
Aortocoronary Bypass [topp]	7
Horizontal [spco]	7
Factor VII level [lbtr]	7
Peroxisome Proliferator-Activated Receptor alpha [aapp, rcpt]	7
Radiotherapy planning [topp]	7
vts [fndg]	7
escape [menp]	7
rating scale [inpr, qnco]	7
Tortuosity [spco]	7
Poison [hops]	7
Twice weekly [tmco]	7
Junction [spco]	7
breed [orgf]	7
Revolution [ftcn]	7
Complete atrioventricular block [dsyn]	7
Absolute Change [idcn]	7
Differential Diagnoses [diap]	7
Peritoneal Dialysis, Continuous Ambulatory [topp]	7
colo-rectal [bpoc]	7
asymmetric [spco]	7
Collagen (vascular) disease NOS [dsyn]	7
monolayers [clnd]	7
Achievements [bhvr]	7
Sympathetic nerve [bpoc]	7
B Vitamins [orch, phsu, vita]	7
hormone deficiency [dsyn]	7
SS [geoa]	7
calculator [mnob]	7
Configuration [spco]	7
IU/kg [qnco]	7
blood cancer [neop]	7
sevoflurane [orch, phsu]	7
Dysplastic [patf]	7
Quality of life score [clna]	7
Intravenous Bolus [ftcn]	7
Activated protein C [aapp, enzy]	7
Physiotherapy [topp]	7
Heterozygotes [orga]	7
Nodules [acab]	7
increased hdl [fndg]	7
normal results [fndg]	7
Primary pulmonary hypertension [dsyn]	7
Markers, Disease [idcn]	7
Gallstones [dsyn]	7
Incomes [qnco]	7
manufactured [ocac]	7
eating habits [inbe]	7
Intraocular Pressure [ortf]	7
Complete Recovery [fndg]	7
Duodenum [bpoc]	7
dienes [orch]	7
Adverse Experience [fndg]	7
Left to right shunt [acab]	7
Prosthetic valve endocarditis [dsyn]	7
New York Heart Association Class IV [fndg]	7
Progenitor Cell [cell]	7
Encode [acty]	7
Resonance [fndg]	7
IP [gngm]	7
Model System [inpr, resd]	7
chronic hypertension [fndg]	7
Seniors [grpa]	7
Biotechnology [bmod]	7
advertising [ocac]	7
prasugrel [orch, phsu]	7
quality measures [inpr]	7
X-Rays [diap]	7
Transcripts [nnon]	7
R-R interval [clna]	7
outcome assessment [ocac]	7
Emission [bdsu]	7
Thromboses [patf]	7
Pneumoniae [dsyn]	7
diuretic treatment [topp]	7
Macaca fascicularis [mamm]	7
Active Control [resa]	7
Neurocognitive [inpr]	7
critically ill children [podg]	7
Nephrotic Syndrome [dsyn]	7
Reconstructive Surgery [topp]	7
Cellulose [bacs, carb]	7
respected [socb]	7
Social factor [grpa]	7
Advice to [hlca]	7
Expectancy [idcn]	7
Gingivitis [dsyn]	7
Arsenal [orch, phsu]	7
Heart tissue [tisu]	7
adjunct therapy [topp]	7
organ failure [sosy]	7
Electrophysiologic studies [diap]	7
Electrocardiographic abnormalities [fndg]	7
Burr [plnt]	7
dietary control [topp]	7
cabergoline [orch, phsu]	7
Cardiovascular structure [bdsy]	7
Basal insulin [aapp, phsu]	7
Abate [acty]	7
Autonomic neuropathy [dsyn]	7
Economics [ocdi]	7
cardiac operations [topp]	7
Cancer, Second Primary [neop]	7
central nervous system effects [ortf]	7
normal patients [fndg]	7
compounded [qlco]	7
Therapeutic Area [cnce]	7
Premature Deaths [fndg]	7
Antiepileptic Drugs [phsu]	7
Cardiopulmonary Exercise Test [diap]	7
communications [socb]	7
Treatment Study [resa]	7
HMO [hcro, mnob]	7
Book [inpr]	7
Internal mammary node [bpoc]	7
Cancer Control [hlca]	7
Diabetes-Related Complications [patf]	7
Morphologic change [anab]	7
Mega [qnco]	7
Drug Therapy Management [hlca]	7
Blood Volume [orga]	7
secrete [celf]	7
hepatic steatosis [dsyn]	7
Carbon [elii]	7
SSA [neop]	7
Mutual [qlco]	7
lomitapide [orch, phsu]	7
Dietary Supplementation [topp]	7
Resource Allocation [qnco]	7
Reduced concentration [fndg]	7
health economics [ocdi]	7
volume overload [dsyn]	7
care seeking [inbe]	7
therapy adherence [inbe]	7
patient attitudes [menp]	7
Group Meetings [socb]	7
Genotypic [orga]	7
Neglect [fndg]	7
OxLDL [aapp, bacs]	7
Nigeria [geoa]	7
dietary restriction [fndg]	7
Moderation [qlco]	7
Remnant lipoprotein [orch]	7
Edition [inpr]	7
Contrast Agent [irda]	7
Prostaglandin F [bacs, eico]	7
Discernible [qlco]	7
Incontinence [dsyn]	7
Gamma Knife Radiosurgery [topp]	7
Local-Regional [spco]	7
Cell Type [cell]	7
Orchidectomy [topp]	7
Decompression [phpr]	7
Diminution [qlco]	7
Cap [mnob]	7
concomitant conditions [patf]	7
Hospital Management [hlca]	7
Isoprostanes [bacs, eico]	7
healthy habits [inbe]	7
cardiac procedures [hlca]	7
Bands [medd]	7
electrophysiological study [diap]	7
Blood Tests [lbpr]	7
Contiguous [spco]	7
Diastolic hypertension [dsyn]	7
Tag [neop]	7
Thromboembolus [dsyn]	7
Subtraction [phpr]	7
North Carolina [geoa]	7
White matter lesions [fndg]	7
cuff [medd]	7
Client [popg]	7
Life Tables [inpr, qnco]	7
Fasting lipid profile [lbpr]	7
Close Up [phsu]	7
Chest tube [medd]	7
cardiovascular problems [sosy]	7
Arteriovenous Malformations, Cerebral [cgab]	7
Thrombolytic Drugs [phsu]	7
Non-obstructive [ftcn]	7
Empowerment [socb]	7
Navigation [acty]	7
Economic Development [qnco]	7
Jewish [idcn]	7
Fears [menp]	7
Arterial occlusion [patf]	7
Biophysical [bmod]	7
Inotropic agent [phsu]	7
Encainide [orch, phsu]	7
United Nations [orgt]	7
Chronically Ill [dsyn]	7
GPIIB IIIA [aapp, imft, rcpt]	7
Adverse Drug Reaction [inpo]	7
Lung volume [ortf]	7
Median Survival Time [tmco]	7
Business [ocac]	7
donor heart [popg]	7
activity levels [fndg]	7
elevated value [spco]	7
trandolapril [orch, phsu]	7
coronary coronary [bpoc]	7
Carotid Artery Stenosis [dsyn]	7
competition [socb]	7
electrophysiological studies [diap]	7
Health policies [rnlw]	7
Small vessels, NOS [bpoc]	7
IU/mL [qnco]	7
Renal arteries [bpoc]	7
Anion [elii]	7
ck mb [aapp, enzy]	7
Functional disorder [qlco]	7
Mean Platelet Volume [lbpr]	7
melanoma [neop]	7
ICER [gngm]	7
Immunisation [topp]	7
Glitazones [orch, phsu]	7
Angina, class II [dsyn]	7
Patient Reported Outcome [inpr]	7
NaCl [bacs, inch, phsu]	7
Contrast Medium [irda]	7
THP [gngm]	7
Heart Block [patf]	7
Nutritional Support [topp]	7
Posterior fossa [bpoc]	7
OGTT [diap]	7
Arterial segment [bpoc]	7
Ra [spco]	7
Malfunction [ftcn]	7
Billing [ocac]	7
Patient sex [orga]	7
Occurrences [tmco]	7
colored [qlco]	7
Subject Age [orga]	7
Frontal [spco]	7
treatment compliance [inbe]	7
Peripheral circulation [fndg]	7
Degeneration [patf]	7
Alpha Blocker [phsu]	7
Caliber [qnco]	7
Fluctuation [sosy]	7
Venous occlusion plethysmography [diap]	7
Dysglycemia [dsyn]	7
Sleep disturbances [sosy]	7
Positive Finding [fndg]	7
fibrose [patf]	7
Committee Members [prog]	7
Expected outcomes [inpr]	7
Dyspareunia [dsyn]	7
Carbon Monoxide [hops, inch]	7
Phosphodiesterase Inhibitors [phsu]	7
Coronary Reperfusion [topp]	7
Radionuclide Ventriculography [diap]	7
g/kg [qnco]	7
Encapsulation [phpr]	7
team work [grup]	7
Acute onset [qlco]	7
Blood Vessel Thrombosis [patf]	7
Treatment information [clna]	7
coronary stents [medd]	7
Comprehension [menp]	7
Centers for Disease Control [hcro]	7
concurrent therapy [topp]	7
Reintroduction [topp]	7
Nitric Oxide Synthase Inhibitor [phsu]	7
Protein concentration [lbpr]	7
tissue remodeling [biof]	7
Prosthetic material [bodm]	7
Yes [idcn]	7
closing [ftcn]	7
Genome Wide Association Studies [mbrt]	7
Study, Outcome [resa]	7
Phytosterols [bacs, phsu, strd]	7
Graft Survival [ortf]	7
fueled [mnob]	7
Next to [spco]	7
climacteric syndrome [dsyn]	7
Racial group [popg]	7
transit [ftcn]	7
electronic data [idcn]	7
Pre-admission [tmco]	7
Dermatitis [dsyn]	7
Caveat [gora]	7
Oximetry, Pulse [diap]	7
Office Visits [hlca]	7
Urban Hospital [hcro]	7
mediated responses [menp]	7
Nerve injury [inpo]	7
handbook [inpr]	7
Bilirubin [bacs, orch]	7
Connecticut [geoa]	7
Proteolytic [moft]	7
Creatine kinase.MB [aapp, enzy]	7
Congenital diaphragmatic hernia [cgab]	7
consolidated [qlco]	7
Center for Epidemiologic Studies Depression Scale [inpr]	7
heart lung [blor]	7
sedative [phsu]	7
Prolonged periods [fndg]	7
Total Volume [qnco]	7
euro [mamm]	7
excess iron [dsyn]	7
Direct Thrombin Inhibitors [aapp, bacs, phsu]	7
Activated Partial Thromboplastin Time [lbpr]	7
stilbene [orch]	7
Birth Weight [orga]	7
Short periods [fndg]	7
Orientation [menp]	7
Patient Discharge [hlca]	7
Grade I [qlco]	8
Gold [elii, phsu]	8
insulin infusion [topp]	8
simulations [resa]	8
Specification [cnce]	8
Standard Score [qnco]	8
cholesterol absorption [celf]	8
Urine sample [bdsu]	8
Coronary Vasospasm [dsyn]	8
Ignore [idcn]	8
Androgen Receptor [aapp, rcpt]	8
Dermal [qlco]	8
Primates [mamm]	8
Washington state [geoa]	8
Region, Promoter [bacs, nnon]	8
Epicardium [tisu]	8
Alpha Glucosidase Inhibitors [phsu]	8
accessing [spco]	8
PAH [dsyn]	8
Ethibloc [orch, phsu]	8
high lipids [fndg]	8
reliance [bodm]	8
Coagulation abnormalities [fndg]	8
drivers [medd]	8
Intravenous immunoglobulin [aapp, imft, phsu]	8
Overall Response [fndg]	8
Chemokines [aapp, imft]	8
shifting [ftcn]	8
Heart Diseases--Prevention [topp]	8
Collections [inpr]	8
Obstructive sleep apnoea syndrome [dsyn]	8
socio economic status [qlco]	8
Emergency Departments [hcro]	8
Anesthesiology [bmod]	8
Absorptiometry, Dual X-Ray [diap]	8
Pre-existing conditions [clna]	8
Uninsured [popg]	8
Community Health [ocdi]	8
Subsequent myocardial infarction [dsyn]	8
Human immunodeficiency virus infection [dsyn]	8
micronized estradiol [orch, phsu]	8
veterinary [qlco]	8
T stage [clas]	8
Aromatase inhibitor [phsu]	8
Epsilon [inpr]	8
Respiration [phsf]	8
Heart Defects [cgab]	8
RAS [gngm]	8
Per Annum [tmco]	8
chronic care [hlca]	8
Consult [hlca]	8
Patents [inpr]	8
Intraosseous [ftcn]	8
Plasma Proteins [aapp, bacs]	8
Population Control [ocdi]	8
Cassette [medd]	8
Iowa [geoa]	8
VWF [gngm]	8
International index of erectile function [inpr]	8
Austria [geoa]	8
PPAR gamma [aapp, rcpt]	8
Parasite [euka]	8
scanner [medd]	8
Hyperpigmentation [patf]	8
Michigan [geoa]	8
Rotational [spco]	8
Absolute Alcohol [orch]	8
Saskatchewan [geoa]	8
Glucose tolerance test [diap]	8
Vaccines [imft, phsu]	8
Educational Attainment [fndg]	8
Encapsulated [qlco]	8
Laboratory studies [lbpr]	8
Isolate [sbst]	8
times/week [qnco]	8
NIDDM [dsyn]	8
AU [qnco]	8
sexuality [bhvr]	8
gram [qnco]	8
Angioma, Cavernous [neop]	8
European Union [orgt]	8
coaching [mnob]	8
Clinical Failure [fndg]	8
HIT [dsyn]	8
Immune Function [ortf]	8
Analyzer [medd]	8
HDLC [dsyn]	8
Maximum oxygen uptake [fndg]	8
N-Acetylcysteine [aapp, phsu]	8
Heterogenous [idcn]	8
Cardiology department [hcro]	8
Pack years [inpr]	8
ASPIRIN RESISTANCE [fndg]	8
Protective Factor [biof]	8
Anger [menp]	8
Haemodynamic measurements [topp]	8
Exercise stress test [diap]	8
Deferred [tmco]	8
Myocardial Blood Flow [ortf]	8
Steering Committee [popg]	8
airways [medd]	8
xenobiotic [bacs, hops]	8
Monetary [mnob]	8
New Zealand White Rabbits [mamm]	8
Cardiac rhythm [ortf]	8
Evacuation [topp]	8
Waveform [npop]	8
Checklist [inpr]	8
Serum ferritin level [lbpr]	8
Vaccine [imft, phsu]	8
surgical treatments [hlca]	8
Blood concentration [lbtr]	8
Diabetes status [orga]	8
demanding [topp]	8
Transfusions [topp]	8
Hyperactivity [fndg]	8
Epidemics [phpr]	8
i d [topp]	8
membrane receptors [rcpt]	8
neurological complication [patf]	8
mate [famg]	8
Asystole [dsyn]	8
Cord [bpoc]	8
Permanent atrial fibrillation [patf]	8
dividing [ftcn]	8
Cu++ [inch, phsu]	8
Mesh [medd]	8
Los Angeles [geoa]	8
aortic surgery [topp]	8
Cognitive dysfunction [mobd]	8
Friendly [qlco]	8
Homeostatic Model Assessment of Insulin Resistance [lbpr]	8
Neuroendocrine Tumors [neop]	8
Significance Level [resa]	8
Group N [inpr]	8
Common Carotid Arteries [bpoc]	8
Embryonic [emst]	8
Sport [dora]	8
cigarette smokers [fndg]	8
Transaminases [aapp, enzy]	8
Satellite [spco]	8
Acute care hospital [hcro, mnob]	8
vice [idcn]	8
regional difference [fndg]	8
topical application [topp]	8
Injectable [bodm]	8
Obesity, Morbid [dsyn]	8
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER [medd]	8
Mast Cells [cell]	8
Ventilated [ftcn]	8
Study Author [prog]	8
Abdominal Pain [sosy]	8
dose-response curve [qnco]	8
Lipemia [fndg]	8
Mitral Stenosis [dsyn]	8
asian countries [geoa]	8
CAS [mobd]	8
Optimistic [fndg]	8
Decreased Sensitivity [fndg]	8
Awake [fndg]	8
adverse drug effects [inpo]	8
[M]Gliomas [neop]	8
triad [bodm, orch]	8
Erythema [sosy]	8
saliva [bdsu]	8
Estrogen Receptor Agonists [moft]	8
Diaries [inpr]	8
Myocardial Ischemic Reperfusion Injury [patf]	8
Larynx [bpoc]	8
delivery methods [topp]	8
wards [hcro, mnob]	8
Scattered [spco]	8
resistance training [hlca]	8
Iloprost [eico, phsu]	8
Gangrene [dsyn]	8
Isomer [npop]	8
Glibenclamide [orch, phsu]	8
Time, Prothrombin [lbpr]	8
Soy product [food]	8
Financial Support [idcn]	8
VII [inpr]	8
microbial [orgm]	8
report data [resa]	8
Drug Safety [qlco]	8
Radiation-Induced Change [clna]	8
Andropause [fndg]	8
Plasma membrane [celc]	8
Healthy child [fndg]	8
Vascular Medicine [bmod]	8
ICD Code [inpr]	8
Drug Exposure [fndg]	8
Thyroxine, Free [lbpr]	8
Cranial Irradiation [topp]	8
tumor recurrence [neop]	8
Matched Group [grup]	8
thiazolidinedione [orch, phsu]	8
laboratory methods [inpr]	8
Vectors [nnon]	8
yttrium-aluminum-garnet [inch]	8
eptifibatide [aapp, phsu]	8
Fontan Operation [topp]	8
MITIGATION [resa]	8
schema [inpr]	8
Inflammatory reaction [patf]	8
Adenomas, Pituitary [neop]	8
Stasis [patf]	8
Fibers [tisu]	8
Cross-Sectional Analyses [resa]	8
Platinum [elii]	8
DAL [carb, phsu]	8
microvasculature [ortf]	8
Tobacco smoke [hops]	8
Anti-Estrogens [phsu]	8
Confirmatory [idcn]	8
Middle Aged Adult [aggp]	8
Spinal arteriovenous malformation [cgab]	8
weighting [orga]	8
Research Priorities [resa]	8
Extrahepatic [spco]	8
Normal renal function [fndg]	8
Blood Viscosity [phsf]	8
False [qlco]	8
glucose uptake [celf]	8
Births [orgf]	8
Bipolar [spco]	8
Secondary to [tmco]	8
rofecoxib [orch, phsu]	8
Subtract [inpr]	8
INSUFFICIENCY, CARDIAC [dsyn]	8
Cereal [food]	8
Caloric Intake [qnco]	8
Pharmacokinetic Parameters [idcn]	8
Wild [inpr]	8
Right ventricular myocardium [bpoc]	8
Placebo Control [resa]	8
Vitamin K antagonists [phsu]	8
Periodically [tmco]	8
Steroid therapy [topp]	8
gynecologic cancer [neop]	8
SEER [hcro]	8
Hemolysis [patf]	8
Lymph [bdsu]	8
Cocaine [hops, orch, phsu]	8
Identifier [inpr]	8
Transitory [tmco]	8
Incentives [qlco]	8
obstructions [patf]	8
letters [inpr]	8
energy homeostasis [biof]	8
vote [inbe]	8
androgen therapy [topp]	8
Antiplasmin [aapp, bacs, phsu]	8
Aspartate Aminotransferase [aapp, enzy]	8
Lymphedema [dsyn]	8
Intrathoracic [ftcn]	8
Well Differentiated [qlco]	8
Factor VII Activity [lbpr]	8
Prenatal Diagnosis [diap]	8
REGISTERED DIETICIAN [prog]	8
Skin Cancer, Non-Melanoma [neop]	8
responsibilities [inbe]	8
Least Square [qnco]	8
Kaplan-Meier Estimate [qnco]	8
Percutaneous coronary angioplasty NOS [topp]	8
Myocytes, Cardiac [cell]	8
Patient Participation [hlca]	8
X Chromosome [celc]	8
Systemic vascular Resistance [clna]	8
Splenectomy [topp]	8
Breast Feeding [orgf]	8
Primary hypertension [dsyn]	8
obliterated [ftcn]	8
mental stress [mobd]	8
anticarcinogenic [qlco]	8
diastolic pressures [clna]	8
human cell [lbtr]	8
health care professional [prog]	8
Testicular seminoma [neop]	8
FORMERLY [gngm]	8
Prostaglandins [bacs, eico, phsu]	8
Arteriovenous shunt [anab]	8
ancova [qnco]	8
Ultrasonography, Doppler, Color [diap]	8
Mask [medd]	8
Superoxide Anion [elii]	8
Valves, Mitral [bpoc]	8
mirrored [mnob]	8
Colestipol [orch, phsu]	8
Confused [mobd]	8
Coach [mnob]	8
Embryogenesis [ortf]	8
Kringle [spco]	8
Fentanyl [orch, phsu]	8
Aortic Valve Stenosis [dsyn]	8
Bone Formation [ortf]	8
diagnostic testing [diap]	8
formats [inpr]	8
Nursing Homes [hcro, mnob]	8
Fragility [comd]	8
New York Heart Association Classification [inpr]	8
ICD Codes [inpr]	8
contrasted [diap]	8
retaining [ftcn]	8
Peptic Ulcer [dsyn]	8
benzothiophene [orch]	8
Beta + thalassaemia [dsyn]	8
Modifications, Dietary [topp]	8
confidentiality [idcn]	8
Devascularisation [topp]	8
Heart valve [bpoc]	8
Colitis, Ischemic [dsyn]	8
cancer progression [neop]	8
Beer [food]	8
antidepressant therapy [topp]	8
Disseminated Intravascular Coagulation [dsyn]	8
stage I non-small cell lung cancer [neop]	8
Flat [spco]	8
Mantle Field [blor]	8
antidiabetic drug [phsu]	8
Anaesthetist [prog]	8
contrast material [irda]	8
Abnormal Finding [fndg]	8
Casein [aapp, bacs]	8
Retrograde [spco]	8
Vitamin D Deficiency [dsyn]	8
Maintenance therapy [topp]	8
Streptococcus [bact]	8
Birthmarks [cgab]	8
Numerical [qnco]	8
Median Sternotomy [topp]	8
Meningitis [dsyn]	8
prevention strategy [inpr]	8
Conformation [spco]	8
Pulmonary Valve [bpoc]	8
Unload [idcn]	8
ciprofibrate [orch, phsu]	8
Plasmid [bacs, nnon]	8
Films [mnob]	8
SCAI [gngm]	8
Ethnic population [popg]	8
impression [inbe]	8
Resume [idcn]	8
Genomic DNA [nnon]	8
Physician, Family [prog]	8
human data [inpr, resa]	8
Airway Obstruction [dsyn]	8
Once weekly [tmco]	8
Custom [idcn]	8
cardiac functions [ortf]	8
Diurnal [tmco]	8
Heart-Lung Transplantation [topp]	8
Races [popg]	8
Salvage Therapy [topp]	8
Physical performance [orga]	8
Age-Adjusted Mortality Rate [qnco]	8
T-cell [cell]	8
Hyperglycemia, Postprandial [fndg]	8
Health screening [hlca]	8
Hypoperfusion [ftcn]	8
Health conditions [clna]	8
Computing [acty]	8
health plans [hlca]	8
Endocrine disorders [dsyn]	8
siRNA [bacs, nnon]	8
Ventricular premature beats [patf]	8
Health Disparities [fndg]	8
SH [geoa]	8
Professional Organizations [pros]	8
Breathlessness [sosy]	8
stage III breast cancer [neop]	8
gradients [qnco]	8
Anti-Obesity Drugs [phsu]	8
Mercury [elii, hops]	8
cardiac troponins [lbpr]	8
Patient counseling [hlca]	8
mammograms [diap]	8
compensate [qlco]	8
Accident [inpo]	8
Pulmonary veins [bpoc]	8
LEFT ATRIAL ENLARGEMENT [fndg]	8
Computer assisted [lbpr]	8
Tissue Engineering [topp]	8
{VP} [qnco]	8
nomegestrol acetate [horm, phsu, strd]	8
abnormal results [fndg]	8
Mission [orgt]	8
Triiodothyronine [aapp, horm, phsu]	8
Diastole [clna]	8
Education, Medical [edac]	8
Inclusive [ftcn]	8
Dermatology [bmod]	8
Assessor [prog]	8
CT angiography [diap]	8
Heart symptoms [sosy]	8
Polysomnography [diap]	8
Carbon Dioxide [bacs, inch]	8
Manipulations NOS [topp]	8
Adipocytokines [aapp, bacs]	8
Coronary Artery Bypass [topp]	8
Chronic renal insufficiency [dsyn]	8
Pericarditis, Constrictive [dsyn]	8
Left atrial thrombus [fndg]	8
Delay time [tmco]	8
Carcinoid syndrome [dsyn]	8
Imaging finding [lbtr]	8
Back Pain [sosy]	8
Open-ended [qlco]	8
San [gngm]	8
Study Characteristics [inpr]	8
Iron Chelation [moft]	8
Authoritative [qlco]	8
American Society of Anesthesiologists [pros]	8
Transfused [idcn]	8
Pre-dialysis [tmco]	8
Parenchyma [bpoc]	8
Exposure to [clna]	8
Myocardial metabolism [lbtr]	8
Sulfonylureas [orch, phsu]	8
Ergometry [hlca]	8
Sleepiness [fndg]	8
Tuberculosis [dsyn]	8
Cancer Center [hcro]	8
mg/kg/d [qnco]	8
Gestation [orgf]	8
Acute infection [dsyn]	8
Matrix Metalloproteinases [aapp, enzy]	8
Cigarette [mnob]	8
Endothelium-Derived Relaxing Factor [bacs, inch, phsu]	8
Inhalation [orgf]	8
Beck depression inventory [diap]	8
cardiovascular imaging [diap]	8
Burning NOS [phpr]	8
Relaxations [acty]	8
ng/dL [qnco]	8
Cine [diap]	8
high low density lipoprotein [fndg]	8
IGF [aapp, horm, nsba]	8
Best Practices [idcn]	8
Screening Tests [hlca]	8
isoflavonoids [orch, vita]	8
METS [gngm]	8
Therapy Effect [fndg]	8
Roadmap [inpr]	8
Knock-out Mice [mamm]	8
Claudication distance [fndg]	8
Facial malformation [cgab]	8
Dippers [bird]	8
Disproportionate [qlco]	8
Medicine, Modern [tmco]	8
Bases [qnco]	8
Intensive Care Units [hcro, mnob]	8
Arterioles [bpoc]	8
resections [topp]	8
foster [dora]	8
Baroreflex [ortf]	8
Single ventricle [cgab]	8
Perfusion Scintigraphy [diap]	8
white race [popg]	8
scholar [prog]	8
Lone atrial fibrillation [dsyn]	8
GFR [diap]	8
Hereditary haemorrhagic telangiectasia [dsyn]	8
Ulcerative Colitis [dsyn]	8
Genetic screening [fndg]	8
LPA [lbpr]	8
Stressor [idcn]	8
olanzapine [orch, phsu]	8
Type D Personality [menp]	8
Cyanotic congenital heart disease [cgab, dsyn]	8
Linoleic Acid [bacs, lipd, phsu]	8
Emphysema [patf]	8
clinical syndromes [clas]	8
Sleep problem [dsyn]	8
Intestine [bpoc]	8
Blue [qlco]	8
Small breast [fndg]	8
Non-acute [inpr]	8
pressor [phsu]	8
Progestagens [horm, phsu, strd]	8
HYPOGLYCEMIC AGENTS, ORAL [phsu]	8
Echocardiography, Three-Dimensional [diap]	8
Interstitial fibrosis [dsyn]	8
Lifestyle Therapy [hlca]	8
Provoked [qlco]	8
EPI [aapp, phsu]	8
reconstructions [topp]	8
Rectal bleeding [patf]	8
Pulmonary Dysfunction [fndg]	8
U/ml [qnco]	8
Extrinsic [spco]	8
Treatment Failures [qlco]	8
Thigh [blor]	8
Non-compliant [qlco]	8
Hypoalbuminaemia [fndg]	8
iron levels [lbpr]	8
Clinical/Radiologic [ftcn]	8
Reversibility [tmco]	8
Heart valve disease [dsyn]	8
First presentation [tmco]	8
Reflex [ortf]	8
Indigenous [grpa]	8
Coincident [tmco]	8
Pharmacological stress [phpr]	8
hormone administration [topp]	8
Plants, Medicinal [plnt]	8
Non-Q wave myocardial infarction [dsyn]	8
Anti-Inflammatory Agents [phsu]	8
Thyrotrophin [aapp, horm, phsu]	8
Primordium [ortf]	8
High molecular weight [qlco]	8
Mammary gland [bpoc]	8
norgestimate [horm, phsu, strd]	8
Accessory pathway [bpoc]	8
node-negative [fndg]	8
Alcoholism [mobd]	8
Friends [popg]	8
Increased weight [fndg]	8
Estrogenic Effect [fndg]	8
Intercellular Communication [celf]	8
test results [fndg]	8
Multicentric [spco]	8
Time Series Analysis [resa]	8
Potassium intake [clna]	8
Lips [bpoc]	8
Beverages [food]	8
laboratory measurements [resa]	8
New York Heart Association Class I [fndg]	8
Generalised [spco]	8
Treatment Protocol [topp]	8
obstetricians [prog]	8
Hypothalamus [bpoc]	8
Proton beam [npop]	8
Tumor Progression [neop]	8
Soft tissues [tisu]	8
TANDEM [orch, phsu]	8
Body Size [orga, qnco]	8
Hidden [qlco]	8
end stage disease [dsyn]	8
Vulnerable Population [popg]	8
RV [clna]	8
Therapeutic response [clna]	8
Databases, Bibliographic [inpr]	8
Circumference [qnco]	8
Lymphatic Vessels [bpoc]	8
VF [dsyn]	8
Saudi Arabia [geoa]	8
DLCO [diap]	8
Relational problem NOS [mobd]	8
Road [mnob]	8
Hearing [phsf]	8
Neurologic Deficits [fndg]	8
Ear [bpoc]	8
Dose-Limiting [idcn]	8
Guideline Adherence [gora]	8
Exercise time [tmco]	8
Mean pressure [qnco]	8
Vegetable intake [fndg]	8
CE [idcn]	8
Hydrolysis [npop]	8
achieving goals [fndg]	8
Fluorescent [irda, orch]	8
ldl hdl ratio [lbtr]	8
Colorectal Cancers [neop]	8
Elapsed [tmco]	8
victims [popg]	8
General medicine [bmod]	8
Vasomotor function [ortf]	8
slopes [qnco]	8
Hepatic function [ortf]	8
Editor [ocdi]	8
Occlusive thrombus [acab]	8
Angiotensin II Receptor Blocker [phsu]	8
URL [inpr]	8
Bronchospasm [dsyn]	8
PSA [aapp, enzy]	8
Autologous Bone Marrow [bdsu]	8
cilostazol [orch, phsu]	8
Sodium, Dietary [food, inch]	8
Increased body mass index [fndg]	8
Transportation [orgt]	8
dienogest [horm, phsu, strd]	8
hospital patients [fndg]	8
Nut [food]	8
observers [prog]	8
TOLL [aapp, rcpt]	8
serum LDL [lbpr]	8
Life Cycle [tmco]	8
couple [famg]	8
Inflammatory disorder [dsyn]	8
MHz [qnco]	8
vasoactive agent [phsu]	8
Food Consumption [acty]	8
predictive variables [inpr]	8
angiograms [diap]	8
Swallowing [orgf]	8
Serum total cholesterol level [lbpr]	8
Macronutrient [cnce]	8
Cadmium [elii, hops]	8
prerequisites [idcn]	8
Lisinopril [aapp, phsu]	8
Aortic Valve Disease [dsyn]	8
Rejected [idcn]	8
Palpable [qlco]	8
vitamin k antagonist [topp]	8
resistin [aapp, horm]	8
Mesenchymal [qlco]	8
Revascularization [topp]	8
Yen [qnco]	8
American Medical Association [pros]	8
Pulmonary Atresia [cgab, dsyn]	8
Synopsis [inpr]	8
Partial Remission [fndg]	8
Pain management [topp]	8
Dysplasia [patf]	8
Cardiotoxic Agents [bacs, hops]	8
AI [geoa]	8
Mitral Valve Prolapse [dsyn]	8
Vaccinations [topp]	8
G-Protein [aapp, enzy]	8
Aortic dissection [dsyn]	8
Ultrasonic [ftcn]	8
Letter [inpr]	8
NIHSS [inpr]	8
Ischemic Pre-Conditioning [topp]	8
NYHA Class II [fndg]	8
prevention programs [inpr]	8
Cough [sosy]	8
patients symptoms [fndg]	8
Electrophysiology, Clinical [inpr]	8
based case study [resa]	8
Dry mouth [sosy]	9
Anticoagulant Drugs [phsu]	9
Atrial tachycardia [patf]	9
Station [mnob]	9
Trans Fatty Acids [food]	9
Influenza vaccination [topp]	9
Oral Medication [topp]	9
Acquire [acty]	9
Therapeutic results [fndg]	9
Locally Advanced Cancer [neop]	9
Acetaminophen [orch, phsu]	9
British Columbia [geoa]	9
prostanoid [bacs, eico, phsu]	9
GI [idcn]	9
Allergic reactions [patf]	9
Machinery [mnob]	9
Dog [mamm]	9
Hyperandrogenism [dsyn]	9
contractions [patf]	9
Erroneous [idcn]	9
pad [medd]	9
Registered Dietitian [prog]	9
Phase I Trial [resa]	9
Isoenzyme [aapp, enzy]	9
.alpha.-Linolenic acid [bacs, lipd]	9
Nuts [food]	9
Coronary Stenoses [dsyn]	9
Serum testosterone level [lbpr]	9
Embolus [fndg]	9
Low molecular weight heparins [carb, phsu]	9
FIVE-DAY [inpr]	9
contexts [fndg]	9
C-reactive protein measurement [lbpr]	9
Tubular [spco]	9
Ascending [qlco]	9
Tumorigenesis [neop]	9
antiepileptic drug [phsu]	9
Upstream [spco]	9
Myocardial oxygen consumption [lbtr]	9
Breast Tumors [neop]	9
RECONCILE [orch, phsu]	9
Spreading [qlco]	9
coronary bypass [topp]	9
Estrogen antagonist [phsu]	9
aggregated [ftcn]	9
Surveys, Cross-Sectional [resa]	9
Dietetics [bmod]	9
olmesartan [orch, phsu]	9
Senior [idcn]	9
Subjective Improvement [cnce]	9
patient evaluation [hlca]	9
Chemicals [chem]	9
invasive treatments [topp]	9
available drugs [fndg]	9
Acute Disease [dsyn]	9
constituent [sbst]	9
secondary tumors [neop]	9
Mobile Health [hlca]	9
Cerebrospinal Fluid [bdsu]	9
QRS complex [fndg]	9
sleep disorders [sosy]	9
associated disorders [ftcn]	9
Neoplastic Disease [neop]	9
patient report [inpr]	9
Clinical Pharmacists [prog]	9
very low density lipoprotein triglyceride [aapp, bacs, lipd]	9
Chest Wall Tumor [neop]	9
EA [orch, phsu]	9
Severe pain [sosy]	9
Sarcoidosis [dsyn]	9
embolizations [topp]	9
Drug Prescribing [hlca]	9
Wavelength [qnco]	9
Brain natriuretic peptide level [lbpr]	9
Radiosensitivity [orga]	9
Liver Cirrhosis [dsyn]	9
pretest [hlca]	9
Acute pancreatitis [dsyn]	9
Stroke unit [hcro]	9
treatment complications [patf]	9
State transition [idcn]	9
mark [qlco]	9
Dentists [prog]	9
Vincristine [orch, phsu]	9
Z-score [qnco]	9
Law [rnlw]	9
Ductal Carcinoma In Situ [neop]	9
Post-radiation [tmco]	9
Radiation Therapy Oncology Group [hcro]	9
Unsolved [cnce]	9
cancer care [topp]	9
Ultracentrifugation [lbpr]	9
Draft [inpr]	9
Meters [medd]	9
Work Flow [cnce]	9
Mix [ftcn]	9
Tumor cells [cell]	9
Hyperparathyroidism, Secondary [dsyn]	9
Flexibility [qlco]	9
Convergence [spco]	9
Mammogram [diap]	9
electrode [medd]	9
pharmacologic effects [ftcn]	9
Isoproterenol [orch, phsu]	9
Absolute Value [qlco]	9
Outcomes Research [resa]	9
intestinal cholesterol absorption [celf]	9
Operating Room [hcro, mnob]	9
Anomaly [fndg]	9
Particulate [sbst]	9
Macronutrients [resa]	9
Pleural effusions [dsyn]	9
Beta thalassaemia major [dsyn]	9
Aortic Pressure [lbtr]	9
Endocardium [tisu]	9
Target cholesterol level [clna]	9
wake [phsf]	9
care planning [inpr]	9
Axial [spco]	9
Paroxysmal supraventricular tachycardia [dsyn]	9
emergencies [phpr]	9
Clonidine [orch, phsu]	9
Thyroxin [aapp, horm, phsu]	9
Electron beam [mnob]	9
Diagnostic Technique [diap]	9
PAR [gngm]	9
Centers for Disease Control and Prevention [hcro]	9
Individual Differences [menp]	9
Vasomotor instability [fndg]	9
Laparotomy [topp]	9
Caput [blor]	9
Population Attributable Risk [qnco]	9
communicate [fndg]	9
Winter [tmco]	9
Arterial diameter [fndg]	9
Autosomal dominant [inpr]	9
Genital [bdsy]	9
russian [lang]	9
Interviewer [prog]	9
peaks [qnco]	9
Fragmented [ftcn]	9
Prematurity [aggp]	9
Ginseng [plnt]	9
Intravenous injection [ftcn]	9
Sequential Treatment [topp]	9
urate [fndg]	9
radiographs [diap]	9
Catheters [medd]	9
male patient [orga]	9
cerivastatin [orch, phsu]	9
Left ventricular diastolic dysfunction [dsyn]	9
stressful [ftcn]	9
skin toxicity [dsyn]	9
Transvaginal [spco]	9
After Care [hlca]	9
Transgenic [anim]	9
Intelligence [menp]	9
Liver Dysfunction [patf]	9
Omega [inpr]	9
Abscess [dsyn]	9
Photocoagulation [topp]	9
Alcohol Drinking [inbe]	9
Neuroprotection [celf]	9
Confluent [qlco]	9
Cardiac MRI [diap]	9
Chronic infection [dsyn]	9
Cyclo-Oxygenase I [aapp, enzy]	9
Target Gene [gngm]	9
Transthoracic [spco]	9
BB [geoa]	9
Amyloidosis [dsyn]	9
research question [idcn]	9
Clinical measurements [hlca]	9
Valvular regurgitation [patf]	9
Philosophy [ocdi]	9
Short stature [cgab, dsyn]	9
care plans [inpr]	9
Warning [gora]	9
Capillary Malformations [cgab]	9
South African [popg]	9
Incision [topp]	9
Postoperative Care [hlca]	9
Microarray [mnob]	9
Southwestern [spco]	9
Nitric Oxide Synthase, Inducible [aapp, enzy]	9
appeal [gora]	9
Multiply [ftcn]	9
Rat Aorta [bpoc]	9
Currency [mnob]	9
JAMA [gngm]	9
blood pressure change [fndg]	9
anesthesiologists [prog]	9
Congruent [qlco]	9
Scars [fndg]	9
grind [topp]	9
NEO [gngm]	9
Long chain fatty acid [bacs, lipd]	9
Hormone Receptor [aapp, rcpt]	9
Family medicine [bmod]	9
Age Distribution [qnco]	9
laboratory testing [lbpr]	9
Te [elii, hops]	9
Castration [topp]	9
Acute-Phase Proteins [aapp, bacs]	9
blood pressure lowering drug [phsu]	9
Immunofluorescence [lbpr]	9
Green tea [food]	9
Ventricles [bsoj]	9
Nucleus [celc]	9
Peripheral Blood Mononuclear Cells [cell]	9
stressors [idcn]	9
Tree [plnt]	9
Transient ischaemic attack [dsyn]	9
cryotherapy [topp]	9
Study, Feasibility [inpr, resa]	9
available drug [fndg]	9
Pass [fndg]	9
Hypothyroid [dsyn]	9
septic [ftcn]	9
telomere [celc]	9
Mexiletine [orch, phsu]	9
cope [inbe]	9
styles [idcn]	9
Organised [ftcn]	9
Calcium Channel [aapp, bacs]	9
Cerebrovascular accident [dsyn]	9
Mexican [popg]	9
QTC interval [clna]	9
blocks [patf]	9
Health assessment [hlca]	9
metre [qnco]	9
Reaches [fndg]	9
partners [famg]	9
Apex [qlco]	9
Hospital, General [hcro, mnob]	9
Three dimensional conformal radiotherapy [topp]	9
Precordium [blor]	9
Unified [idcn]	9
Soy Foods [food]	9
Arteries, Femoral [bpoc]	9
Potential, Action [celf]	9
NO Synthase [aapp, enzy]	9
Data Quality [qlco]	9
IMRT [topp]	9
Liquid Chromatography Mass Spectrometry [lbpr]	9
Fitting [sosy]	9
Prevail [phsu]	9
Left ventricular dilatation [cgab]	9
Therapeutic Trials [resa]	9
New South Wales [geoa]	9
Emotions [menp]	9
Carcinoid Heart Disease [dsyn]	9
prenatal [aggp]	9
Globalization [phpr]	9
Sex Steroid Hormones [horm, phsu]	9
Integrin [aapp, imft, rcpt]	9
right ventricular failure [dsyn]	9
Higher education [inpr]	9
derivation [idcn]	9
Live Births [qlco]	9
Somatostatin analogue [aapp, horm, phsu]	9
Insulin-like growth factor [aapp, horm, nsba]	9
pulmonary stenosis [anab, dsyn]	9
vascular access [medd]	9
Hospital Readmission [hlca]	9
Pulmonary Fibrosis [dsyn]	9
Pre-study [tmco]	9
Induction Chemotherapy [topp]	9
Kidney transplant [topp]	9
Muscle Strength [ortf]	9
Nerve [tisu]	9
Symptom Management [hlca]	9
Metabolic disorder [dsyn]	9
exclusions [ftcn]	9
Indapamide [orch, phsu]	9
Carcinomas [neop]	9
Indeterminate [idcn]	9
bypass grafting [topp]	9
alpha blockers [phsu]	9
Medrogestone [horm, phsu, strd]	9
Episodic [qlco]	9
Induced ventricular tachycardia [dsyn]	9
Cardiomyopathy, Idiopathic Dilated [dsyn]	9
Tricuspid Valve [bpoc]	9
shear stress [npop]	9
vte [orch]	9
Intravenous infusion [topp]	9
Fetuses [emst]	9
OPT [gngm]	9
Arteriovenous fistula [anab]	9
primary tumors [neop]	9
Peripheral Resistance [phsf]	9
growth hormone secretion [celf]	9
Neuroimaging [diap]	9
IHD [dsyn]	9
Regressing [patf]	9
Milestone [cnce]	9
Cognitive functions [menp]	9
Miss [cnce]	9
Bile acid [bacs, strd]	9
Nutritional counselling [edac]	9
Allogeneic [qlco]	9
Chronic phase [tmco]	9
exercise stress testing [diap]	9
Hospitals, Community [hcro, mnob]	9
stretch [topp]	9
Leukocyte Count [lbpr]	9
Generator [mnob]	9
Requisite [ftcn]	9
Retroperitoneal [bsoj]	9
Laser photocoagulation [topp]	9
Humor [inpr]	9
Anxiety Disorders [mobd]	9
Plasma C-reactive protein level [lbpr]	9
Nadir [qlco]	9
Likert scale [inpr]	9
Boston [geoa]	9
Subcutaneous Fat [tisu]	9
Taiwanese [popg]	9
post surgery [tmco]	9
Constrained [cnce]	9
DU [idcn]	9
endovenous [bsoj]	9
Black and White [orch, phsu]	9
Gonadotrophin [aapp, horm, phsu]	9
Stand alone [fndg]	9
cardiac cell [cell]	9
Hysterectomies [topp]	9
employers [prog]	9
Budget [inpr]	9
Centralized [idcn]	9
Communicating [ftcn]	9
Inequalities [qlco]	9
Piece [qnco]	9
ad libitum [qlco]	9
Coronary Angiographies [diap]	9
lipid lipoprotein [aapp, lipd]	9
Nuclear Translocation [moft]	9
hepatic lipase activity [moft]	9
HDL particle [celc]	9
Neighborhood [geoa]	9
Fistulas [anab]	9
holistic approach [idcn]	9
Nephrology [bmod]	9
Non-HDL cholesterol [bacs, strd]	9
intensities [qlco]	9
lipid oxidation [moft]	9
Psychiatric illness [mobd]	9
Appendix [bpoc]	9
Merged [acty]	9
Defibrillation Threshold [qnco]	9
Angiotensin I [aapp, nsba]	9
Neuroprotective Effects [ftcn]	9
Secondary Outcome Measure [inpr]	9
Cell Membrane [celc]	9
Small vessel [bpoc]	9
Ascites [fndg]	9
Nitric Oxide Pathway [moft]	9
Pellet [mnob]	9
Therapy, Complementary [topp]	9
Cyclosporin A [aapp, phsu]	9
Estradiol + Norethisterone [horm, phsu, strd]	9
Residency [edac]	9
Lung Cancers [neop]	9
Renal Failure, End-Stage [dsyn]	9
First Degree Relatives [qnco]	9
Paediatric intensive care unit [hcro, mnob]	9
Biological Therapy [topp]	9
Anti-Androgen [phsu]	9
Cytoplasm [celc]	9
Capillaries [bpoc]	9
Present Absent [cnce]	9
Antiretroviral Therapy, Highly Active [topp]	9
Polish [popg]	9
blood supply [bpoc]	9
Clozapine [orch, phsu]	9
Insulin level [lbpr]	9
Month-Year [tmco]	9
Employer [prog]	9
Blindness [dsyn]	9
Coronary artery surgery [topp]	9
Factor VIII [aapp, bacs, phsu]	9
Excite [acty]	9
Thyroid Hormones [aapp, horm]	9
Referent [cnce]	9
LF [gngm]	9
Gender Relations [socb]	9
Facial Nerve [bpoc]	9
Chicago [geoa]	9
Prostate cancer risk [fndg]	9
Restart [qlco]	9
Procedure complication [fndg]	9
managers [prog]	9
Informing [hlca]	9
Sera [bdsu]	9
INTERN [prog]	9
Regulatory Authority [gora]	9
Menopausal syndrome [dsyn]	9
Autoimmune Disease [dsyn]	9
norethindrone acetate [horm, phsu, strd]	9
Green [qlco]	9
Intra-operative [tmco]	9
Germ Cell Cancer [neop]	9
Single Nucleotide Polymorphism [nusq]	9
postmortem [diap]	9
Small Lesion [fndg]	9
level evidence [fndg]	9
signalling [biof]	9
Appetite [orgf]	9
post mi [dsyn]	9
Cyst [dsyn]	9
peri-menopausal [sosy]	9
increased triglycerides [fndg]	9
PGI [aapp, imft]	9
neonatal period [tmco]	9
Renal transplant [topp]	9
Lymphangiomas [neop]	9
Disagree [inpr]	9
Rural Population [popg]	9
Angiogenic Factor [bacs]	9
Immunoassay [lbpr]	9
Propofol [orch, phsu]	9
TWO VESSEL DISEASE [dsyn]	9
Hepatocytes [cell]	9
Malaysia [geoa]	9
Fatty Acids, Saturated [bacs, food, lipd]	9
Ideas [menp]	9
reassurance [topp]	9
Rehabilitation Outcome [qlco]	9
grading system [hlca]	9
Thailand [geoa]	9
Certification [gora]	9
Experimental Model [inpr]	9
Anecdotes [inpr]	9
Genetic Counseling [topp]	9
Mothers [famg]	9
White matter [tisu]	9
Benign Tumors [neop]	9
Hydroxylation [npop]	9
arterio-venous fistula [anab]	9
Critique [resa]	9
Nutraceuticals [food]	9
Antimicrobial [phsu]	9
PUFA [bacs, lipd]	9
Non-infected [ftcn]	9
bypass grafts [topp]	9
GE [gngm]	9
Heart transplant [topp]	9
hypothermic [fndg]	9
accepting [qlco]	9
Serum insulin [lbpr]	9
Upper Extremity [bpoc]	9
Age related macular degeneration [dsyn]	9
Watchful Waiting [hlca]	9
Kawasaki Disease [dsyn]	9
Chest Radiography [diap]	9
Walls [mnob]	9
qalys [tmco]	9
Monte Carlo [qnco]	9
Stereotactic radiotherapy [topp]	9
Raised blood pressure [fndg]	9
Pubertal [fndg]	9
New finding [fndg]	9
SAW [medd]	9
Body fat mass [orga]	9
management program [ocac]	9
Metric [orch, phsu]	9
Catecholamines [nsba, phsu]	9
undefined [idcn]	9
oxygenation [ortf]	9
Follow-up visit [hlca]	9
Orthostatic [phsf]	9
Medication therapy [topp]	9
Biological Factors [bacs]	9
Lymphatic System [bdsy]	9
Flux [npop]	9
von Willebrand factor antigen [aapp, bacs, phsu]	9
manager [prog]	9
Human Cell Line [cell]	9
Drug resistance [biof]	9
high-density lipoprotein particle [celc]	9
Cr [lbpr]	9
PATH [lbpr]	9
Speckled [qlco]	9
Cmax [qnco]	9
meditation [menp]	9
Equol [orch]	9
Model, Economic [inpr, qnco]	9
Pennsylvania [geoa]	9
Rhythmicities [tmco]	9
Adult care [topp]	9
Synthetic steroid [strd]	9
HP [neop]	9
Thyroid-Stimulating Hormone [aapp, horm, phsu]	9
dronedarone [orch, phsu]	9
Centre [spco]	9
superoxide dismutase activity [moft]	9
Posterior wall [spco]	9
Visualized [ftcn]	9
Supine Position [spco]	9
Prolonged QT interval [fndg]	9
osteoporosis risk [dsyn]	9
deferiprone [orch, phsu]	9
Antirheumatic Drugs, Disease-Modifying [phsu]	9
Scarring [patf]	9
medication taking [dora]	9
Control Animal [anim]	9
Thing [enty]	9
genetic profile [lbpr]	9
Teaching Hospitals [hcro, mnob]	9
Kidney Diseases [dsyn]	9
patient interview [hlca]	9
Viewpoint [inpr]	9
Adhesive [mnob]	9
ENGL [gngm]	9
Bioavailable [qlco]	10
VAS [diap]	10
Normal limits [qnco]	10
Electron Beam Computed Tomography [diap]	10
Blood Pressure, Low [fndg]	10
filtration [lbpr]	10
classifying [clas]	10
antihyperglycemic [phsu]	10
house [cnce]	10
Precautions [cnce]	10
Impaired left ventricular function [fndg]	10
Peripheral edema [fndg]	10
Impairments [patf]	10
overexpress [genf]	10
Low Dose Radiation [topp]	10
ERS [clna]	10
Pulmonary Edema [dsyn]	10
Atrial arrhythmias [patf]	10
Prices [qnco]	10
mg/kg body weight [qnco]	10
Finish [ftcn]	10
Microscopic [qlco]	10
Prolactin [aapp, horm, phsu]	10
Reduced life expectancy [fndg]	10
Steady [qlco]	10
Duke [lbpr]	10
Timed [tmco]	10
cancer therapies [topp]	10
Phase II Trial [resa]	10
Injections, Intralesional [topp]	10
neurological disease [dsyn]	10
Calf [blor]	10
Myocardial Reperfusion [topp]	10
Speaking [dora]	10
Supraclavicular [spco]	10
Target lesion [dsyn]	10
elders [orch, phsu]	10
Over-the-Counter [phsu]	10
Leisure physical activity [dora]	10
health care services [hlca]	10
Lumen Diameter [qnco]	10
tomography [diap]	10
narrowed [qnco]	10
cell therapies [topp]	10
kinetic [npop]	10
Bile Acid Sequestrant [phsu]	10
controlling hypertension [fndg]	10
Global Health [grpa]	10
Speak [dora]	10
Destination [spco]	10
Cholesterol Inhibitors [phsu]	10
Redistribution [ftcn]	10
stress reduction [inbe]	10
Duplex ultrasound [diap]	10
psychosomatic [qlco]	10
Flow Cytometries [lbpr]	10
secondary cancer [neop]	10
Chile [geoa]	10
Pre-specified [qlco]	10
Focus Groups [grup]	10
blood pressure increase [fndg]	10
Trough [qnco]	10
Conventional Surgery [topp]	10
Chronic Obstructive Lung Disease [dsyn]	10
Intestine, Small [bpoc]	10
Estrogen receptor positive [lbtr]	10
Dietary Fiber [food]	10
REGAIN [food]	10
Detector [medd]	10
Cardiovascular Physiology [ortf]	10
Prostaglandin [bacs, eico, phsu]	10
Treatment Protocols [topp]	10
Endocrine therapy [topp]	10
symptomatic relief [idcn]	10
DD [fndg]	10
Antitumor [qlco]	10
Estradiol + norethindrone acetate [horm, phsu, strd]	10
patient safety [hlca]	10
Western Australia [geoa]	10
Obstructed [ftcn]	10
Population Study [resa]	10
Vegetation [anab]	10
OTC [phsu]	10
Faculty [prog]	10
ranolazine [orch, phsu]	10
Methionine [aapp, bacs, phsu]	10
instructions [inpr]	10
Construction [topp]	10
Mice, Transgenic [mamm]	10
medical record review [hlca]	10
exponential [qlco]	10
Dehydration [dsyn]	10
Area Under Curve [qnco]	10
Neta [fngs]	10
Symptom control [topp]	10
Indometacin [orch, phsu]	10
Heart Failure, Systolic [dsyn]	10
Resin [bodm]	10
Levothyroxine [aapp, horm, phsu]	10
CONGENITAL ANOMALIES [cgab]	10
Peak Concentration [qnco]	10
Rheology [ocac]	10
Asians [popg]	10
Atria [bpoc]	10
Infrared [qlco]	10
Barium enema [diap]	10
Abstraction [inpr]	10
Transfection [genf, mbrt]	10
Russia [geoa]	10
tailed [bpoc]	10
Preexisting [qlco]	10
debulking [topp]	10
virtual [inpr]	10
Thoracotomy [topp]	10
Gadolinium [elii, irda]	10
Sarcopenia [fndg]	10
thienopyridines [orch, phsu]	10
Labor [orgf]	10
Cholesterol, VLDL [bacs, strd]	10
Tower [mnob]	10
Noradrenaline [nsba, orch, phsu]	10
Medical practitioners NOS [prog]	10
Elderly Adult [aggp]	10
Disadvantaged [popg]	10
pharmacogenomic [bmod]	10
electronic health record [idcn]	10
Cardiac fibrosis [dsyn]	10
artery wall [bpoc]	10
Moderate to severe [qlco]	10
proteomic [bmod]	10
Coronary Occlusion [dsyn]	10
health care policy [rnlw]	10
Nerve damage [inpo]	10
Fluoroscopic guidance [diap]	10
Minorities [popg]	10
Increased cholesterol [fndg]	10
Caribbean [geoa]	10
endometrial biopsy [diap]	10
Multiple Sclerosis [dsyn]	10
Destroy [idcn]	10
serum estrogen [lbpr]	10
external-beam radiation [topp]	10
Conflict [inbe]	10
controlled randomized trial [inpr, resa]	10
arteriosclerotic [ftcn]	10
Cardiopathy [dsyn]	10
Pre-intervention [tmco]	10
General Public [popg]	10
Talk [orgf]	10
Barthel index [inpr]	10
Subset Analysis [resa]	10
LP [diap, topp]	10
Photons [sbst]	10
Medication Nonadherence [fndg]	10
White Cell [cell]	10
Interventricular septum [bpoc]	10
Population-Based Registry [inpr]	10
Coarctation [cgab]	10
Serum homocystine level [lbpr]	10
Transcription Factors [aapp, bacs]	10
high estradiol [fndg]	10
symptomatic aortic stenosis [dsyn]	10
Postnatal [tmco]	10
Twins [famg]	10
thrombotic occlusion [patf]	10
mimetic [bmod]	10
cavity [dsyn]	10
Department of Veterans Affairs [hcro]	10
Eyes [bpoc]	10
Jupiter [geoa]	10
Exercise Tests [diap]	10
Tail [bpoc]	10
Air Pollution [eehu]	10
Anti-anginal Agent [phsu]	10
Great vessels [bpoc]	10
Ventricular Tachycardias [patf]	10
Osteopenia [patf]	10
Active Surveillance [hlca]	10
Myoglobin [aapp, bacs]	10
Response, Acute-Phase [patf]	10
Hydrophilic [qlco]	10
Epidemiological Study [resa]	10
Nutrition Intervention [topp]	10
creatine kinase levels [fndg]	10
Risk Adjustment [qnco]	10
quantities [qnco]	10
Adipocyte [cell]	10
Drug action [patf]	10
Health care facilities [hcro, mnob]	10
Iranian [popg]	10
disciplines [hlca]	10
Low-Dose Treatment [resa]	10
Stress, Psychological [mobd]	10
Health Expenditure [qnco]	10
SEP [gngm]	10
Myositis [dsyn]	10
Developing Country [qlco]	10
Wolff-Parkinson-White Syndrome [dsyn]	10
Myocardial disease [dsyn]	10
Local Therapy [topp]	10
normal glucose [fndg]	10
currents [tmco]	10
Compartments [bsoj]	10
increasing incidence [ftcn]	10
Liver Transplantation [topp]	10
Resistance.index [clna]	10
Ambiguous [orga]	10
fibric acid [orch, phsu]	10
Outcome Studies [resa]	10
QTC PROLONGATION [fndg]	10
Downward [spco]	10
likelihood ratio [qnco]	10
Breast Density [clna]	10
Cardiovascular symptoms [sosy]	10
Hematologic [bmod]	10
Survey, Community [resa]	10
Florida [geoa]	10
racial differences [fndg]	10
prerequisite [idcn]	10
Irregular bleeding NOS [sosy]	10
Fluid retention NOS [patf]	10
Partner [famg]	10
miRNAs [bacs, nnon]	10
Appearances [qlco]	10
Hypertension, Portal [dsyn]	10
Cardiovascular History [clna]	10
lymph nodes [bpoc]	10
NEW MYOCARDIAL INFARCTION [fndg]	10
Para [fndg]	10
Bottom [spco]	10
Urine Collection [lbpr]	10
Wire [medd]	10
Le [bdsy]	10
L-Carnitine [aapp, phsu]	10
Hypertensive crisis [dsyn]	10
Mechanical Circulatory Support [topp]	10
Balancing [orgf]	10
Supratentorial [spco]	10
Head+Neck [blor]	10
Operable [qlco]	10
Infantile hemangioma [neop]	10
Conventional angiography [diap]	10
symposium [hcpp]	10
Autoimmune disorders [dsyn]	10
Physician Decision [cnce]	10
Neurohumors [nsba]	10
oncologists [prog]	10
payment [qnco]	10
Middle Age [tmco]	10
Accrual [ftcn]	10
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]	10
Powder [bodm]	10
Arteriovenous Fistulas [anab]	10
Plasma lipoprotein levels [lbpr]	10
IM [idcn]	10
Urbanization [hcpp]	10
Smoking History [fndg]	10
Tonometry [diap]	10
Mood Disorders [mobd]	10
Bacterial Endocarditis [dsyn]	10
Secondary Malignant Neoplasm [neop]	10
Estrogen Receptors alpha [aapp, rcpt]	10
Extubation [topp]	10
Singapore [geoa]	10
Cell Lines [cell]	10
invasive cancer [neop]	10
Serum Amyloid A [aapp, imft]	10
Alternative Medicine [bmod]	10
Giant [dsyn]	10
T-Cells [cell]	10
Felodipine [orch, phsu]	10
Psychotropic [phsu]	10
Intravenous Glucose Tolerance Test [diap]	10
ex smokers [fndg]	10
Residue [cnce]	10
Perioperative Care [hlca]	10
Practice nurse [prog]	10
Pharmacy, Community [hcro]	10
Adenosine Diphosphate [bacs, nnon]	10
Hormone preparation [mnob]	10
Tube [medd]	10
Cervical Cancer [neop]	10
Degenerative Disease [dsyn]	10
Gastrointestinal symptoms NOS [sosy]	10
Fuel [mnob]	10
Lab [mnob, orgt]	10
Arterial structure [bpoc]	10
American College of Physicians [prog]	10
educational intervention [topp]	10
Acute kidney injury [dsyn]	10
Engineering [ocdi]	10
affected patients [qlco]	10
Breast surgery [topp]	10
Genetic Risk [qnco]	10
positioning [topp]	10
metabolic equivalent [qnco]	10
Private Sector [popg]	10
forces [phpr]	10
HL [aapp, enzy]	10
Loop [medd]	10
Thoracic Surgery [bmod]	10
Presyncope [sosy]	10
Nutrient intake [qnco]	10
Breakthrough [qlco]	10
Diagnostic Imaging [diap]	10
National Institutes of Health stroke scale score [clna]	10
Prosthetic Valve Thrombosis [dsyn]	10
Miscellaneous [qlco]	10
Nanotechnology [ocdi]	10
Type III [clas]	10
Box [mnob]	10
Death certificate [inpr, mnob]	10
Accidents [inpo]	10
Micturition [orgf]	10
EZETIMIBE/SIMVASTATIN [orch, phsu]	10
Supraventricular tachyarrhythmias [patf]	10
Atropine [orch, phsu]	10
Adipokines [aapp, bacs]	10
Critical Illness [dsyn]	10
Investigational [qlco]	10
Random Allocation [resa]	10
Left side [spco]	10
displays [ftcn]	10
OC [gngm]	10
Coronary arteriography [diap]	10
Monkey [mamm]	10
Platelet glycoprotein IIb-IIIa [aapp]	10
homocysteine metabolism [moft]	10
RI [geoa]	10
Decision Aids [inpr]	10
Nanoparticle [mnob]	10
Pre-Existing Diseases [rnlw]	10
Chlamydia pneumoniae [bact]	10
Low Cardiac Output [fndg]	10
Norgestrel [horm, phsu, strd]	10
Coated [qlco]	10
Sex Ratio [qnco]	10
Supplied [acty]	10
National Institutes of Health stroke scale [inpr]	10
Prone Position [spco]	10
Hemorheology [phsf]	10
Lymph node [bpoc]	10
Hormone Replacement Preparation [phsu]	10
Early Childhood [tmco]	10
Reproductive History [fndg]	10
Cardiac biomarkers [clna]	10
Type IV [clas]	10
biosynthesis [ftcn]	10
agenda [inpr]	10
Gene Transcription [genf]	10
IU/L [qnco]	10
Displacement [menp]	10
Surrogate End Point [qlco]	10
bradyarrhythmias [dsyn]	10
moved [ftcn]	10
Angle [spco]	10
associated symptoms [sosy]	10
Acute Rheumatic Fever [dsyn]	10
Micro RNA [bacs, nnon]	10
Ions [elii]	10
BrAnd [phsu, strd]	10
Hypoplastic Left Heart Syndrome [cgab, dsyn]	10
Spinal cord injury [inpo]	10
infarcted [ftcn]	10
Erythropoietin [aapp, horm, phsu]	10
Right heart [blor]	10
angiogram [diap]	10
Estrogen hormone therapy [topp]	10
Stent placement [topp]	10
Psychotherapy [topp]	10
flavonoid [orch, phsu]	10
Pan [mamm]	10
Lengths [qnco]	10
Loop Diuretics [phsu]	10
Attending physician [prog]	10
olive oil [lipd, phsu]	10
unreliable [idcn]	10
Reduced Activity [sosy]	10
Pearson Correlation Coefficient [qnco]	10
c-AMP [nnon, phsu]	10
aborted [inpr]	10
effusion [patf]	10
Glomerular [bpoc]	10
Late Adverse Effect [patf]	10
High risk factors [fndg]	10
anti inflammatory drugs [phsu]	10
Antiplatelet drug [phsu]	10
Crosstalk [moft]	10
signaling pathway [celf]	10
diary [inpr]	10
plasminogen activator activity [moft]	10
Sales [ocac]	10
positions [spco]	10
killed [socb]	10
Fasting state [fndg]	10
Bronchial [bpoc]	10
increased insulin [dsyn]	10
Wound Healing [orgf]	10
Virus [virs]	10
Vector [nnon]	10
Wild Type Mouse [mamm]	10
Menopausal symptom [sosy]	10
Dazed [mobd]	10
Prostaglandin E [bacs, eico]	10
Birth Cohort [qnco]	10
Left ventricular failure [dsyn]	10
Ulcers [patf]	10
Renal Artery [bpoc]	10
Reference Range [qnco]	10
categorization [clas]	10
consulted [hlca]	10
Fats [lipd, phsu]	10
Chemical Structure [inpr]	10
Cardiac troponin I [aapp, bacs]	10
elasticity [npop]	10
Cheek [blor]	10
QT interval [clna]	10
Echocardiography, Stress, Dobutamine [diap]	10
Profession [ocdi]	10
Population Analysis [resa]	10
Group P [inpr]	11
Psychometric [diap]	11
occlusions [patf]	11
Cystic [qlco]	11
mipomersen [nnon, phsu]	11
coalition [socb]	11
Micronutrient [bacs, elii]	11
Chronic Renal Disease [dsyn]	11
Literacy [ftcn]	11
Undetermined [idcn]	11
Respiratory function [phsf]	11
Deployment [acty]	11
Pulmonary Diseases [dsyn]	11
workforce [ftcn]	11
Pearson Correlation [inpr]	11
Treatment Costs [qnco]	11
treatment field [blor]	11
SEVEN-DAY [inpr]	11
Hyperphosphataemia [dsyn]	11
Extracorporeal Membrane Oxygenation [topp]	11
Vagina [bpoc]	11
Paraoxonase [aapp, enzy]	11
Mesenchymal Stem Cells [cell]	11
t-Test [inpr]	11
Paired t-Test [inpr]	11
Fibrin D-dimer [aapp, bacs]	11
EPIC [lbpr]	11
Insensitivity [fndg]	11
Trust [inbe]	11
ED [idcn]	11
Inappropriate Prescribing [hlca]	11
belgian [popg]	11
Large artery [bpoc]	11
peak flow [fndg]	11
Poverty [grpa]	11
Conception [orgf]	11
Euglycaemic Clamp [resd]	11
warnings [gora]	11
signal intensity [qnco]	11
Assisting [hlca]	11
Nasal [bpoc]	11
Digit [bpoc]	11
Girl [aggp]	11
FATE [gngm]	11
Gall Bladder Disease [dsyn]	11
Ventricular Remodeling [ortf]	11
Skeleton [bdsy]	11
Suite [inpr]	11
Intraluminal [spco]	11
Irradiate [topp]	11
triggers [clna]	11
Synchronous [tmco]	11
South Africa [geoa]	11
Abuse [fndg]	11
PR+ [lbtr]	11
Speech [orgf]	11
Neoplastic [qlco]	11
Benign condition [fndg]	11
Bioequivalence [qlco]	11
Euthyroid [fndg]	11
hydrochloride [inch, phsu]	11
Microbiological [inpr]	11
Utilities [orgt]	11
blood pressure regulation [orgf]	11
A-BETA [gngm]	11
Clarity [clna]	11
Dysphagia [dsyn]	11
Impedance [phsf]	11
Involution [orgf]	11
Predisposing Factor [tmco]	11
Embolic Agent [chvf]	11
subtotal [qnco]	11
Methylene Tetrahydrofolate Reductase [aapp, enzy]	11
Mortalities [qnco]	11
Modem [mnob]	11
Hyperparathyroidism [dsyn]	11
catabolism [ftcn]	11
cleared [ftcn]	11
metabolic disturbance [dsyn]	11
Carotene [bacs, orch]	11
Manipulate [topp]	11
Tumor stage [clna]	11
Respiratory Diseases [dsyn]	11
Delirium [mobd]	11
BAX [aapp, bacs]	11
recurring [phpr]	11
Addiction [mobd]	11
Mental illness [mobd]	11
TIMI Flow [clna]	11
Introduces [ftcn]	11
Western Blotting [lbpr, mbrt]	11
Hypotension, Orthostatic [fndg]	11
Increased thickness [fndg]	11
Proton Therapy [topp]	11
Reluctance [menp]	11
Cardioverter [medd]	11
Activated Protein C Resistance [dsyn]	11
Soy Isoflavone [aapp, phsu]	11
untreated hypertension [fndg]	11
disease duration [tmco]	11
Androstenedione [horm, phsu, strd]	11
Octreotide [aapp, horm, phsu]	11
Bile [bdsu]	11
editorials [inpr]	11
Heat [npop]	11
Neoadjuvant Therapy [topp]	11
Drug Discovery [resa]	11
Open heart surgery [topp]	11
mainstream [edac]	11
Diabetes Complications [patf]	11
female sex hormone [lbtr]	11
Cell Cycle [celf]	11
Capital [qnco]	11
Oral Route [ftcn]	11
compositions [clna]	11
Pharmacist, Clinical [prog]	11
Total testosterone [horm, phsu, strd]	11
Plasmapheresis [topp]	11
Multicenter Studies [resa]	11
Kidney Failure [dsyn]	11
Depressed Mood [mobd]	11
Benchmark [qnco]	11
retinyl palmitate [orch, phsu, vita]	11
Revise [topp]	11
Combination Chemotherapy [topp]	11
Sodium intake [clna]	11
calorie [qnco]	11
Right breast [bpoc]	11
Acute infarct [patf]	11
Exam [hlca]	11
Cysts [dsyn]	11
Definitive Treatment [topp]	11
Norfolk [geoa]	11
TNF [aapp, imft]	11
cost treatment [qnco]	11
Educating [edac]	11
conduction disturbance [patf]	11
Amino Acids [aapp, bacs, phsu]	11
Down Syndrome [cgab, dsyn]	11
Calendar year [tmco]	11
Survival Analyses [resa]	11
Bloodstream [phsf]	11
Palliative Care [hlca]	11
Substance Abuse [mobd]	11
Russian Federation [geoa]	11
wellness [idcn]	11
Enzyme Immunoassay [lbpr]	11
NIH [hcro]	11
Chronic nephritis [dsyn, fndg]	11
contour [inch]	11
Proliferating [ftcn]	11
Sudden onset [inpr]	11
Telemedicine [hlca]	11
Prosthetic valve [medd]	11
Geographic Area [geoa]	11
Hepatic Metabolism [ortf]	11
Radiation Oncologist [prog]	11
Saturation [phpr]	11
Cardiac Volume [orgf]	11
Tree, Decision [inpr]	11
c group [clas]	11
stress testing [diap]	11
Border [spco]	11
Normal saline [inch, phsu]	11
Blood pressure elevation [fndg]	11
Left coronary artery [bpoc]	11
Lower body [bpoc]	11
Refill [idcn]	11
Vital signs [clna]	11
Bearing [medd]	11
Married [fndg]	11
Blood Vessel [bpoc]	11
Primary Reason [idcn]	11
Tricuspid Regurgitation [dsyn]	11
Aortas [bpoc]	11
Blood Treatment [topp]	11
Renal diseases [dsyn]	11
Autonomy [idcn]	11
Proton [elii]	11
Pituitary Adenoma [neop]	11
WT [fish]	11
Disclosure [inbe]	11
Arterial system [bdsy]	11
treatment program [hlca]	11
lung function [ortf]	11
Storm NOS [inpo]	11
diabetes prevention [edac]	11
Venous thromboembolic disease [patf]	11
Direct current cardioversion [topp]	11
Knee [bpoc]	11
Mesenteric [blor]	11
Legal [inpr]	11
cardiovascular collapse [patf]	11
categorize [acty]	11
HPLC [lbpr]	11
Mexico [geoa]	11
Pai [idcn]	11
Myocytes [cell]	11
Hypoglycaemic [phsu]	11
Allergy [bmod]	11
Blood Transfusion [topp]	11
Endometriosis [dsyn]	11
Card [inpr]	11
HIV/AIDS [dsyn]	11
Angiotensinogen [aapp, bacs]	11
Peritoneal [bpoc]	11
Appointments [idcn]	11
conduits [medd]	11
venous drainage [phsf]	11
low-density lipoprotein particle [celc]	11
adrenoceptor [aapp, rcpt]	11
Nucleotide [nnon]	11
Apnea hypopnea index [fndg]	11
immune responses [ortf]	11
Digestive [orgf]	11
conventional medicine [bmod]	11
Cardiac troponin T [aapp, bacs]	11
Patient Records [inpr]	11
Digestion [orgf]	11
health care use [inbe]	11
Hypolipidemic Drugs [phsu]	11
neurological symptoms [sosy]	11
Customized [acty]	11
peer [popg]	11
Molecular Biology [bmod]	11
Phospholipid [bacs, lipd]	11
Cerebral Blood Flow [ortf]	11
Low Prevalence [qnco]	11
Curcumin [irda, orch, phsu]	11
free fatty acid [lipd]	11
Xanthine Oxidase [aapp, enzy]	11
Withdrawal bleeding [dsyn]	11
daily activities [dora]	11
Phenomena [phpr]	11
Dexamethasone [phsu, strd]	11
Conscious [menp]	11
cholesterol biosynthesis [moft]	11
Charge [qnco]	11
Cellular proliferation [patf]	11
UN [orgt]	11
Acute heart disease [dsyn]	11
Nervous [sosy]	11
Certified [gora]	11
dietary intakes [orgf]	11
Right side [spco]	11
Liver diseases [dsyn]	11
Neointima [acab]	11
Anterior myocardial infarction [dsyn]	11
Sectional [spco]	11
Octogenarians [aggp]	11
Seropositive [qlco]	11
Serum uric acid level [lbpr]	11
Fluids [bdsu]	11
Delivery system [ftcn]	11
Publisher [ocdi]	11
Albumin/creatinine ratio [lbpr]	11
Lymphangioma [neop]	11
Arterial flow [fndg]	11
Intra-Abdominal Fat [tisu]	11
Myeloperoxidase [aapp, enzy]	11
drug response [orgf]	11
surgeries [hlca]	11
estrogen therapies [topp]	11
physiopathology [ftcn]	11
Southeastern [spco]	11
Remnant [emst]	11
Long Q-T syndrome [dsyn]	11
Dyslipoproteinemia [patf]	11
Publishing [ocac]	11
Pulmonary Circulation [ortf]	11
Cholesteryl Esters [bacs, strd]	11
Perfusion Imaging [diap]	11
Aldosterone Antagonists [phsu]	11
Intravascular ultrasound [diap]	11
Tissue damage [inpo]	11
Endothelin Receptor Antagonists [moft]	11
Pandemic [phpr]	11
Caucasians [popg]	11
TIA [dsyn]	11
elevated serum cholesterol [fndg]	11
cholesterol inhibitor [phsu]	11
THIRTY-DAY [inpr]	11
transporters [aapp, bacs]	11
shear [medd]	11
Thromboembolism, Pulmonary [dsyn]	11
Cell Signaling [celf]	11
Uraemia [dsyn]	11
Grouping [ftcn]	11
Rapamycin [antb, orch]	11
Glucose concentration [lbpr]	11
Discipline [hlca]	11
Musculoskeletal [ftcn]	11
Carotid artery disease [dsyn]	11
connections [inpr]	11
Coronary artery calcification [patf]	11
Defibrillators [medd]	11
Identity [menp]	11
Familial combined hyperlipidaemia [dsyn]	11
Hypertensive disease [dsyn]	11
Raloxifene Hydrochloride [orch, phsu]	11
Interventional Cardiology [inpr]	11
vehicles [bodm]	11
Cell Viability [celf]	11
diuretic therapy [topp]	11
Strains [inpo]	11
polyps [anab]	11
Percutaneous Transluminal Angioplasty [topp]	11
functional recovery [sosy]	11
Thiazide diuretic [orch, phsu]	11
Behavioral Interventions [topp]	11
Experimental Design [resa]	11
Localised [spco]	11
Thoracic aorta [bpoc]	11
bone markers [medd]	11
Arterial patency [orga]	11
National Health Insurance [hlca]	11
Cancer Research [resa]	11
partial response [fndg]	11
Acute phase reactant [aapp, bacs]	11
Character [menp]	11
Transitional [spco]	11
Genome, Human [gngm]	11
Joints [bsoj]	11
risk population [popg]	11
current medication [fndg]	11
Three times daily [tmco]	11
Orbit [bsoj]	11
EPC [opco, phsu]	11
Staphylococcus aureus [bact]	11
Tea [food]	11
Paris [geoa]	11
argument [socb]	11
Transplantation, Renal [topp]	11
communicated [fndg]	11
Intentions [menp]	11
Gauge [spco]	11
Round [spco]	11
Lymphoblastic Leukemia, Acute, Childhood [neop]	11
Health Benefit [qnco]	11
Upward [spco]	11
New Diagnosis [diap]	11
msec [tmco]	11
Perfuse [ftcn]	11
Initial presentation [ftcn]	11
Plant Sterols [bacs, phsu, strd]	11
Serious Event [qlco]	11
Geography [ocdi]	11
VASOSPASM [ortf]	11
Repaired [ftcn]	11
contacting [ftcn]	11
Nd-YAG laser [medd]	11
criticism [socb]	11
Medication Management [hlca]	11
Inner [spco]	11
Observational Trial [resa]	11
physical conditioning [dora]	11
N-terminal pro-B-type natriuretic peptide [aapp, bacs]	11
Meat [food]	11
SPECT [diap]	11
Counterbalance [mnob]	11
Ventricular volume [qnco]	11
Anticholinergic [phsu]	11
Mixed hyperlipidaemia [dsyn]	11
Recurrent strokes [fndg]	11
Low testosterone [fndg]	11
predisposed [ftcn]	11
Uterine Artery [bpoc]	11
Saturated [phpr]	11
Microspheres [medd]	11
Pakistan [geoa]	11
Particle Size [qnco]	11
Psychological Factors [menp]	11
Paediatrician [prog]	11
Recurrence Risk [qnco]	11
Analgesic [phsu]	11
Small artery [bpoc]	11
vegetations [anab]	11
Stereotactic [spco]	11
cholesterol efflux [celf]	11
Blood Flow Velocity [lbtr]	11
normal control [qlco]	11
Laparoscopic [diap]	11
Pleural [spco]	11
IU/day [qnco]	11
physical therapy [bmod]	11
DXA [diap]	11
Exertion [orgf]	11
control population [ocdi]	11
resins [bodm]	11
Proxy [grup]	11
New York Heart Association Class II [fndg]	11
Crohn Disease [dsyn]	11
sexual dimorphism [ortf]	11
Conditioning [menp]	11
pulmonary toxicity [patf]	11
MOLECULAR BASIS [idcn]	11
Healthy Aging [grpa]	11
Managed Care Organization [hcro, mnob]	11
Severity score [qnco]	11
Cysteine [aapp, bacs]	11
Quinidine [orch, phsu]	11
formulary [inpr]	11
Aortic Arch [bpoc]	11
Lipopolysaccharide [lipd]	11
Fund [qnco]	11
glucose level [lbpr]	11
Hereditary [ftcn]	11
Familiarity [menp]	12
Progesterone therapy [topp]	12
Setup [idcn]	12
geriatric patients [podg]	12
Appreciation [cnce]	12
Vascular anomaly [anab]	12
Epigenetic [bmod]	12
Androgen level [lbpr]	12
Myocardial Scintigraphy [diap]	12
torcetrapib [orch]	12
medical services [hlca]	12
doubts [menp]	12
Corrected QT Interval [qnco]	12
Epinephrine [horm, nsba, orch, phsu]	12
Ectopic [spco]	12
QRS duration [orga]	12
Electron Beam Tomography [diap]	12
reflux [dsyn]	12
Care Giver [prog]	12
In progress [ftcn]	12
Baseline pressure [qnco]	12
layers [bpoc]	12
mg/g [qnco]	12
Fish Oils [bacs, lipd, phsu]	12
Cystic Fibrosis [dsyn]	12
Cavernous haemangioma [neop]	12
Subclass [clas]	12
Assemble [acty]	12
Physiological Processes [phsf]	12
testicular [spco]	12
Phytochemical [bacs, orch]	12
Plant food [mnob]	12
deteriorate [fndg]	12
anginal attacks [dsyn]	12
Cardiac defects [dsyn]	12
Unwilling [menp]	12
Major Depressive Disorder [mobd]	12
Massage [topp]	12
Smallest [qnco]	12
contoured [inch]	12
Low estradiol [fndg]	12
Blood pressure response [clna]	12
Normoglycaemic [fndg]	12
serum calcium [lbtr]	12
How Much [qnco]	12
Antibiotic Prophylaxis [topp]	12
Cardiology clinic [inpr]	12
Durations [tmco]	12
Bicycle [mnob]	12
Relative Survival [qnco]	12
trastuzumab [aapp, imft, phsu]	12
pacemakers [medd]	12
cardiac symptoms [sosy]	12
Nicorandil [orch, phsu]	12
trimegestone [orch, phsu]	12
Edge [spco]	12
Lipolyses [orgf]	12
Anti-Oxidant Effect [phsf]	12
urban area [spco]	12
Tip [medd]	12
Neutrophils [cell]	12
mounted [fndg]	12
Breath [bdsu]	12
Right heart catheterisation [diap]	12
Principal diagnosis [qlco]	12
BNP [lbpr]	12
stress test [diap]	12
Cooperative Group [prog]	12
Hospital clinic [hcro, mnob]	12
Monoclonal Antibodies [aapp, imft]	12
Right ventricular outflow tract [bsoj]	12
Hyperthyroidism [dsyn]	12
Meals [dora]	12
plasma glucose level [lbtr]	12
Union [clas]	12
Taking medication [dora]	12
Inaccurate [qlco]	12
Infarcts [patf]	12
pulmonary arterial pressure [diap]	12
Transcatheter Aortic Valve Implantation [topp]	12
Chronic atrial fibrillation [dsyn]	12
Vascular structure [bpoc]	12
Cell surface [celc]	12
Muscular [tisu]	12
homeostatic [biof]	12
Quercetin [orch, phsu, vita]	12
Confidence Limits [qnco]	12
Antiestrogen [phsu]	12
Medication review [hlca]	12
Wound [inpo]	12
Transmural [ftcn]	12
Right bundle branch block [dsyn]	12
PAS [orch, phsu]	12
battery [mnob]	12
Energy Balance [orgf]	12
Critical Care [hlca]	12
Pharmacies [hcro]	12
adaptations [orgf]	12
SP [tmco]	12
recur [phpr]	12
Healed [ftcn]	12
Copy [mnob]	12
Melatonin [horm, nsba, orch, phsu]	12
Elderly person [popg]	12
Nano [qnco]	12
Adenosine Triphosphate [bacs, nnon, phsu]	12
Study duration [tmco]	12
t cruzi [dsyn]	12
Relieves [ftcn]	12
Cyanosis [sosy]	12
expressions [topp]	12
Stress management [hlca]	12
Chest X-ray [diap]	12
Reassuring [hlca]	12
transparency [qlco]	12
Antidiabetic Agents [phsu]	12
antagonism [socb]	12
pre-diabetic [dsyn]	12
Genomics [bmod]	12
one time [inpr]	12
Alteplase [aapp, enzy, phsu]	12
percentiles [qnco]	12
Secondary Care [hlca]	12
Grapes [food]	12
Economically [ocdi]	12
Pulsatile [tmco]	12
Rheumatology [bmod]	12
Glaucoma [dsyn]	12
Glue [mnob]	12
Thymidine [bacs, nnon]	12
Insulin resistance syndrome [patf]	12
Multifocal [spco]	12
proposal [idcn]	12
MicroRNAs [bacs, nnon]	12
Foci [spco]	12
Consented [qlco]	12
Venous blood [tisu]	12
Cardiac rate [clna]	12
ESRD [dsyn]	12
U/L [qnco]	12
Gestational Age [orga]	12
iron chelation therapy [topp]	12
clots [acab]	12
experimental study [resa]	12
Bilateral Ovariectomy [topp]	12
Arrhythmias, supraventricular [patf]	12
Tumor Bed [spco]	12
restrict [ftcn]	12
Ranking [inpr]	12
Proteome [aapp, bacs]	12
Electrocardiographic changes [fndg]	12
Middle Cerebral Artery [bpoc]	12
Goes [euka]	12
Knowledgeable [fndg]	12
Immunity [phsf]	12
SMR [geoa]	12
Target vessel [blor]	12
resolving [idcn]	12
depleted [ftcn]	12
colesevelam [orch, phsu]	12
chow [mamm]	12
Varicosities [dsyn]	12
Hypertrophic [patf]	12
Care management [clna]	12
health information [hlca]	12
Limbs [bpoc]	12
Dilute [ftcn]	12
Hyperkalaemia [fndg]	12
Penetration [ftcn]	12
LDL Particle Size [lbpr]	12
malignant tumors [neop]	12
Paradoxical [qlco]	12
Patient symptoms [fndg]	12
Time frame [tmco]	12
Diagnostic Method [diap]	12
Magnetic Resonance Angiography [diap]	12
Vascular calcification [patf]	12
nursing home resident [popg]	12
Premature ventricular contractions [patf]	12
Pre-Eclampsia [patf]	12
Quality Indicators [qlco]	12
expenses [qnco]	12
Electrocardiographic monitoring [diap]	12
Classifications [clas]	12
Neural [ftcn]	12
Coronary Circulation [ortf]	12
Pelvis [bpoc]	12
questioning [menp]	12
L-Arginine [aapp, bacs, phsu]	12
Mother [famg]	12
cGMP [bacs, nnon]	12
Metabolic disease [dsyn]	12
Primary Data [idcn]	12
cavernous angiomas [neop]	12
Oral health [idcn]	12
Urgency [tmco]	12
Rates, Heart [clna]	12
Osteocalcin [aapp, bacs]	12
Rheumatic Fever [dsyn]	12
Metastatic Prostate Cancer [neop]	12
vigilance [menp]	12
Story [geoa]	12
Chronic lung disease [dsyn]	12
Rectal Cancer [neop]	12
Advocacy [socb]	12
accessed [spco]	12
Special Population [popg]	12
Variations, Genetic [npop]	12
Neurodegenerative Diseases [dsyn]	12
clinical syndrome [clas]	12
Laboratory Finding [fndg]	12
Dissimilar [qlco]	12
ingested [biof]	12
NF-kappa B [aapp, imft]	12
Mononuclear [clna]	12
Endometrial Carcinoma [neop]	12
Gut [bdsy]	12
treatment factors [inpr]	12
Quarterly [tmco]	12
Multidimensional [spco]	12
Society, Medical [pros]	12
effectiveness use [idcn]	12
SAO [gngm]	12
enzyme activity [moft]	12
Falling [fndg]	12
Colonic [bpoc]	12
cardioverter defibrillators [medd]	12
Sudden Cardiac Arrest [patf]	12
quality control [ftcn]	12
Adjuvant Radiation Therapy [topp]	12
Lipid Measurement [lbpr]	12
Sweating [fndg]	12
inactivation [comd]	12
risk indicators [qnco]	12
Thrombolytic agent [phsu]	12
Pro-oxidant [bacs, elii]	12
Septal [spco]	12
Proximity [spco]	12
STEMI [fndg]	12
Isodose [qnco]	12
Infantile haemangioma [neop]	12
Cost Benefit [qnco]	12
Left ventricular myocardium [bpoc]	12
Hz [qnco]	12
Surrogate Marker [qlco]	12
Attrition [acab]	12
Hepatotoxicity [inpo]	12
SCI [prog]	12
homocysteine level [lbpr]	12
Dispute [socb]	12
Forced [phpr]	12
Coupling [ftcn]	12
request [ftcn]	12
Prostanoids [bacs, eico, phsu]	12
Dose Adjustment [hlca]	12
Survivorship [acty]	12
Continuous infusion [topp]	12
Allopurinol [orch, phsu]	12
Not Defined [qlco]	12
study drug [resa]	12
Femoral Artery [bpoc]	12
Thrombectomy [topp]	12
Bath [topp]	12
Neointima Formation [patf]	12
eN [gngm]	12
Dural Arteriovenous Fistulas [anab]	12
Blockage [fndg]	12
pediatricians [prog]	12
Retinal [bpoc]	12
named [inpr]	12
Serum lipoprotein levels [lbpr]	12
Community Pharmacies [hcro]	12
Bacteria [bact]	12
Acne [dsyn]	12
Sugar [carb]	12
secure [bodm]	12
Atrial natriuretic peptide [aapp, bacs]	12
Late stage [tmco]	12
INCREASED SENSITIVITY [phpr]	12
Area under the curve [qnco]	12
Carrier [fndg]	12
TACT [elii]	12
Buffer [irda, phsu]	12
Dietary Fat [food]	12
Thyroid dysfunction [patf]	12
healthcare workers [prog]	12
Multicenter Trials [resa]	12
Impacted [anab]	12
Self Efficacy [menp]	12
Second Malignancy [neop]	12
ST Depression [fndg]	12
Blood coagulation [ortf]	12
Assign [ftcn]	12
Chronic inflammatory disease [dsyn]	12
Pleurodesis [topp]	12
angina attacks [dsyn]	12
Bupropion [orch, phsu]	12
Biological Function [phsf]	12
Blinding [resa]	12
Breast tenderness [sosy]	12
Cellular Adhesion [celf]	12
Overlapping [topp]	12
Hypokalaemia [fndg]	12
Serum LDL Cholesterol [lbpr]	12
Oral contraceptive pill [phsu]	12
Dextran Sulfate [carb, phsu]	12
Master [qlco]	12
Pentoxifylline [orch, phsu]	12
International Classification of Diseases [inpr]	12
poly [nnon]	12
Venography [diap]	12
Iso [fish]	12
collective [orgt]	12
rehabilitation program [topp]	12
Hemorrhage, Intracranial [patf]	12
Myocardial perfusion defect [lbtr]	12
Causation [idcn]	12
Undertaking [ocdi]	12
Plateau [qnco]	12
Amplification [mbrt]	12
Autoantibodies [aapp, imft]	12
Managed Care Organizations [hcro, mnob]	12
hormone therapies [topp]	12
mum [plnt]	12
Amino acid [aapp, bacs, phsu]	12
Liver Function Tests [lbpr]	12
dual chamber [medd]	12
Rings [medd]	12
Phlebography [diap]	12
Monoclonal antibody [aapp, imft]	12
Ferritin [aapp, bacs, phsu]	12
Transarterial [spco]	12
g/dL [qnco]	12
Decreased Activity [sosy]	12
cholesteryl ester [bacs, strd]	12
Reminder [cnce]	13
Testosterone, Free [lbpr]	13
Microorganisms [orgm]	13
PI [clna]	13
Gait [fndg]	13
Congestive cardiac failure [dsyn]	13
Band [medd]	13
Capsules [bodm]	13
Plane [spco]	13
Circadian Rhythm [orgf]	13
myelopathy [dsyn]	13
Equilibrium [orgf]	13
coronary stenting [medd]	13
Qualifying [qlco]	13
L-NAME [aapp, bacs]	13
Smoker [fndg]	13
Comprehensive Care [hlca]	13
Viscosity [npop]	13
stabilizing [qlco]	13
accord [socb]	13
dofetilide [orch, phsu]	13
Lidocaine [orch, phsu]	13
insulin metabolism [moft]	13
GG [geoa]	13
Erythrocyte [cell]	13
Hyperlipoproteinaemia [dsyn]	13
Gynaecologist [prog]	13
Ch. [prog]	13
Radiation Oncology [bmod]	13
Gender Bias [socb]	13
Post-Therapy [tmco]	13
telmisartan [orch, phsu]	13
inflammatory cells [cell]	13
Cardiovascular Pathology [dsyn]	13
Normal diet [dora]	13
Doxycycline [antb, orch]	13
prednisolone [phsu, strd]	13
Interventional radiology [bmod]	13
Not Known [qlco]	13
Dietary Guidelines [inpr]	13
Tocopherol [lipd, phsu, vita]	13
compensatory [ftcn]	13
associated conditions [patf]	13
Local anaesthesia [topp]	13
Tachycardias [fndg]	13
hear [phsf]	13
IL [geoa]	13
witnessed [popg]	13
dietary interventions [topp]	13
ESC [enzy]	13
Maximum Concentration [qnco]	13
beta-Adrenergic Blockers [phsu]	13
adopting [fndg]	13
Fluoroscopies [diap]	13
Review Board, Institutional [prog]	13
Wine [food]	13
Communicable disease [dsyn]	13
Ostium [bsoj]	13
Low HDL-cholesterol [fndg]	13
Leakage [patf]	13
beta-Blocking agent [phsu]	13
Fontan Procedure [topp]	13
progestin therapy [topp]	13
Accelerated atherosclerosis [fndg]	13
Assembly [acty]	13
Gynecologic [spco]	13
ailments [fndg]	13
stress response [phsf]	13
Prostatectomy [topp]	13
Pneumonitis [dsyn]	13
Estrogenic preparation [horm, phsu, strd]	13
disease onset [tmco]	13
Scottish [popg]	13
Silent myocardial ischaemia [dsyn]	13
Fetus [emst]	13
Abandoned [qlco]	13
Culturally [idcn]	13
large arteries [bpoc]	13
masked [resa]	13
Translational Research [resa]	13
Arrived [acty]	13
glycoprotein IIb IIIa receptor [aapp, imft, rcpt]	13
Transposition [topp]	13
projections [inpr]	13
Out-of-Hospital Cardiac Arrest [patf]	13
Heart Failure, Diastolic [dsyn]	13
Research Methods [resa]	13
Siblings [famg]	13
Geographic Region [geoa]	13
check up [fndg]	13
Cold [npop]	13
facial malformations [cgab]	13
Patient chart [medd]	13
Statistical Method [resa]	13
cardiac disorders [dsyn]	13
Dopamine Agonists [phsu]	13
Pulmonary embolus [dsyn]	13
Cats [mamm]	13
biventricular [spco]	13
Cholesterol-lowering diet [topp]	13
authorities [socb]	13
determinism [idcn]	13
Dilator [medd]	13
Evaluable [dsyn]	13
Clamp [medd]	13
combination therapies [topp]	13
Atrioventricular Block [dsyn]	13
Column [bpoc]	13
Bomb, Atomic [mnob]	13
Ovulation [ortf]	13
discharge diagnosis [inpr]	13
lipophilic [qnco]	13
Antiestrogenic [phsu]	13
Deposits [ftcn]	13
valerate [lipd]	13
Translational [genf]	13
FMD [cgab, dsyn]	13
Probe [medd]	13
creatinine levels [lbtr]	13
Alendronate [opco, phsu]	13
Azathioprine [orch, phsu]	13
Pharmacoepidemiology [bmod]	13
Premarin [horm, phsu, strd]	13
Infarctions [patf]	13
Health behavior [inbe]	13
Mitochondria [celc]	13
Mutant [comd]	13
Carotenoid [bacs, orch, phsu]	13
shaped [spco]	13
Confident [inbe]	13
Ancillary [idcn]	13
Fusion [ftcn]	13
Curative treatment [fndg]	13
valsartan [orch, phsu]	13
differentiating [qlco]	13
chemotherapeutic agent [orch, phsu]	13
Alanine Aminotransferase [aapp, enzy]	13
Mobility [fndg]	13
Specify [qlco]	13
Disposition [idcn]	13
Lymphocytes [cell]	13
Serum uric acid [lbpr]	13
Money [mnob]	13
THANK [gngm]	13
Newborn [aggp]	13
Surrogate Endpoints [qlco]	13
RNA [nnon]	13
public health policy [gora, inpr]	13
Transdermal route [ftcn]	13
exerting [orgf]	13
Antitachycardia Pacing [topp]	13
LIPOPROTEIN LIPASE [aapp, enzy]	13
Phenylephrine [orch, phsu]	13
insulin treatment [topp]	13
Cholesterol ester transfer protein [aapp, bacs]	13
Premature Menopause [dsyn]	13
Surgical repair [topp]	13
Risk Marker [qlco]	13
LDL Receptor [aapp, rcpt]	13
Gross [qlco]	13
Calcitonin [aapp, horm, phsu]	13
Hypercoagulable state [dsyn]	13
Pain relief [topp]	13
Anthropometric Measures [clna]	13
Thallium [elii]	13
Applanation tonometry [diap]	13
print [ocac]	13
Nurse Practitioners [prog]	13
Pulmonary Arteries [bpoc]	13
Erythrocyte Sedimentation Rate [lbpr]	13
Aging Process [orgf]	13
Supra- [spco]	13
Reluctant [menp]	13
Compensated [qlco]	13
Referring [ftcn]	13
Requested [ftcn]	13
High School [mnob, orgt]	13
plasma insulin [lbpr]	13
Teeth [bpoc]	13
THREE VESSEL DISEASE [dsyn]	13
Resorption [orgf]	13
Conferences [hcpp]	13
Carboplatin [orch, phsu]	13
Amputations [topp]	13
Consultant [prog]	13
ADP [lbpr]	13
Package [medd]	13
Static [qlco]	13
Periodontal [ftcn]	13
report study [inpr]	13
mg ml [qnco]	13
endometrium thickness [qnco]	13
psychological symptoms [sosy]	13
Chemically [chem]	13
Academic medical centre [hcro, mnob]	13
Natural Products [bacs]	13
Id [idcn]	13
Wanted [fndg]	13
telephone survey [resa]	13
Refused [idcn]	13
Dietary Supplement [food]	13
Ticlopidine [orch, phsu]	13
Pulsed dye laser [medd]	13
Dissolve [ftcn]	13
Hg [elii, hops]	13
Muscles [tisu]	13
Chylothorax [dsyn]	13
Case Fatality Rate [qnco]	13
Intracerebral [spco]	13
Complaint [fndg]	13
progressing [ftcn]	13
Perforation [fndg]	13
Respiratory Failure [dsyn]	13
Receptors, Nuclear [aapp, rcpt]	13
In Person [idcn]	13
Dataset [inpr]	13
Thick [qlco]	13
Infiltrating [patf]	13
Permeability [npop]	13
Brain Tumors [neop]	13
Expectation [idcn]	13
Classification Scheme [cnce]	13
hospitalisations [hlca]	13
nodes [bpoc]	13
Mediterranean [popg]	13
Capsule [bodm]	13
Ulcer [patf]	13
Opioids [hops, orch, phsu]	13
citizens [popg]	13
Antithrombotic Agents [phsu]	13
Gamma Knife [topp]	13
Artificial [qlco]	13
Employment [qlco]	13
Haplotypes [orga]	13
Suppressive [ftcn]	13
mind body [idcn]	13
Ventricular septum [bpoc]	13
Acute chest pain [sosy]	13
theories [idcn]	13
Body Weight Gain [fndg]	13
Alberta [geoa]	13
N-butyl-cyanoacrylate [bodm, orch]	13
Shrinkage [ftcn]	13
radiologist [prog]	13
GSH [aapp, bacs]	13
Comment [inpr]	13
Electronic Health Records [inpr]	13
Short Forms [inpr]	13
Catecholamine [nsba, phsu]	13
craniofacial [bpoc]	13
Spleen [bpoc]	13
Bile Acids [bacs, strd]	13
Dead [orgf]	13
cholesterol ldl [bacs, strd]	13
Mayo [geoa]	13
concise [bodm, orch]	13
legislation [rnlw]	13
anthropometric measurements [qnco]	13
site specific [spco]	13
RT-PCR [mbrt]	13
Gene Transfer [mbrt]	13
Rare disorder [dsyn]	13
Comfort [menp]	13
Sickness [fndg]	13
Opioid [hops, orch, phsu]	13
gonadotropin-releasing hormone agonist [aapp, horm, phsu]	13
sibutramine [orch, phsu]	13
Diabetic Retinopathy [dsyn]	13
Left lung [bpoc]	13
Myocardial tissue [tisu]	13
follow up visits [hlca]	13
Myalgia [sosy]	13
chronic disorders [dsyn]	13
Calcified [qlco]	14
Risk-Benefit Assessment [resa]	14
grafting [tisu]	14
Pre-Therapy [tmco]	14
Preconditioning [menp]	14
Left ventricular systolic dysfunction [patf]	14
Ethnic group [popg]	14
coronary artery atherosclerosis [dsyn]	14
attend [ftcn]	14
Family Practice [bmod]	14
Thiazides [orch, phsu]	14
allograft [topp]	14
Attached [fndg]	14
anti-apoptosis [celf]	14
Phone [cnce]	14
vaginal atrophy [dsyn]	14
Lip [bpoc]	14
Passed [fndg]	14
Triacylglycerol [bacs, lipd]	14
Retinoid [bacs, orch, phsu]	14
Dopamine [nsba, orch, phsu]	14
triglyceride lipoprotein [aapp, lipd]	14
dimer [chvs]	14
Antineoplastic [orch, phsu]	14
stressed [fndg]	14
temperature [orga]	14
preceded [tmco]	14
eligibility criteria [qlco]	14
Unavailable [ftcn]	14
Heart Diseases, Coronary [dsyn]	14
Stable Disease [fndg]	14
Cerebral Arteries [bpoc]	14
Abilities [orga]	14
Health Authority [hcro]	14
Membranes [tisu]	14
Hirsutism [fndg]	14
Reproductive Factors [fndg]	14
SIC [clas]	14
Stays, Hospital [tmco]	14
flutter [patf]	14
Preferences, Patient [qlco]	14
high-dose radiation [topp]	14
Therapeutic Method [topp]	14
LOT [inpr]	14
Statistical Power [resa]	14
gynaecologists [prog]	14
Psoriasis [dsyn]	14
Phosphate [inch, phsu]	14
Phase III Trials [resa]	14
Image Quality [qlco]	14
Polymer [bodm, chvs]	14
economic evaluations [ocac]	14
Dose Level [qnco]	14
perturbation [ftcn]	14
External beam radiotherapy [topp]	14
Transcriptional [genf]	14
Portal [blor]	14
paracrine [phsf]	14
Chronic liver disease [dsyn]	14
Tertiary Care [hlca]	14
Linear accelerator [medd]	14
Procedure-related [fndg]	14
steroid hormones [horm, strd]	14
Quebec [geoa]	14
Bidirectional [qlco]	14
Echocardiography, Stress [diap]	14
Antibiotic therapy [topp]	14
placing [spco]	14
Style [idcn]	14
Rapid onset [fndg]	14
tumor growth [neop]	14
Mobile [ftcn]	14
Vascular surgeon [prog]	14
Bladder [bpoc]	14
exercise group [topp]	14
Resuscitate [fndg]	14
herbs [plnt]	14
Sitting [fndg]	14
Predominate [qlco]	14
lowers [spco]	14
re-evaluation [resa]	14
Periodontitis [dsyn]	14
Haemodynamically stable [fndg]	14
Fatal Outcome [patf]	14
Sexual function [orgf]	14
final diagnosis [qlco]	14
phenolic [orch, phsu]	14
Major Depression [mobd]	14
apparatus [mnob]	14
Apolipoprotein AI [aapp, bacs]	14
Traditional Chinese Medicine [bmod]	14
SNP [nusq]	14
Autoimmune Diseases [dsyn]	14
Growth Factors [aapp, bacs]	14
undesirable effects [ftcn]	14
In Vivo Model [resa]	14
intravenous administration [spco]	14
diagnostic test [diap]	14
Pericardial [blor]	14
Lipid lowering agent [phsu]	14
Acute Renal Failure [dsyn]	14
Defibrillation [topp]	14
Solubility [qlco]	14
bosentan [orch, phsu]	14
Controlled release [tmco]	14
Genetic Study [resa]	14
interfering [qlco]	14
LLC [celc]	14
Twin [famg]	14
dehydroepiandrosterone [horm, phsu, strd]	14
Intractable [ftcn]	14
disrupted [qlco]	14
sulphonylureas [orch, phsu]	14
Evoked [qlco]	14
Neurons [cell]	14
recurrent atrial fibrillation [dsyn]	14
Anticoagulants, Oral [orch, phsu]	14
Suspected heart disease [fndg]	14
Open surgery [topp]	14
angina symptoms [sosy]	14
B-Type Natriuretic Peptide [aapp, horm, phsu]	14
diminishing [qnco]	14
Aortic root [bpoc]	14
HI [geoa]	14
Parathyroid Hormone [aapp, horm, phsu]	14
distressing [menp]	14
Thin [qlco]	14
Hemorrhages [patf]	14
Pulmonary function [ortf]	14
Exercise duration [clna]	14
Caffeine [orch, phsu]	14
Selective Serotonin Reuptake Inhibitors [phsu]	14
Positive attitude [menp]	14
Signal Transduction [celf]	14
Ultrasound examination [diap]	14
serum estradiol [lbpr]	14
muscle mass [fndg]	14
eNOS [aapp, enzy]	14
Arrangement [spco]	14
Venous system [bdsy]	14
Postmenopausal state [tmco]	14
Name [inpr]	14
Lung disease NOS [dsyn]	14
Photographs [mnob]	14
Arterial Embolization [dsyn]	14
Acupuncture [bmod]	14
therapeutic range [lbtr]	14
RRS [dsyn]	14
carvedilol [orch, phsu]	14
Varicose Veins [dsyn]	14
Pulsed [phpr]	14
Myocyte [cell]	14
Hypoxaemia [fndg]	14
Progenitor Cells [cell]	14
Fibrinolytic Therapy [topp]	14
expression level [idcn]	14
Anastomosis [acab]	14
Gastric [bpoc]	14
Unresponsive [ftcn]	14
Replication [genf]	14
Volumetric-Modulated Arc Therapy [topp]	14
Conjugated oestrogens [horm, phsu, strd]	14
Normal sinus rhythm [fndg]	14
Clarification [acty]	14
Mammalian [mamm]	14
Organisms [orgm]	14
Captopril [aapp, phsu]	14
Normal Values [qnco]	14
Thiobarbituric Acid Reactive Substances [irda, orch]	14
major surgery [topp]	14
Left anterior [spco]	14
alternate [ftcn]	14
Endomyocardial biopsy [diap]	14
Lactate Dehydrogenase [aapp, enzy]	14
codes [clas]	14
Walk distance [fndg]	14
research center [mnob, orgt]	14
Caloric Restriction [topp]	14
Squamous cell carcinoma [neop]	14
Nursing home [hcro, mnob]	14
Ischemic Heart Diseases [dsyn]	14
Nervous System [bdsy]	14
Chronic Illness [dsyn]	14
drug targets [medd]	14
research studies [resa]	14
progressive disease [neop]	14
Controlled Clinical Trials, Randomized [resa]	14
Heart Rhythm [ortf]	14
interstitial [blor]	14
Forced Expiratory Volume [ortf]	14
Sexual Activity [bhvr]	14
Zinc [bacs, elii, phsu]	14
dietary counseling [edac]	14
Outpatient Care [hlca]	14
Fine [qlco]	14
shifts [ftcn]	14
Chemistry [ocdi]	14
Micronutrients [bacs]	14
Total body [ffas]	14
exercise intervention [topp]	14
Compensation [menp]	14
Insured [inpr]	14
Opened [spco]	14
Rev. [prog]	14
Synthetic Progestins [horm, phsu, strd]	14
attendant [prog]	14
Biological Processes [phsf]	14
Chemistry, Clinical [bmod]	14
Seated [fndg]	14
high systolic blood pressure [fndg]	14
Ambulatory Care [hlca]	14
Infectious disease [dsyn]	14
emergency care [hlca]	14
engineered [prog]	14
fibrotic [ftcn]	14
Ventricle [bpoc]	14
previous diagnosis [qlco]	14
High recurrence rate [fndg]	14
Ascending Aorta [bpoc]	14
hospital care [hlca]	14
Treating Physician [prog]	14
Aggregate [qlco]	14
successes [socb]	14
MIS [aapp, horm]	14
vascular disorders [dsyn]	14
Coffee [food]	14
Diastolic Pressure [clna]	14
Limb ischaemia [dsyn]	14
Angiotensin II Receptor Antagonists [phsu]	14
exhibiting [inpr]	14
Prothrombin [aapp, bacs, phsu]	14
Fresh [qlco]	14
Weakness [sosy]	14
calories [qnco]	14
Bone Marrow Cells [cell]	14
vasomotion [ortf]	14
Observer [prog]	14
stand [fndg]	14
Vital status [clna]	14
Aqueous [qlco]	14
Magnetic [ocdi]	14
Endovascular Techniques [diap, topp]	14
Optional [qlco]	14
Night sweats [sosy]	14
Constipation [sosy]	14
Biphasic [tmco]	14
pharmacogenetic [bmod]	14
Cardiorespiratory Fitness [clas]	14
Cancer related [fndg]	14
Congestive [qlco]	14
heart function [ortf]	14
engaging [fndg]	14
Tissue Plasminogen Activator Antigen [imft]	14
Completeness [qlco]	14
Donors [popg]	14
ASA [orch, phsu]	14
Proton Pump Inhibitors [phsu]	14
rules [inpr]	14
Paediatric cardiologist [prog]	14
adult female? [popg]	14
Glucocorticoid [horm, strd]	14
AIL [neop]	14
Adenoma [neop]	14
versions [ftcn]	14
Velocities [qnco]	14
Saline [sbst]	14
Normal coronary arteries [fndg]	14
Combined Oral Contraceptives [phsu]	14
Within [spco]	14
Enzyme Inhibitors [phsu]	14
Red Clover [plnt]	14
paradigms [resa]	14
Aortic Aneurysm, Abdominal [dsyn]	14
defective [ftcn]	15
Ninth [qnco]	15
Cyanotic [ftcn]	15
Platelet Inhibitors [phsu]	15
documenting [hlca]	15
South Asian [popg]	15
Clotting factors [aapp, bacs, phsu]	15
Vasculitis [dsyn]	15
Follow-up examination [fndg]	15
Follow-Up Studies [resa]	15
Norwegian [popg]	15
Free radical [bacs, chvs]	15
NSAID [phsu]	15
Spearman Correlation [inpr]	15
Consortium [prog]	15
Aspiration [hlca]	15
Title [idcn]	15
Liver function [ortf]	15
Carotid Endarterectomy [topp]	15
effect sizes [qnco]	15
female patient [orga]	15
Neuroradiology [inpr]	15
Real-Time Polymerase Chain Reaction [mbrt]	15
Sclerosing Agents [phsu]	15
Proteomics [bmod]	15
Crown [medd]	15
Close Relationship [fndg]	15
Chronic Stable Angina [dsyn]	15
Collecting [ftcn]	15
Imaging modality [ftcn]	15
Precipitation [npop]	15
In care [fndg]	15
analogs [chvs]	15
Menstrual [orgf]	15
Blind [resa]	15
Adipocytes [cell]	15
Angiotensin II Receptor Blockers [phsu]	15
Secreted [celf]	15
Antianginal therapy [topp]	15
Fertile [orgf]	15
ruled [qlco]	15
In situ [spco]	15
Moderate Exercise [dora]	15
Leukocytes [cell]	15
dietetic [bmod]	15
Serum creatinine level [lbtr]	15
Radiotherapy, Conformal [topp]	15
medical profession [bmod]	15
Mean Heart Rate [qnco]	15
Postmenopausal status NOS [fndg]	15
Lymphocyte [cell]	15
Lower triglycerides [fndg]	15
Polymeric [bodm, chvs]	15
Uterine Cancer [neop]	15
Never Smoker [fndg]	15
Charged [orga]	15
Double-Blinded [resa]	15
Prosthesis [medd]	15
competitive [socb]	15
Nonmetastatic [qlco]	15
SINGLE BLIND [resa]	15
Service, National Health [hlca]	15
Cortical [bpoc]	15
Erectile [ortf]	15
coil [spco]	15
payor [inpr]	15
Neurology [bmod]	15
Ki [gngm]	15
Glucocorticoids [horm, strd]	15
angiotensin converting enzyme activity [moft]	15
Volumetric [spco]	15
Tricuspid [spco]	15
verification [resa]	15
global assessment [resa]	15
Breasts [bpoc]	15
Right Atrium [bpoc]	15
Drug administration [hlca]	15
Class II [inpr]	15
Ventricular Dysfunction, Right [patf]	15
UPS [inpr]	15
Inflammatory bowel disease [dsyn]	15
Menses [orgf]	15
Rat Heart [bpoc]	15
CKD [dsyn]	15
Occult [idcn]	15
Weight management [topp]	15
treatment success [qlco]	15
Very Good [inpr]	15
demands [topp]	15
International Normalized Ratio [lbpr]	15
Trial Design [inpr]	15
Investigator [prog]	15
Purified [ftcn]	15
Conduction abnormalities [patf]	15
SEVERE DYSFUNCTION [fndg]	15
Rodent [mamm]	15
Segmental [spco]	15
Femoral Neck [bpoc]	15
face-to-face [idcn]	15
mimics [topp]	15
Axillary [blor]	15
Chronic respiratory disease [dsyn]	15
Vegetable [food]	15
Transarterial embolisation [topp]	15
Dehydroepiandrosterone Sulfate [bacs, phsu, strd]	15
Homozygotes [orga]	15
Glycemic Index [qnco]	15
Calcium Channel Antagonists [moft]	15
Dural Arteriovenous Fistula [anab]	15
diabetes risk [qnco]	15
False Positive [lbtr]	15
Paediatric surgery [bmod]	15
breast cancer diagnosis [neop]	15
porcine [mamm]	15
Hypocholesterolaemia [patf]	15
cardiovascular surgery [topp]	15
Lung Transplantation [topp]	15
Deferoxamine [bacs, irda, orch]	15
Sinus [anab]	15
Microsurgery [topp]	15
treatment failure [qlco]	15
Architecture [ocdi]	15
shorten [topp]	15
Hands [bpoc]	15
Drinks [food]	15
Layer [bpoc]	15
offices [mnob]	15
Duplicate [ftcn]	15
Supportive care [topp]	15
Disfigurement [fndg]	15
DR [prog]	15
Oxygen Consumption [clna]	15
Drug Metabolism [moft]	15
revealing [qlco]	15
pitavastatin [orch, phsu]	15
Metals [inch]	15
Total score [qnco]	15
Standard Error [qnco]	15
Sublingual [ftcn]	15
Stage I Seminoma [neop]	15
Anonymous [qlco]	15
RESTING HEART RATE [fndg]	15
Sensitive to [ftcn]	15
drug trials [phsu]	15
rectal [spco]	15
Coronary Care Units [hcro, mnob]	15
Intramedullary [ftcn]	15
chemoradiation [topp]	15
profit [orgt]	15
daidzein [orch, phsu]	15
Evidence-Based Practice [ftcn]	15
EDTA [orch, phsu]	15
Ankle brachial pressure index [clna]	15
Personal History [fndg]	15
Beta cell [cell]	15
Recurrent disease [dsyn]	15
Perindopril [orch, phsu]	15
Nutraceutical [food]	15
Lower Limbs [blor]	15
Lipid panel [lbpr]	15
postmenopausal symptoms [dsyn]	15
Postmenopausal Bone Loss [dsyn]	15
Erythrocytes [lbpr]	15
Coronary Vessels [bpoc]	15
aggravate [fndg]	15
Cardioverter-Defibrillator [medd]	15
Lung diseases [dsyn]	15
Fibric Acid Derivatives [orch]	15
sustain [ftcn]	15
comparative analysis [resa]	15
Occupation [ocdi]	15
Reading [dora]	15
Left Ventricular Remodeling [ortf]	15
neglected [fndg]	15
Cultures [idcn]	15
Gas [chvs]	15
Concentrated [bodm]	15
Comments [inpr]	15
N-terminal pro-Brain Natriuretic Peptide [lbpr]	15
Serum Markers [qlco]	15
Pharmacological Treatments [topp]	15
spending [qnco]	15
Prednisone [horm, phsu, strd]	15
replicated [ftcn]	15
Mouth [bsoj]	15
Rotation [ftcn]	15
MA [idcn]	15
Drug-Eluting Stents [medd]	15
Continuous Positive Airway Pressure [topp]	15
Citation [inpr]	15
Plethora [fndg]	15
Uterine Bleeding [patf]	15
Metabolic Pathways [ftcn]	15
Spironolactone [phsu, strd]	15
solid tumors [neop]	15
PM [tmco]	15
Midazolam [orch, phsu]	15
Voltage [qnco]	15
Spring [tmco]	15
Ally [hops, orch]	15
low hdl [fndg]	15
Enlarged [qlco]	15
Probucol [orch, phsu]	15
Lymphoma, Non-Hodgkin [neop]	15
Normal blood pressure [fndg]	15
Heart Volume [orgf]	15
recover [qlco]	15
Secretory [celf]	15
Interrupted [qlco]	15
Periodontal disease [dsyn]	15
Coronary Thrombosis [dsyn]	15
Electron [qnco]	15
repeated measures [resa]	15
Incidental [ftcn]	15
pharmacoeconomic [qnco]	15
Sclerosis, Systemic [dsyn]	15
Rectum [bpoc]	15
Weight change [fndg]	15
Corrective [orch, phsu]	15
Stage III [inpr]	15
tables [mnob]	15
Contraception [topp]	15
Visceral Adipose Tissue [tisu]	15
Vein, Pulmonary [bpoc]	15
Mail [mnob]	15
Hepatic Lipase [aapp, enzy]	15
Cerebrovascular accidents [dsyn]	15
Cell types [inpr]	15
lipoprotein cholesterol [aapp, bacs, lipd]	15
predictions [idcn]	15
restricting [ftcn]	15
Vaginal Bleeding [patf]	15
spatial [gngm]	15
Radioimmunoassay [lbpr]	15
Anticoagulation Therapy [topp]	15
intervention therapy [topp]	16
surgical removal [topp]	16
Radio [inpr]	16
Myocardial Infarct [dsyn]	16
Discrete [qlco]	16
Transdermal Administration [ftcn]	16
Class IV [inpr]	16
Thalassaemia [dsyn]	16
emergency visits [hlca]	16
vascular bed [bpoc]	16
therapeutic alternative [inpr]	16
human subjects [resa]	16
Neoadjuvant [topp]	16
Bones [bpoc]	16
Eastern [spco]	16
Coronary artery calcium score [qnco]	16
icds [medd]	16
Troponin I [aapp, bacs]	16
Run-in Period [tmco]	16
sustaining [ftcn]	16
Pleural Effusion [dsyn]	16
PCR [lbpr, mbrt]	16
new technologies [inpr]	16
mRNA Expression [genf]	16
Antiestrogens [phsu]	16
Pharmaceutical Care [inpr]	16
Idiopathic Pulmonary Arterial Hypertension [dsyn]	16
Plasminogen Activator [aapp, enzy, phsu]	16
Filter [mnob]	16
Diabetic Complications [patf]	16
Body Surface Area [orga]	16
retard [qlco]	16
blood vessel remodeling [ortf]	16
Operator [inpr]	16
Tissue factor pathway inhibitor [aapp, phsu]	16
Candidate Genes [gngm]	16
New York Heart Association Class III [fndg]	16
Thrombomodulin [aapp, rcpt]	16
mol/L [qnco]	16
female sex hormones [lbtr]	16
Sequencing [inpr]	16
Organic heart disease NOS [dsyn]	16
feeling [menp]	16
External Beam Radiation Therapy [topp]	16
Cause Specific Survival [qnco]	16
LDLC [gngm]	16
immunosuppressive [imft, phsu]	16
Survivor [podg]	16
Nested Case-control Study [resa]	16
Polymorphic [qlco]	16
Peripheral arterial occlusive disease [dsyn]	16
OH- [elii]	16
Ia [mamm]	16
permanent pacemaker [medd]	16
Industrialized Countries [qlco]	16
estimations [menp]	16
lupus [dsyn]	16
Sizes, Sample [qnco]	16
Patient Information [inpr]	16
Rates, Death [qnco]	16
Computerized tomography [diap]	16
Apical [spco]	16
Peak systolic [ortf]	16
Diffusion [npop]	16
KIT [medd]	16
Defibrillators, Implantable [medd]	16
Periodic [tmco]	16
indexed [inpr]	16
ethanolamine oleate [orch, phsu]	16
Equivalents [qnco]	16
Ruptured [ftcn]	16
Switzerland [geoa]	16
Apoptotic [qlco]	16
Chemoradiotherapy [topp]	16
recurred [phpr]	16
radiation toxicity [inpo]	16
atrial fibrillation recurrent [dsyn]	16
Pre-operative evaluation [diap]	16
Aromatase Inhibitors [phsu]	16
Gastric Cancer [neop]	16
GENITOURINARY [bdsy]	16
Cerebral Ischemia [dsyn]	16
Stage IV [inpr]	16
Conflict of Interest [idcn]	16
Intubation [topp]	16
NADPH Oxidase [aapp, enzy]	16
Leaves [plnt]	16
Ventricular Function, Right [ortf]	16
weaknesses [sosy]	16
possession [qnco]	16
Primary Tumor [neop]	16
chd risk [fndg]	16
DNA Damage [comd]	16
Intrauterine [bsoj]	16
Diet, Atherogenic [resa]	16
Troponin T [aapp, bacs]	16
Safety Issues [inpo]	16
Incubated [lbpr]	16
Relapses [phpr]	16
Performance Status [clna]	16
Slice [sbst]	16
Motion [npop]	16
Topical [spco]	16
gene polymorphism [genf]	16
cancer cells [cell]	16
displaying [ftcn]	16
CT Scans [diap]	16
Self Medication [inbe]	16
thyroid function [phsf]	16
Thrombocytopenia [fndg]	16
failures [ftcn]	16
HIV(+) patient [inpr]	16
Gout [dsyn]	16
Legs [blor]	16
Regurgitation [fndg]	16
HMG CoA Reductase [aapp, enzy]	16
Respiratory disease [dsyn]	16
Ischemic Myocardium [fndg]	16
Resuscitation [topp]	16
Plasma triglyceride level [lbpr]	16
Mental disorders [mobd]	16
Sharing [socb]	16
Preventive treatment [topp]	16
Physical Fitness [idcn]	16
Atrial Ablation [topp]	16
Outlook [menp]	16
Statistical Tests [inpr]	16
Adenocarcinoma [neop]	16
Productivity [qnco]	16
Subtlety [clna]	16
Unaltered [qlco]	16
Post-intervention [inpr]	16
Echocardiography, Two-Dimensional [diap]	16
Anesthetized [fndg]	16
mL/kg [qnco]	16
Cross-Sectional Studies [resa]	16
Pancreatic [bpoc]	16
GLUCOSE CONTROL [irda]	16
Work Place [spco]	16
Western Blot [lbpr, mbrt]	16
Left Bundle-Branch Block [dsyn]	16
regulators [medd]	16
fluctuations [sosy]	16
Transdermal Patch [medd]	16
simulate [bodm]	16
Acquired disease [dsyn]	16
Systolic dysfunction [patf]	16
break down [qlco]	16
Turkey [geoa]	16
pellets [bodm]	16
cooperative [orgt]	16
Limb Salvage [topp]	16
Glycoprotein [aapp, carb]	16
Washington [geoa]	16
Atrial Septal Defect [cgab]	16
Total protein [lbpr]	16
Cell Growth [celf]	16
quality assurance [ocac]	16
Town [geoa]	16
Smooth [qlco]	16
Environments [spco]	16
Thrombophilia [dsyn]	16
histologic examination [lbpr]	16
Self Care [hlca]	16
Plastic [sbst]	16
Coronary Artery Stenosis [dsyn]	16
Ultrasonography, Doppler [diap]	16
Apo-A [aapp, bacs]	16
Garlic [plnt]	16
Students [prog]	16
Coding [ocac]	16
Maturation [orgf]	16
Crisis [fndg]	16
Nomenclature [inpr]	16
Scleroderma [dsyn]	16
internists [prog]	16
Trace [qnco]	16
Equivocal [qlco]	16
Antihypertensive agent [phsu]	16
playing [dora]	16
Boy [aggp]	16
Norway [geoa]	16
Elective Surgery [topp]	16
Conformity [socb]	16
Neurological Disorders [dsyn]	16
Intestinal [bpoc]	16
Social Class [qlco]	16
psychological distress [mobd]	16
Chronic ischaemic heart disease [dsyn]	16
Processed [phpr]	16
Congenital Lesion [fndg]	16
scanned [diap]	16
Acarbose [carb, phsu]	16
Primary care clinic [inpr]	16
Coagulopathy [dsyn]	16
Total body fat [fndg]	16
Firmly [qlco]	16
Cardiomyocyte [cell]	16
Physiological Effects [phsf]	16
GLUTATHIONE PEROXIDASE [aapp, enzy]	16
Emergency Medical Services [hlca]	16
Natriuretic Peptides [aapp, horm, phsu]	16
tumor necrosis factor [aapp, imft]	16
Read [dora]	16
Clinical Treatment [topp]	16
One Thousand [qnco]	16
Haplotype [orga]	16
doubling [ftcn]	17
Transaminase [aapp, enzy]	17
Superoxide [elii]	17
Kinase [aapp, enzy]	17
Insulin-Like Growth Factor I [aapp, bacs]	17
CD [idcn]	17
Agencies [orgt]	17
Demonstrable [ftcn]	17
internal carotid [bpoc]	17
Big [qnco]	17
Lumen [bsoj]	17
Cross-Over Design [resa]	17
Building [ftcn]	17
Hot [qlco]	17
Myocardial fibrosis [patf]	17
end stage heart disease [dsyn]	17
Low Density Lipoprotein Receptor [aapp, rcpt]	17
Randomized Controlled Clinical Trial [resa]	17
Viral [ftcn]	17
Rats, Spontaneously Hypertensive [mamm]	17
Carbohydrates [carb]	17
Mucosal [tisu]	17
Abstinent [inbe]	17
permitted [fish]	17
degrees C [qnco]	17
Headaches [sosy]	17
bras [mnob]	17
heart attacks [dsyn]	17
whole blood [bdsu]	17
Tight [qlco]	17
Rates, Case Fatality [qnco]	17
Orbital [spco]	17
Immunohistochemical [lbpr]	17
ecgs [fndg]	17
ORS [inch, phsu]	17
Abundance [qlco]	17
drug problems [fndg]	17
goal attainment [socb]	17
Early death [fndg]	17
Workshop [edac]	17
replacing [ftcn]	17
Real-Time PCR [mbrt]	17
Diet therapy [topp]	17
Electronic Medical Record [inpr]	17
Compartment [bsoj]	17
Organs at Risk [blor]	17
Complete Response [fndg]	17
Titer [qnco]	17
Leaflet [mnob]	17
Dispersion [spco]	17
Neutrophile [cell]	17
Volunteer [prog]	17
prime [ftcn]	17
National Cancer Institute [hcro]	17
Voluntary [inbe]	17
All [qnco]	17
Bariatric Surgery [topp]	17
Drug Costs [qnco]	17
Phosphorus [elii]	17
Coronary Stenosis [dsyn]	17
Long-term drug therapy [topp]	17
Designated [ftcn]	17
Internal mammary nodes [bpoc]	17
Aortic ring [bpoc]	17
Aggravated [fndg]	17
Post-Procedure [tmco]	17
alarming [medd]	17
Events, Adverse Drug [inpo]	17
elastic [ftcn]	17
treatment duration [tmco]	17
Cancer Therapy [topp]	17
Baby [aggp]	17
Treatment outcome [qlco]	17
Traumatic [ftcn]	17
Liposomes [lipd]	17
Young Child [aggp]	17
reality [idcn]	17
Bradykinin [aapp, horm, nsba]	17
Extracellular Matrix [tisu]	17
Implantable defibrillator [medd]	17
renin activity [moft]	17
Monitoring, Ambulatory [diap]	17
T-PA [aapp, enzy, phsu]	17
Serotonin [nsba, orch]	17
Rare Disease [dsyn]	17
Benzodiazepines [orch, phsu]	17
Overnight [tmco]	17
clinical aspects [clna]	17
Clinical Medicine [bmod]	17
Influenza [dsyn]	17
Pressures [phpr]	17
Latin American [popg]	17
Extremity [bpoc]	17
adapt [orch]	17
Urology [bmod]	17
threat [idcn]	17
Contraceptives [phsu]	17
Scopus [bird]	17
confirming [qlco]	17
preventive services [hlca]	17
Making decisions [menp]	17
Ovarian Failure [dsyn]	17
Diet, High-Fat [topp]	17
BREAK [phpr]	17
Pet [anim]	17
Nicotine [hops, orch, phsu]	17
Troponin [aapp, bacs]	17
Non-Hispanic [popg]	17
Tachyarrhythmia [fndg]	17
Nocturnal [tmco]	17
Paediatric cardiology [bmod]	17
exchange [socb]	17
antihyperlipidemic [phsu]	17
Dietitians [prog]	17
RUN-IN [tmco]	17
Split [ftcn]	17
Parallel Study [resa]	17
Sulfate [inch]	17
Circumferential [spco]	17
Blood sampling [diap]	17
Insomnia [sosy]	17
Predisposing Factors [tmco]	17
Trypanosoma cruzi [euka]	17
R AW [ortf]	17
Right heart failure [dsyn]	17
Ingredient [chvf]	17
Interviews, Telephone [resa]	17
Energy Expenditure [phsf]	17
EGG [food]	17
Fluorescence [npop]	17
Palpitations [fndg]	17
Uncomplicated Hypertension [dsyn]	17
Sports [dora]	17
Patches [medd]	17
adrenergic [ftcn]	17
Implants [medd]	17
Reocclusion [inpo]	17
Therapeutic Procedures [topp]	17
Progression-Free Survival [qnco]	17
Psychiatric disorders [mobd]	17
Grades [clas]	17
Stereotactic Radiosurgery [topp]	17
Uteri [bpoc]	17
Complete Remission [fndg]	17
Embolotherapy [topp]	17
Primary disease [dsyn]	17
Lumbar [blor]	17
Geometric Mean [qnco]	17
Health education [edac]	17
Isoform [aapp]	17
Pregnant [fndg]	17
ultra [medd]	17
Increased heart rate [fndg]	17
Treadmill Test [diap]	17
Estrogen Receptor Antagonist [phsu]	17
Medical record [inpr]	17
Liver enzymes [aapp, enzy]	17
parent [famg]	17
CT SCAN [diap]	17
Subclinical hypothyroidism [dsyn]	17
Radiobiology [bmod]	17
Cost Analysis [ocac]	17
rosiglitazone [orch, phsu]	17
Conservation [qlco]	17
Habitual [tmco]	17
Genesis [gngm]	17
economic analysis [ocac]	17
Antidiabetic Drugs [phsu]	17
Service, Health [hlca]	17
Cardiac Hypertrophy [patf]	17
Macro [cnce]	17
Point of care [idcn]	17
Immediate Release [bodm]	17
Contract [inpr]	17
COPD NOS [dsyn]	17
Pharmacology, Clinical [bmod]	17
Na+ [elii, phsu]	17
Belgium [geoa]	17
Enzyme-Linked Immunosorbent Assay [lbpr]	17
Lower total cholesterol [fndg]	17
Economy [qnco]	17
Mobilisation [topp]	17
Irregular [qlco]	17
Athletes [prog]	17
Evening [tmco]	17
secondary malignancies [neop]	17
Aberrant [qlco]	17
Blood Pressure, Arterial [fndg]	17
Referrals [hlca]	17
High-Risk Cancer [neop]	17
Intranasal [spco]	17
Aortic Stiffness [patf]	17
cynomolgus monkeys [mamm]	17
Vasorelaxation [phsf]	17
Intensity modulated radiation therapy [topp]	17
Deformity [cgab]	17
Medical Problem [fndg]	17
Red [fndg]	17
Cell Adhesion Molecules [aapp, bacs]	17
Coils [spco]	17
Driving [dora]	17
Self-Report [resa]	17
Unresolved [qlco]	17
Texas [geoa]	17
interpretations [inpr]	17
Transvenous [spco]	17
Therapeutic agent [inpr]	17
Libido [menp]	17
Fractional shortening [fndg]	17
Peripheral Blood Vessel [bpoc]	17
Multiple therapy [topp]	17
Critically Ill [dsyn]	18
Anti-Oxidant Effects [phsf]	18
Attendance [acty]	18
Electrical cardioversion [topp]	18
Low frequency [tmco]	18
Calendar [tmco]	18
Pregnancies [orgf]	18
stratifying [qlco]	18
Radiation injury [inpo]	18
Foot [bpoc]	18
biopsies [diap]	18
Vascular injury [inpo]	18
kcal [qnco]	18
bleed [patf]	18
economic impact [qnco]	18
Cardiac index [fndg]	18
Apoprotein [aapp, bacs]	18
Hypertrophic Cardiomyopathy [dsyn]	18
DI [gngm]	18
funded [qnco]	18
Red wine [food]	18
Calibration [qnco]	18
Fractionated [qlco]	18
Serum triglyceride levels [lbpr]	18
Coordination [phsf]	18
Relatives [famg]	18
Writing [ocdi]	18
Growth Factor [aapp, bacs]	18
Non-steroidal Antiinflammatory Drug [phsu]	18
Malignant disease [dsyn]	18
Etoposide [carb, phsu]	18
Query [inpr]	18
Eisenmenger Syndrome [cgab, dsyn]	18
ivabradine [orch, phsu]	18
Oral cavity [bsoj]	18
Drug Prescription [inpr]	18
Primary Care Provider [idcn]	18
Fluid Therapy [topp]	18
Polycystic Ovary Syndrome [dsyn]	18
Polyunsaturated Fatty Acids [bacs, lipd]	18
Myocardial dysfunction [patf]	18
Case Study [inpr]	18
Cardiac Resynchronization Therapy [topp]	18
thiazide [orch, phsu]	18
Clotting [ortf]	18
Hypercoagulability [dsyn]	18
Apnea, Sleep [dsyn]	18
ethnic differences [fndg]	18
Non-steroidal anti-inflammatory drug [phsu]	18
Hepatocellular carcinoma [neop]	18
Opening [spco]	18
Vascular Endothelial Cells [cell]	18
Neovascularisation [patf]	18
Plasma sample [bdsu]	18
Medication Errors [qlco]	18
Bacterial [qlco]	18
Plasminogen activator inhibitor [aapp, bacs]	18
Patient status [fndg]	18
Wales [geoa]	18
Stem cell [cell]	18
KILLER [gngm]	18
Patient History [hlca]	18
Destruction [topp]	18
Oxygen saturation [orga]	18
B mode ultrasound [diap]	18
patient profile [hlca]	18
Antiplatelet agent [phsu]	18
Sacrifice [idcn]	18
Epithelial [qlco]	18
Kidney Transplantation [topp]	18
Tertiary Hospital [hcro, mnob]	18
Transforming Growth Factor beta [aapp, bacs]	18
Nitrite [chvs]	18
Serum Albumin [aapp]	18
nitric oxide synthesis [moft]	18
Vaccination [topp]	18
Price [qnco]	18
Alternative Therapy [bmod]	18
Selection Bias [qnco]	18
Estrogen Progestin Replacement Therapy [topp]	18
specimens [sbst]	18
Power tool [mnob]	18
Thromboxane [bacs, eico]	18
inflammatory responses [patf]	18
Alkaline Phosphatase [aapp, enzy]	18
Known Coronary Artery Disease [qnco]	18
abciximab [aapp, imft, phsu]	18
stenotic [ftcn]	18
Polyphenol [orch, phsu]	18
Mitral Valve Replacement [topp]	18
conference proceedings [inpr]	18
Pancreatitis [dsyn]	18
Secondly [qnco]	18
primary diagnosis [qlco]	18
discharges [bdsu]	18
Subunit [qnco]	18
Metal [inch]	18
ROS [bacs, elii]	18
Extremities, Lower [blor]	18
Serving [qnco]	18
Localized Cancer [neop]	18
PCI [topp]	18
INT [orch]	18
behavior change [inbe]	18
Analysis, Cohort [resa]	18
Sustained Release [bodm]	18
Cortisol [horm, phsu, strd]	18
Very rare [fndg]	18
metastatic disease [neop]	18
TRANSCRIPTION FACTOR [aapp, bacs]	18
Unsatisfactory [qlco]	18
Square [spco]	18
Soy bean [food]	18
Hyperaemia [patf]	18
health plan [hlca]	18
Soft [qlco]	18
Door [mnob]	18
Narrowing [spco]	18
Thyroid disease [dsyn]	18
Justification [idcn]	18
Indirect Costs [qnco]	18
used drug [ftcn]	18
Study Protocol [inpr]	18
Mini [orga]	18
Clinical information [clna]	18
Fibroblasts [cell]	18
Format [inpr]	18
Exacerbated [fndg]	18
medical centers [hcro, mnob]	18
diameters [qnco]	18
Gynaecology [bmod]	18
Subarachnoid Hemorrhage [dsyn]	18
Continuity [qlco]	18
interpret [ftcn]	18
Lumpectomy [topp]	18
Electronic Medical Records [inpr]	18
Lysis [patf]	18
Dihydropyridine [orch, phsu]	18
Hong Kong [geoa]	18
Stabilized [qlco]	18
Losartan [orch, phsu]	18
chair [medd]	18
Extracellular [celc]	18
risk control [inbe]	18
celecoxib [orch, phsu]	18
Ended [qlco]	18
quit [idcn]	18
end organ damage [dsyn]	18
Best Practice [idcn]	18
NYHA Class [fndg]	18
anti hypertensive drug [phsu]	18
Radial [cnce]	18
small group [grpa]	18
Infiltration [patf]	18
messages [inpr]	18
Dietary advice [edac]	18
Enlargement, NOS [patf]	18
Genotyping [lbpr]	18
shunting [topp]	18
Infrequently [tmco]	18
Schedules [inpr]	18
Intravenous therapy [topp]	18
arguments [socb]	18
retinol [orch, phsu, vita]	18
Supervision [topp]	18
Developmental [qlco]	18
Conservative management [topp]	18
Rejection [socb]	18
Rodents [mamm]	18
Perioperative Period [tmco]	18
Dedications [acty]	18
lilacs [plnt]	18
origins [clas]	18
corticosteroid [horm, phsu, strd]	18
Suicide [fndg]	18
Personalized Medicine [topp]	18
prevention trial [resa]	18
Dependency [menp]	18
Fibrinogen level [lbpr]	18
Cirrhosis [dsyn]	18
Lipid-lowering diet [topp]	18
Family Members [famg]	18
Deletion [comd]	19
Newborns [aggp]	19
Health Care Utilization [hlca]	19
pmol/L [qnco]	19
Ventricular Dysfunction [patf]	19
Inserted [hlca]	19
Zero [qnco]	19
Sub-Saharan Africa [geoa]	19
Endurance [fndg]	19
Iran [geoa]	19
Classification system [clas]	19
Time periods [tmco]	19
Propafenone [orch, phsu]	19
Thromboembolic disease [dsyn]	19
Stroke Volume [clna]	19
Two Times [qnco]	19
Progesterone Receptor [aapp, rcpt]	19
Weights [qnco]	19
Trimetazidine [orch, phsu]	19
Analogue [chvs]	19
Death rate [qnco]	19
Post-menopausal Period [orgf]	19
Hf [elii]	19
overlap [topp]	19
Health center [hcro, mnob]	19
Food Frequency Questionnaire [inpr]	19
testosterone level [lbtr]	19
in vivo study [resa]	19
Carrying [acty]	19
contrasting [diap]	19
Autonomic nervous system [bdsy]	19
Data Source [qnco]	19
Decision Making, Shared [menp]	19
Seed [plnt]	19
Combined hyperlipidemia NOS [dsyn]	19
Geographic [spco]	19
Very large [fndg]	19
Moderate-Dose [resa]	19
Glutathione [aapp, bacs]	19
decision support [inpr]	19
Grain [food]	19
Chromatography, High Performance Liquid [lbpr]	19
deteriorated [fndg]	19
engagement [fndg]	19
Cardiac abnormalities [cgab]	19
Pharmacotherapies [topp]	19
Width [qnco]	19
Endocardial [tisu]	19
Bowel [bpoc]	19
Outpatient Clinics [hcro, mnob]	19
Aortic Regurgitation [dsyn]	19
Scales [medd]	19
Obesity, Visceral [sosy]	19
primary cancer [fndg]	19
Left ventricular wall [bpoc]	19
Acute ischaemic heart disease [dsyn]	19
patient condition [fndg]	19
interventional procedures [diap, topp]	19
Impaired fasting glucose [fndg]	19
Matrix [spco]	19
Thalassaemia major [dsyn]	19
Photon [sbst]	19
Firstly [qlco]	19
Reactive Hyperemia [patf]	19
Prescription drug [phsu]	19
drug effects [ftcn]	19
America [geoa]	19
Walk [dora]	19
Frail [fndg]	19
Diagnostic Accuracy [qlco]	19
pharmacotherapeutic [ftcn]	19
Elderly man [aggp]	19
Aorta, Abdominal [bpoc]	19
Tongue [bpoc]	19
alert [fndg]	19
Prescribed medications [clna]	19
Check [acty]	19
Triage [topp]	19
mid-life [tmco]	19
Direct Costs [qnco]	19
collections data [resa]	19
Interface [mnob]	19
Diagnostic tests [diap]	19
organ systems [bdsy]	19
Pathogen [orgm]	19
breath hold [sosy]	19
Irradiated volume [qnco]	19
age differences [aggp]	19
Cavernoma [neop]	19
lycopene [bacs, orch, phsu]	19
Painful [sosy]	19
Modified Rankin Scale [inpr]	19
Hypotensive [patf]	19
Informative [qlco]	19
Estriol [horm, phsu, strd]	19
Patient Preference [qlco]	19
Pancreas [bpoc]	19
Cyclo-Oxygenase [aapp, enzy]	19
Wealthy [qlco]	19
Web Site [inpr]	19
Neuroendocrine [bdsy]	19
Loaded [acty]	19
adopt [fndg]	19
chronology [inpr]	19
Increased stress [ftcn]	19
London [geoa]	19
Energy Intake [qnco]	19
Organism [orgm]	19
Bone Resorption [ortf]	19
Cast [medd]	19
Publication Bias [qlco]	19
Digitalis [plnt]	19
early disease [tmco]	19
Fat-free mass [fndg]	19
Ciclosporin [aapp, phsu]	19
Employ [ftcn]	19
WISE [gngm]	19
instruments [medd]	19
Investigates [ftcn]	19
Coping [inbe]	19
Free Fatty Acids [lipd]	19
Hyperuricaemia [dsyn]	19
ranked [inpr]	19
Oxidised low density lipoprotein [aapp, bacs]	19
injured [ftcn]	19
transferred [ftcn]	19
Surrogate End Points [qlco]	19
cooperation [socb]	19
Vascular resistance [phsf]	19
Orchiectomy [topp]	19
Grading [clas]	19
Realism [idcn]	19
Serum Glucose [lbpr]	19
Angiography, Digital Subtraction [diap]	19
Illnesses, Chronic [dsyn]	19
Drug Side Effects [inpo]	19
Primary care physician [prog]	19
Transplantation, Cardiac [topp]	19
Chronic pain [dsyn]	19
Cell Death [celf]	19
haemoglobin level [lbtr]	19
Highly sensitive [qlco]	19
Pre-diabetes NOS [dsyn]	19
Absolute Risk Reduction [qnco]	19
Independence [idcn]	19
Additional Therapy [fndg]	19
Urinary Incontinence [patf]	19
Investment [mnob]	19
Self Monitoring [topp]	19
treatment method [topp]	19
Laboratories [mnob, orgt]	19
colonoscopy [diap]	19
educate [edac]	19
electrophysiologic study [diap]	19
High priority [tmco]	19
Emergency Room [hcro]	19
TH [geoa]	19
Organizational [orgt]	19
pioglitazone [orch, phsu]	19
CLINICAL SIGNS [fndg]	19
sonography [diap]	19
Stomach [bpoc]	19
Defense [cnce]	19
Genetic Testing [lbpr]	19
data sets [inpr]	19
Occupational [ftcn]	19
node-positive [fndg]	19
Medicaid [gora]	19
Diet, Low-Fat [topp]	19
Models, Experimental [inpr]	19
Visual Analog Scale [diap]	19
blood concentrations [lbtr]	19
Systemic hypertension [dsyn]	19
CV [idcn]	20
Gonadal [bpoc]	20
Separation [patf]	20
Neoplasms [neop]	20
Harvest [hlca]	20
glucose homeostasis [phsf]	20
Apolipoprotein A [aapp, bacs]	20
Distress [menp]	20
Ambulance [medd]	20
Autopsy [diap]	20
executive [prog]	20
long-term care [hlca]	20
Oxygen uptake [fndg]	20
Complexes [chvs]	20
Diet, Mediterranean [topp]	20
NHS [cgab, dsyn]	20
attacks [socb]	20
Licensed [rnlw]	20
interpreting [ftcn]	20
Coronary angiogram [diap]	20
Antiretroviral therapy [topp]	20
western blot analysis [lbpr]	20
Antidepressants, Tricyclic [phsu]	20
Trial, Crossover [resa]	20
Medical Research [resa]	20
Renal Replacement Therapy [topp]	20
Withdraw [acty]	20
VLDL [lbpr]	20
ptca [topp]	20
Therapies, Hormone Replacement [topp]	20
Exclusive [idcn]	20
Hierarchy [ftcn]	20
MECHANISTIC STUDIES [rnlw]	20
Osteoporotic fracture [dsyn]	20
Chi-Square Test [inpr]	20
stabilize [qlco]	20
population health [hlca]	20
Interested [menp]	20
Tertiary care center [hcro, mnob]	20
Skin necrosis [patf]	20
Cerebral Infarction [dsyn]	20
Lean body mass [clna]	20
Immune response [ortf]	20
labeling [menp]	20
Retain [ftcn]	20
Digital [inpr]	20
Vertebral [bpoc]	20
Vasoconstrictor [phsu]	20
Puberty [phsf]	20
Ligands [chem]	20
Aldosterone [horm, phsu, strd]	20
PACE [aapp, enzy]	20
Klippel-Trenaunay Syndrome [cgab]	20
health care resources [qnco]	20
Mammography [diap]	20
Sedentary lifestyle [fndg]	20
PG [lbpr]	20
Mismatch [qlco]	20
deceased [orgf]	20
strengths [idcn]	20
Work Load [qnco]	20
Africa [geoa]	20
Genetic Susceptibility [orga]	20
Antibody [aapp, celc, imft]	20
Exaggerated [qlco]	20
qualitative study [resa]	20
Clinical Observation [idcn]	20
Heritable [ftcn]	20
Herbal [qlco]	20
Vaginal dryness [fndg]	20
Ramipril [orch, phsu]	20
Time course [tmco]	20
Socioeconomic Factors [grpa]	20
Serum ferritin [lbpr]	20
Head and Neck Cancer [neop]	20
Gastrointestinal bleeding [patf]	20
late effect [fndg]	20
Questionable [qlco]	20
makers [prog]	20
Nutritional status [orga]	20
Methotrexate [orch, phsu]	20
Organic [qlco]	20
disease risk factor [fndg]	20
critical limb ischaemia [patf]	20
Suspicion [menp]	20
Echocardiography, Transesophageal [diap]	20
Pre-Hypertension [dsyn]	20
Scandinavian [popg]	20
Good prognosis [qlco]	20
economic evaluation [ocac]	20
Bacteraemia [dsyn]	20
Reconstructed [qlco]	20
Fertility [orgf]	20
Dietary Patterns [resa]	20
Anaesthetic [phsu]	20
Ocular [bpoc]	20
asymmetric dimethylarginine [aapp, phsu]	20
Patent ductus arteriosus [cgab]	20
Job [ocdi]	20
NSAIDs [phsu]	20
Protein level [lbtr]	20
NON-ST ELEVATION MYOCARDIAL INFARCTION [fndg]	20
prev [idcn]	20
Adolescent [aggp]	20
Linear Models [qnco]	20
peers [popg]	20
Tissue specific [bdsu]	20
steady state [npop]	20
Representation [cnce]	20
surgical patients [podg]	20
Lignans [orch]	20
Whole body [anst]	20
Premature Ovarian Failure [dsyn]	20
Spectral [qnco]	20
CATALASE [aapp, enzy]	20
Clinical stage [tmco]	20
Grafts [tisu]	20
valves [medd]	20
Hypoxic [patf]	20
Calculating [acty]	20
Mitral Valve [bpoc]	20
Plasmin [aapp, enzy, phsu]	20
Flow Cytometry [lbpr]	20
Menstruation [orgf]	20
Veterans Affairs [orgt]	20
Norepinephrine [nsba, orch, phsu]	20
Cytotoxic [topp]	20
fractionation [lbpr]	20
Lifetime Risk [qnco]	20
Supportive [cnce]	20
Veterans [popg]	20
Phospholipids [bacs, lipd]	20
Enalapril [aapp, phsu]	20
Movement [orgf]	20
Recent myocardial infarction [fndg]	20
Health Care Delivery [hlca]	20
Virus, Human Immunodeficiency [virs]	20
relapsed [tmco]	20
Senescence [fndg]	20
imaging modalities [ftcn]	20
Glycoprotein IIb/IIIa [aapp, imft, rcpt]	20
education level [edac]	20
Hospitals, University [hcro, mnob]	20
Apo A-I [aapp, bacs]	20
Study, Intervention [resa]	20
haemangiomas [neop]	20
Decompensation [fndg]	20
Force [phpr]	20
Latin America [geoa]	20
Fat intake [clna]	20
Promoter [bacs, nnon]	20
drug efficacy [qlco]	20
Hispanics [popg]	20
Pharmaceutical Industry [hcro]	20
Partnership [orgt]	21
cardiac ischaemia [dsyn]	21
diastolic bp [clna]	21
Consent [ftcn]	21
heart disease risk [fndg]	21
Preventive Intervention [topp]	21
congenital malformations [cgab]	21
Mediator [aapp, bacs]	21
New York [geoa]	21
Gastrointestinal Tract [bdsy]	21
Image Study [diap]	21
disease control [topp]	21
Animal Experiments [resa]	21
androgen deprivation [topp]	21
Abdomen [blor]	21
Seventh [qnco]	21
Desogestrel [horm, phsu, strd]	21
IMPRECISION [phpr]	21
Cities [geoa]	21
Weight control [topp]	21
Antibiotic [antb]	21
Sector [geoa]	21
Pericardial effusion [dsyn]	21
Sodium Nitroprusside [orch, phsu]	21
Engaged [fndg]	21
Washout [tmco]	21
Wash [acty]	21
Coenzyme A [bacs, nnon]	21
bodies [humn]	21
affordability [qnco]	21
mU/kg [qnco]	21
Nursing [orgf]	21
Atenolol [orch, phsu]	21
Analgesics [phsu]	21
Acute lymphoblastic leukaemia [neop]	21
Redox [moft]	21
Non-Malignant [qlco]	21
Alcohol abuse [mobd]	21
Gestodene [phsu, strd]	21
Sclerosants [phsu]	21
Model, Linear [qnco]	21
gene polymorphisms [genf]	21
BLOOD PRESSURE, INCREASED [dsyn]	21
Readings [dora]	21
Regeneration [ortf]	21
Lesion size [spco]	21
Oral contraception [topp]	21
serum low density lipoprotein [lbpr]	21
Carotid Stenosis [dsyn]	21
Overexpression [genf]	21
Gel [bodm]	21
Minerals [inch]	21
Postal [ftcn]	21
smooth muscle cell proliferation [celf]	21
Inference [menp]	21
Conceptual [cnce]	21
artery disease [dsyn]	21
Pericardium [bpoc]	21
rural area [spco]	21
Scientists [prog]	21
Survival time [clna]	21
Infrastructure [clas]	21
match [resa]	21
Sequences [nusq]	21
Flavonoids [orch]	21
cholesterol synthesis [moft]	21
Breast Carcinoma [neop]	21
effect size [qnco]	21
DIS [fndg]	21
AACR [pros]	21
Re-operation [topp]	21
Pharmaceuticals [topp]	21
employing [fndg]	21
Premature Death [fndg]	21
Haematocrit [lbpr]	21
Hip circumference [clna]	21
Muscle, Skeletal [tisu]	21
Preventive Medicine [bmod]	21
Pooling [ftcn]	21
Root [bpoc]	21
Unfractionated Heparin [bacs, carb, phsu]	21
networks [cnce]	21
Death Certificates [inpr, mnob]	21
Intracerebral Hemorrhage [patf]	21
Prevalences [qnco]	21
Brain Stem [bpoc]	21
Decompensated [qlco]	21
Second Malignancies [neop]	21
Tract [bpoc]	21
Haemodynamic instability [dsyn]	21
high glucose [fndg]	21
past history [qlco]	21
Iatrogenic [qlco]	21
negative predictive value [qnco]	21
Tertiary care hospital [hcro, mnob]	21
Microcyst [fndg]	21
learn [menp]	21
Pharmacologic Management [hlca]	21
TRANS [idcn]	21
ventilation [phsf]	21
QTC [qnco]	21
Ligand [chem]	21
Conservative therapy [topp]	21
Map [mnob]	21
Clinical status [qlco]	21
Reperfusion Injury [inpo]	21
Identifiable [qlco]	21
Paediatrics [bmod]	21
Cholestyramine [orch, phsu]	21
Genetic Predisposition [orga]	21
breast cancers [neop]	21
Census [qnco]	21
Muscle, Smooth [tisu]	21
Marketing [ocac]	21
recurrent myocardial infarction [dsyn]	21
Ischaemic cardiomyopathy [dsyn]	21
early identification [topp]	21
Heightened [qlco]	21
prevention strategies [inpr]	21
Health Insurance [hlca]	21
Intra-arterial [spco]	21
former smokers [fndg]	21
suppressing [ftcn]	21
systolic bp [clna]	21
physical function [fndg]	21
Agency [orgt]	21
Hybrid [orgm]	21
Pharmaceutical Company [hcro]	21
Consultations [hlca]	21
Repeatedly [ftcn]	21
University Medical Center [hcro, mnob]	21
maxillofacial surgeons [prog]	21
powered [hcpp]	21
SERM [horm, phsu]	21
pingyangmycin [antb, orch]	21
Intolerance [orgf]	21
Atherosclerotic heart disease NOS [dsyn]	21
Air [sbst]	21
Cyclophosphamide [opco, phsu]	21
gynecological [bmod]	21
serum high density lipoprotein [lbpr]	21
American Diabetes Association [pros]	21
Self Administration [topp]	21
Urokinase [aapp, enzy, phsu]	21
Counter [mnob]	22
traits [orga]	22
Therapeutic regimen [topp]	22
Arachidonic Acid [eico]	22
comply [food]	22
IU [qnco]	22
mmol/dL [qnco]	22
Inhaled [orgf]	22
Postoperative Period [tmco]	22
Dipyridamole [orch, phsu]	22
Zone [spco]	22
Killip Class [fndg]	22
Intervention Strategies [topp]	22
Ward [hcro, mnob]	22
Decision Analysis [ocdi]	22
Health Policy [rnlw]	22
IGF-I [aapp, bacs]	22
Moving [orgf]	22
Maternal [famg]	22
Monkeys [mamm]	22
Doppler ultrasound [diap]	22
deep breath [sosy]	22
Carotenoids [bacs, orch, phsu]	22
hormonal changes [fndg]	22
Internet [mnob]	22
national level [spco]	22
Sympathetic Nervous System [bdsy]	22
Geometry [spco]	22
First episode [tmco]	22
Bulk [food]	22
Cis [euka]	22
Retained [ftcn]	22
Interactive [ftcn]	22
elicited [qlco]	22
Cardiac structure [bpoc]	22
cultured cells [cell]	22
Dietary Factors [ftcn]	22
ACE inhibitor [phsu]	22
echocardiograms [diap]	22
Slow progression [fndg]	22
Nuclear Factor kappa B [aapp, imft]	22
student [prog]	22
Creation [topp]	22
Vertical [spco]	22
Pain-Free [orch]	22
infusions [topp]	22
Shortening [topp]	22
SERMs [horm, phsu]	22
Sharp [fndg]	22
Exercise, Aerobic [topp]	22
Collateral [bpoc]	22
Tailor [prog]	22
Terminology [inpr]	22
oxidize [moft]	22
Great extent [qlco]	22
Tension [mobd]	22
opinions [menp]	22
Health Behaviors [inbe]	22
Aging [orgf]	22
Pulmonary Artery [bpoc]	22
Menarche [orgf]	22
Study Subject [grup]	22
Platelet Count [lbpr]	22
cGy [qnco]	22
Node [bpoc]	22
Immune system [bdsy]	22
Cost Savings [qnco]	22
Food Intake [orgf]	22
Arteriography [diap]	22
Frame [nusq]	22
Dichotomous [qlco]	22
Angiotensin Receptor [aapp, rcpt]	22
Relieved [qlco]	22
ICU [hcro, mnob]	22
unaware [resa]	22
Angiogenic [ortf]	22
Leukaemia [neop]	22
body mass [fndg]	22
sedation [fndg]	22
Household [famg]	22
C-Peptide [aapp, bacs]	22
Stenoses [anab]	22
brought [ftcn]	22
Computed tomography angiography [diap]	22
Non-Sustained Ventricular Tachycardia [dsyn]	22
claudication [fndg]	22
youth [aggp]	22
transmission [idcn]	22
Radical prostatectomy [topp]	22
myocardial injury [inpo]	22
AUC [qnco]	22
Dietary Modification [topp]	22
Teaching hospital [hcro, mnob]	22
cardiac deaths [patf]	22
Aneurysms [dsyn]	22
intolerant [ftcn]	22
consciousness [fndg]	22
degenerative [patf]	22
Vitamin A [orch, phsu, vita]	22
Cease [acty]	22
School [mnob, orgt]	22
oxidized LDL [aapp, bacs]	22
Anticoagulant therapy [topp]	22
chemo [topp]	22
Vertebral Fracture [inpo]	22
Plants [plnt]	22
WISH [gngm]	22
Retrospective Studies [resa]	22
adaptive [ftcn]	22
left heart [blor]	22
Eicosapentaenoic Acid [bacs, lipd, phsu]	22
HDL/cholesterol ratio [lbpr]	22
FDA [hcro]	22
Latent [qlco]	22
Cancer Diagnosis [diap]	22
Intralesional injection [topp]	22
palliation [hlca]	22
Hypopituitarism [dsyn]	22
Logic [idcn]	22
Coronary artery disease, premature [fndg]	22
front [spco]	22
Serum sample [bdsu]	22
Cardiomyopathies [dsyn]	22
Thrombin-antithrombin complex [aapp, enzy]	22
Hip Fractures [inpo]	22
Laboratory Data [idcn]	22
Flecainide [orch, phsu]	22
Basic Research [resa]	22
Weighing [diap]	23
Aa [plnt]	23
Parental [famg]	23
Academy [orgt]	23
Post-Operative [tmco]	23
peripheral blood [bdsu]	23
q wave [diap]	23
elevated triglycerides [fndg]	23
Protein S [aapp, bacs]	23
persistently [idcn]	23
Early Therapy [topp]	23
Interference [qlco]	23
Deep-Venous Thrombosis [dsyn]	23
ST segment depression [fndg]	23
Heart disease, premature [fndg]	23
Renin [aapp, enzy]	23
Primary Health Care [hlca]	23
Bisphosphonates [opco, phsu]	23
approaching [spco]	23
Endocrinology [bmod]	23
potentials [qlco]	23
LVEF [clna]	23
Invasion [fndg]	23
Storage [ftcn]	23
Downstream [spco]	23
Drink [food]	23
Kidneys [bpoc]	23
Fasting blood glucose [lbpr]	23
Hydrochlorothiazide [orch, phsu]	23
new information [inpr]	23
Narrow [qlco]	23
employees [ftcn]	23
Biomedical [bmod]	23
THROMBOLYTICS [phsu]	23
Low cholesterol [fndg]	23
Estrogen Receptor beta [aapp, rcpt]	23
serum triglyceride [lbpr]	23
Label [mnob]	23
Bed [mnob]	23
Expenditures [qnco]	23
Nitric Oxide Synthase [aapp, enzy]	23
Straightforward [qlco]	23
IC [idcn]	23
IR [geoa]	23
Hospital Records [inpr, mnob]	23
Estrogenic Effects [fndg]	23
learning [edac]	23
Recanalisation [topp]	23
blood glucose levels [lbtr]	23
Adenosine [nnon, nsba, phsu]	23
Urea [bacs, orch, phsu]	23
Supine [spco]	23
Metabolic Diseases [dsyn]	23
Vitamin supplementation [phsu]	23
Young Adult [aggp]	23
physical health [fndg]	23
Thyroid hormone [aapp, horm]	23
Ankle Brachial Index [clna]	23
laterality [orga]	23
Cancer Registry [inpr]	23
citations [inpr]	23
Eat [orgf]	23
Immunological [ftcn]	23
ethical [idcn]	23
Mature [tmco]	23
visualization [menp]	23
Peripheral Artery Disease [dsyn]	23
Heart Diseases, Congenital [cgab, dsyn]	23
SOY ISOFLAVONES [aapp, phsu]	23
GH [aapp, enzy]	23
Mono [popg]	23
commitment [menp]	23
Stimulus [phpr]	23
recombinant tissue plasminogen activator [aapp, enzy, phsu]	23
Associate [idcn]	23
positive predictive value [qnco]	23
Caregivers [prog]	23
cholesterol metabolism [moft]	23
delivery systems [ftcn]	23
Deviation [spco]	23
transplanted [topp]	23
Copper [bacs, elii, phsu]	23
Leadership [socb]	23
Proportional Hazard Models [inpr, qnco]	23
Planning target volume [qnco]	23
Asia [geoa]	23
INTRAMUSCULAR [ftcn]	23
population studies [resa]	23
gleason score [clas]	23
American Cancer Society [pros]	23
Liver disease [dsyn]	23
Meta [euka]	23
Clinical Center [orgt]	23
Plasma C-reactive protein [aapp]	23
Unilateral [spco]	23
Disruption [ftcn]	23
pragmatic [socb]	23
ORG [prog]	23
Diarrhea [sosy]	23
Migraine [dsyn]	23
Harbor [mnob]	23
Diagnostic procedures [diap]	23
GPS [dsyn]	23
Exogenous hormones [horm, orch]	23
played [fndg]	23
Releasing [ftcn]	23
Modifier [qlco]	23
macrophage [cell]	23
Thinking [menp]	23
population survey [resa]	23
Processing [acty]	23
explanatory [inpr]	23
Sulfonylurea [orch, phsu]	23
Neurologic [qlco]	23
Drug Combinations [phsu]	23
Catheter Ablation, Radiofrequency [topp]	23
Angioplasty, Balloon [topp]	24
Ulceration [patf]	24
Second Cancer [neop]	24
counts [qnco]	24
Group C [clas]	24
First pass [tmco]	24
boys [aggp]	24
Meal [dora]	24
Extending [spco]	24
Responsibility [inbe]	24
Histories [ocdi]	24
Cardiac care [topp]	24
quality care [qlco]	24
Metabolized [celf]	24
Ion [elii]	24
gynecologists [prog]	24
lifestyle change [socb]	24
Pregnant Women [popg]	24
Most significant [qlco]	24
Equipment [mnob]	24
Discriminate [qlco]	24
Neurosurgery [bmod]	24
Blood Pressure Monitoring, Ambulatory [diap]	24
Unproven [qlco]	24
Property [qlco]	24
Titrate [hlca]	24
Heparin, Low-Molecular-Weight [carb, phsu]	24
g d [qnco]	24
sexual dysfunction [dsyn]	24
Luminal [spco]	24
stem cell therapy [topp]	24
experimental animal [anim]	24
Percutaneous Coronary Interventions [topp]	24
Thorax [blor]	24
acute care [hlca]	24
Stimuli [phpr]	24
natriuretic peptide [aapp, horm, phsu]	24
Depletion [ftcn]	24
Dobutamine [orch, phsu]	24
Discordant [cnce]	24
Quantity [qnco]	24
Folic Acid [orch, phsu, vita]	24
Vascular Endothelial Growth Factor [aapp, phsu]	24
scar [fndg]	24
Medical therapies [topp]	24
Rhabdomyolysis [patf]	24
Visible [qlco]	24
ACC [cgab, dsyn]	24
Sensitivity and Specificity [qnco]	24
Immunosuppression [topp]	24
Substance [sbst]	24
atherosclerotic vascular disease [dsyn]	24
Conduit [medd]	24
Nutrient [food]	24
Non-alcoholic Fatty Liver Disease [dsyn]	24
Prevention Study [resa]	24
Time Interval [tmco]	24
Hypogonadism [dsyn]	24
Ovary [bpoc]	24
Extracranial [spco]	24
La [elii]	24
Division [topp]	24
intervention program [topp]	24
Nidus [lbtr]	24
Wall motion [clna]	24
Angina Pectoris, Unstable [dsyn]	24
ambulatory blood pressure [fndg]	24
Paired [qlco]	24
Retention [menp]	24
Thrombi [patf]	24
Self-Management [hlca]	24
Closed [ftcn]	24
Cyproterone Acetate [phsu, strd]	24
Output [cnce]	24
Carotid Artery, Internal [bpoc]	24
Free Radicals [bacs, chvs]	24
Healing [orgf]	24
Pituitary, NOS [bpoc]	24
Policy Makers [prog]	24
Sporadic [tmco]	24
salt intake [orga]	24
Clinical investigation [hlca]	24
Parkinson Disease [dsyn]	24
Spread [qlco]	24
Shape [spco]	24
Microcirculation [ortf]	24
beneficiary [idcn]	24
Dependence [menp]	24
Vaginal [bpoc]	24
Serum.total [lbtr]	24
Seldom [qlco]	24
Fluoroscopy [diap]	24
Genistein [bacs, orch, phsu]	24
orlistat [orch, phsu]	24
Subacute [tmco]	24
Oestradiol level [lbpr]	25
Empirical [qlco]	25
Extremities [bpoc]	25
Tumor size [spco]	25
Rats, Wistar [mamm]	25
guideline recommendation [inpr]	25
Concomitant Therapy [topp]	25
Case-Control Studies [resa]	25
Motivation [menp]	25
Arrest [tmco]	25
Dietary Habits [inbe]	25
AKT [aapp, enzy]	25
Estrogenic Compounds [horm, phsu, strd]	25
Stage II [inpr]	25
Dose Regimen [topp]	25
metrics [orch, phsu]	25
CABG [topp]	25
Vomiting [sosy]	25
Study Objective [idcn]	25
CARDIOVASCULAR MEDICATIONS [phsu]	25
Industry [ocac]	25
Element [elii]	25
Handling [bhvr]	25
invasive treatment [topp]	25
Kinetics [npop]	25
Health Care Cost [qnco]	25
Homogeneity [qlco]	25
subclasses [clas]	25
Inpatients [podg]	25
Bezafibrate [orch, phsu]	25
Esophageal [spco]	25
Dangerousness [idcn]	25
Liquid [sbst]	25
Blood Cell Count, White [lbpr]	25
Amplitude [spco]	25
tailoring [prog]	25
scored [qnco]	25
Demographic Factors [idcn]	25
Motor [ftcn]	25
primary therapy [topp]	25
High Risk Populations [popg]	25
Automatic [ftcn]	25
Affiliated [qlco]	25
Event-Free Survival [qnco]	25
Ventricular tachycardia, monomorphic [dsyn]	25
Drug Development [bmod]	25
Social support [socb]	25
Sclerosis [patf]	25
Coordinated [fndg]	25
small size [fndg]	25
Differentiated [celf]	25
Coronary Lesion [fndg]	25
Dental [qlco]	25
Aortic Valve [bpoc]	25
Habit [inbe]	25
PA [tmco]	25
Encoding [idcn]	25
Seminoma [neop]	25
Extended Release [bodm]	25
Seizure [sosy]	25
Particle [chvs]	25
Risk Estimate [qnco]	25
Chronic heart disease [dsyn]	25
Surgeon [prog]	25
Normal weight [fndg]	25
Message [inpr]	25
Flushing [sosy]	25
respect [socb]	25
Instability [fndg]	25
Behaviours [inbe]	25
Occasionally [tmco]	25
favoring [orch, phsu, vita]	25
Longest [qlco]	25
Manuscript [inpr, mnob]	25
Cardiovascular drug [phsu]	25
Disseminated [spco]	25
Negligible [qlco]	25
Increased C-reactive protein [fndg]	25
Alternative Therapies [topp]	25
slowing [qlco]	25
Head and neck region [blor]	25
Systolic hypertension [dsyn]	25
Retinoids [bacs, orch, phsu]	25
Surgical procedure [hlca]	25
Congenital Heart Defects [cgab]	25
interruption [ftcn]	25
Korea [geoa]	25
Insufficiency [ftcn]	25
Ingestion [biof]	25
Offspring [famg]	25
preclinical studies [resa]	26
Assisted [fndg]	26
Scintigraphy [diap]	26
Vascular Tumors [neop]	26
Pharmacogenomics [bmod]	26
Worst [qlco]	26
Epilepsy [dsyn]	26
Metastatic [ftcn]	26
Official [qlco]	26
Plasma viscosity [lbpr]	26
Scotland [geoa]	26
Neuropathy [dsyn]	26
Cell Therapy [topp]	26
Abdominal Fat [tisu]	26
Albuminuria [fndg]	26
g/day [qnco]	26
low estrogen [fndg]	26
Health systems [gora]	26
Selectin [aapp, bacs]	26
Human Umbilical Vein Endothelial Cells [cell]	26
Recommendation to [hlca]	26
Newly Diagnosed [qlco]	26
TM [aapp, rcpt]	26
Monocyte [cell]	26
Noncompliance [fndg]	26
Private [orgt]	26
Radio Frequency [npop]	26
Extracorporeal [spco]	26
Discomfort [sosy]	26
Territory [geoa]	26
Readiness [fndg]	26
Needle [medd]	26
Serum C reactive protein level [lbpr]	26
uncertainties [idcn]	26
chapter [idcn]	26
peer reviewed [hlca]	26
Biased [idcn]	26
Total population [qnco]	26
Descending [qlco]	26
Radiographic [npop]	26
Radiologic [bmod]	26
Very low density lipoprotein cholesterol [bacs, strd]	26
Display [mnob]	26
complicating [ftcn]	26
Ventricular Septal Defect [anab]	26
Lag [gngm]	26
Menstrual cycle [orgf]	26
ST segment [fndg]	26
Mortality, Premature [fndg]	26
Savings [qnco]	26
Genetic Variation [npop]	26
Haemangioma [neop]	26
Analytical [resa]	26
Physically active [fndg]	26
Reproduction [orgf]	26
Persistent atrial fibrillation [patf]	26
Ovaries [bpoc]	26
Disease-Free Survival [qnco]	26
Expenditure [qnco]	26
Molecular Target [chvf, chvs]	26
Clinical findings [sosy]	26
beats/min [qnco]	26
board [medd]	26
Growth hormone deficiency [dsyn]	26
East [spco]	26
Up [spco]	26
O NOS [inpr]	26
Open Label Study [resa]	26
Metoprolol [orch, phsu]	26
Conditional [qlco]	26
Implant [medd]	26
Tomography, Emission-Computed, Single-Photon [diap]	26
Systolic Pressure [clna]	26
Right coronary artery [bpoc]	26
isolated systolic hypertension [fndg]	26
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]	26
Preliminary results [idcn]	26
Hypertension, mild [fndg]	26
Retinopathy [dsyn]	26
simulated [bodm]	26
Nonsteroidal Anti-inflammatory Drugs [phsu]	26
Spine [bpoc]	26
African [popg]	26
Divergence [spco]	26
DOT [topp]	26
overall survival rate [qnco]	26
Early-onset [fndg]	26
Interventional Study [resa]	26
Kappa [inpr]	26
Abstract [ocac]	26
Somatic [qlco]	26
Metabolic Profile [npop]	26
CLOT [orch, phsu]	26
Q-T interval [clna]	26
Fill [acty]	26
Low density lipoprotein apheresis [topp]	26
kidney function [ortf]	26
Arterial thrombosis [dsyn]	26
Laser treatment [topp]	26
ANTIARRHYTHMICS [phsu]	26
Arterial disease [dsyn]	26
conducting [inbe]	26
Creatinine clearance [fndg]	26
Fistula [anab]	26
Endoscopy [diap]	26
Cut [inpo]	26
VOL [qnco]	26
Arginine [aapp, bacs, phsu]	26
Follicle Stimulating Hormone [aapp, horm, phsu]	26
Dietary Supplements [food]	26
Polymerase Chain Reaction [lbpr, mbrt]	26
Exercise Tolerance [clna]	26
Donor [popg]	27
Cigarettes [mnob]	27
Breast tissue [bpoc]	27
Cyclo-Oxygenase II [aapp, enzy]	27
Tachyarrhythmias [fndg]	27
Binary [qlco]	27
Economic Burden [qnco]	27
Nodal [spco]	27
Healthy adult [fndg]	27
Pericarditis [dsyn]	27
reverse cholesterol transport [celf]	27
VI [inpr]	27
European country [geoa]	27
End systolic [tmco]	27
Medical center [hcro, mnob]	27
Reside [acty]	27
discount [inpr]	27
Endothelin [aapp, bacs]	27
Infertility [dsyn]	27
new onset [fndg]	27
cholesterol lowering drugs [phsu]	27
Drinking [inbe]	27
Night time [tmco]	27
Compliant [qlco]	27
Antipsychotics [phsu]	27
Breast Cancer Treatment [topp]	27
Epicardial [spco]	27
Unmet [acty]	27
Thiazolidinediones [orch, phsu]	27
Pulmonary Disease [dsyn]	27
low fat [inpr]	27
ovid [mamm]	27
Memory [menp]	27
Washout Period [tmco]	27
arterial pressure [ortf]	27
Antipsychotic [phsu]	27
Inoperable [qlco]	27
Stroke prevention [topp]	27
Surgical Interventions [hlca]	27
covering [medd]	27
End-stage [tmco]	27
Constituents [sbst]	27
Subtype [clas]	27
Preserving [ftcn]	27
lipid disorders [dsyn]	27
quick [qlco]	27
Confidence [menp]	27
dose-response relationship [biof]	27
Coagulation Factors [aapp, bacs, phsu]	27
Pulmonary Vascular Resistance [phsf]	27
Pharmacogenetics [bmod]	27
cerebrovascular diseases [patf]	27
Autoimmune [patf]	27
functional capacity [topp]	27
de novo [idcn]	27
Natriuretic Peptide, Brain [aapp, horm, phsu]	27
Bolus [topp]	27
TT [geoa]	27
Suggestions [idcn]	27
risk analysis [qlco]	27
blood pressures [fndg]	27
Ethnic Groups [popg]	27
Type II [clas]	27
Lower Extremity [blor]	27
personnel [ftcn]	27
HTTP [idcn]	27
Flexible [qlco]	27
[pH] [qnco]	27
Translating [ocac]	27
Multifaceted [spco]	27
Blood Cells [cell]	27
Acromegaly [dsyn]	27
Isoforms [aapp]	27
Marital Status [grpa]	27
pound [qnco]	27
move [orgf]	27
Chemotherapy, Adjuvant [topp]	27
Mechanical ventilation [topp]	27
preference [idcn]	27
fragment [ftcn]	27
Intracardiac [bsoj]	27
Denied [qlco]	27
Soy Protein [aapp, bacs, phsu]	27
esophageal cancer [neop]	27
Palliative [qlco]	27
SEM [medd]	27
bound [spco]	27
Creatine Kinase [aapp, enzy]	27
Cardiovascular therapy [topp]	27
MILDLY [idcn]	27
National Institutes of Health [hcro]	27
Predisposition [clna]	27
Infectious Diseases [dsyn]	27
Lumbar spine [bpoc]	27
hormone levels [lbtr]	27
Carcinogen [hops]	27
collagen vascular diseases [dsyn]	27
Male gender [fndg]	27
Cardiovascular Abnormalities [dsyn]	27
elevate [qlco]	27
Educational Level [fndg]	27
Pelvic [blor]	27
Identifying patient [hlca]	28
Homogeneous [qlco]	28
Insurance [idcn]	28
Pulmonary artery pressure [lbtr]	28
Serum lipid levels [lbpr]	28
Brachytherapy [topp]	28
control rates [ftcn]	28
Endoscopic [diap]	28
Familiar [qlco]	28
resected [topp]	28
Surgical Management [hlca]	28
attack [socb]	28
ERalpha [aapp, rcpt]	28
Advanced Cancer [neop]	28
Echocardiography, Doppler [diap]	28
chart [medd]	28
Dominant [ftcn]	28
FACTORIAL [resa]	28
HT [geoa]	28
Western World [idcn]	28
limits [ftcn]	28
Firm [qlco]	28
Type I [clas]	28
Visual [ftcn]	28
Myocardial Perfusion Imaging [diap]	28
Dilated [ftcn]	28
Cross-Over Study [resa]	28
Metabolic Control [moft]	28
Oral Glucose Tolerance Test [diap]	28
Nation [orgt]	28
involuted [qlco]	28
RES [fndg]	28
Abundant [qlco]	28
LDL particle [celc]	28
Coronary artery bypass graft [topp]	28
Unacceptable [qlco]	28
Laboratory Tests [lbpr]	28
girls [aggp]	28
Haematoma [patf]	28
QALY [tmco]	28
failing [ftcn]	28
Torsade de Pointes [dsyn]	28
Inspiration [orgf]	28
Obliteration [ftcn]	28
Blunted [qlco]	28
Estrogen Effect [fndg]	28
Exploration [topp]	28
Staging [ftcn]	28
Reversal [ftcn]	28
Pills [bodm]	28
Ontario [geoa]	28
Superoxide Dismutase [aapp, enzy, phsu]	28
Sponsor [humn]	28
docosahexaenoic acid [bacs, lipd, phsu]	28
Constraint [ftcn]	28
Object [phob]	28
Malnutrition [dsyn]	28
Antigen [imft]	28
Differential Diagnosis [diap]	28
FISH OIL [bacs, lipd, phsu]	28
Self-Administered [ftcn]	28
Interim [tmco]	28
beta adrenoceptor [moft]	28
Occlusive [ftcn]	28
Wild Type [orga]	28
Circ [qnco]	28
progesterone, micronized [horm, phsu, strd]	28
injuries [inpo]	28
Visceral Fat [tisu]	28
Shortened [qlco]	28
Vasoactive [qlco]	28
Mouse [mamm]	28
Esophagus [bpoc]	28
Bone Marrow [tisu]	28
Mean deviation [clna]	28
Balloon [mnob]	28
Cranial [bpoc]	28
Nutrition Therapy [topp]	28
Predictability [menp]	28
liter [qnco]	28
Diabetic Nephropathy [dsyn]	28
ex vivo [ftcn]	28
Forming [ftcn]	28
routes [spco]	28
skeletal [bdsy]	28
X-ray [ftcn]	28
Transplant Recipients [podg]	28
Histologic [ftcn]	28
Measurable [ftcn]	28
Israel [geoa]	28
Concentrate [mnob]	28
Comparative Studies [inpr]	28
insulin secretion [celf]	28
Priorities [tmco]	28
Multimodality [diap]	28
Remote [spco]	28
ERbeta [aapp, rcpt]	28
Turner Syndrome [cgab, dsyn]	29
Ring [spco]	29
Single Nucleotide Polymorphisms [nusq]	29
Intervention Studies [resa]	29
gender difference [orga]	29
Murine [mamm]	29
Proportional Hazard Model [inpr, qnco]	29
Transcription [genf]	29
Psychiatric [ftcn]	29
Hypertensive heart disease [dsyn]	29
Health Care Provider [prog]	29
Toxic effect [inpo]	29
picture [mnob]	29
Lower Limb [blor]	29
vascular inflammation [dsyn]	29
error [qlco]	29
Sound [npop]	29
Autonomic [bdsy]	29
Psychosocial Factors [qlco]	29
Slope [qnco]	29
New York Heart Association Class [fndg]	29
Suggestion [idcn]	29
Urine [bdsu]	29
Comorbidity Index [qnco]	29
ERT [topp]	29
Mind [menp]	29
Propranolol [orch, phsu]	29
wait [ftcn]	29
Receiver Operating Characteristic [qnco]	29
Audit [cnce]	29
Chelation [moft]	29
Procoagulant [aapp, bacs]	29
Quintile [clna]	29
Standardized Mortality Ratio [qnco]	29
Peritoneal Dialysis [topp]	29
Antibodies [aapp, celc, imft]	29
Disagreement [socb]	29
Mineral [inch]	29
disease risk [fndg]	29
Longitudinal Studies [resa]	29
Thiazide Diuretics [orch, phsu]	29
Speed [qnco]	29
Sex hormone [horm, phsu]	29
Cholesteryl Ester Transfer Protein [aapp, bacs]	29
ovarian function [ortf]	29
Histogram [mnob]	29
Assistance [socb]	29
bone metabolism [ortf]	29
high risks [qlco]	29
Parents [famg]	29
Primary hypercholesterolaemia [dsyn]	29
Distant metastasis [clas]	29
Acute heart failure [dsyn]	29
Enthusiasm [menp]	29
REGULATOR [medd]	29
Serum cholesterol level [lbpr]	29
Bridge [medd]	29
Nifedipine [orch, phsu]	29
invasive procedures [ftcn]	29
HIV infection [dsyn]	29
Patient data [inpr]	29
Supraventricular tachycardia [dsyn]	29
translated [ocac]	29
Cervical [blor]	29
Fish [fish]	29
Iron Overload [dsyn]	29
Comparator [mnob]	29
Health Services [hlca]	29
Leucocyte [cell]	29
bone mass [clna]	29
short period [fndg]	29
chi square [qnco]	29
Derivative [ftcn]	29
enriched [food]	29
Rate control [ftcn]	30
Specified [qlco]	30
Korean [popg]	30
Stem cells [cell]	30
Chamber [bpoc]	30
coronary bypass surgery [topp]	30
High grade [qlco]	30
Extraction [topp]	30
Renal Impairment [dsyn]	30
Locus [gngm]	30
Uncomplicated [qlco]	30
Biases [idcn]	30
Massachusetts [geoa]	30
worsened [fndg]	30
Inflammatory disease [dsyn]	30
Complementary and alternative medicine [topp]	30
Caring [inbe]	30
Smooth Muscle Cells [cell]	30
Aerobic [qlco]	30
Outlines [inpr]	30
Vehicle [bodm]	30
Positron-Emission Tomography [diap]	30
Manipulation [topp]	30
Commence [acty]	30
Dual-Energy X-Ray Absorptiometry [diap]	30
Missed [qlco]	30
Cardiac Arrhythmia [patf]	30
Treatment Arm [resa]	30
Reader [prog]	30
recombinant [orgm]	30
Reactions, Adverse Drug [inpo]	30
Health Maintenance Organization [hcro, mnob]	30
Staining [lbpr]	30
Ethinyl Estradiol [horm, phsu, strd]	30
Sclerosing agent [phsu]	30
residence [spco]	30
Health Care Costs [qnco]	30
Diastolic dysfunction [patf]	30
Serum creatinine [lbpr]	30
Protein C [aapp, bacs, phsu]	30
antidiabetic [phsu]	30
disease management [ftcn]	30
Signal Pathways [moft]	30
Perimenopause [phsf]	30
morphological [spco]	30
Thoracic surgeon [prog]	30
Cognitive decline [mobd]	30
Cumulative Dose [cnce]	30
Monitoring, Holter [diap]	30
TG [lbpr]	30
Monocytes [cell]	30
Enabled [menp]	30
Volunteers [prog]	30
Deficit, NOS [dsyn]	30
Non-Surgical [ftcn]	30
Mouse Model [emod]	30
Health Promotion [hlca]	30
Doxorubicin [antb, orch]	30
cee [orch]	30
P-Selectin [aapp, imft]	30
Replaced [ftcn]	30
Ankle [blor]	30
Survival Analysis [resa]	30
Drug Delivery [medd]	30
Amenorrhea [dsyn]	30
Low-Density Lipoproteins [aapp, bacs, lipd]	30
Intracoronary [ftcn]	30
Analog [chvs]	30
commercial [inpr]	30
workers [ftcn]	30
Arteriosclerosis [dsyn]	30
Triple [qnco]	30
Stimulating [npop]	30
Cognitive impairment [mobd]	30
Microalbuminuria [dsyn]	30
Radical [chvs]	30
Blood loss [patf]	30
Track [mnob]	30
Transthoracic Echocardiography [diap]	30
Diversity [qlco]	30
Slowly [qlco]	30
Attitude [menp]	30
Finnish [popg]	30
brazilian [fndg]	30
Exercise Test [diap]	30
arrival [idcn]	30
Carcinoma [neop]	31
Working Group [popg]	31
Walking distance [fndg]	31
pre treatment [tmco]	31
Mount [medd]	31
LV [geoa]	31
histopathology [ftcn]	31
patent [inpr]	31
Contraction [patf]	31
integrity [qlco]	31
Immunohistochemistry [lbpr]	31
Apolipoprotein E [aapp, bacs]	31
Physicians, Family [prog]	31
Risk Ratios [qnco]	31
blocked [patf]	31
Targeted Therapy [topp]	31
Contraindication [qlco]	31
Fatty Acids [lipd]	31
Genome [gngm]	31
Metastases [neop]	31
PULSE [clna]	31
Antihypertensives [phsu]	31
Biochemistry [ocdi]	31
Hazards [qlco]	31
Informed Consent [rnlw]	31
Adhere [fndg]	31
Revision [tmco]	31
Neurological deficit [fndg]	31
Periodicals [inpr, mnob]	31
Diabetes Mellitus, Non-Insulin-Dependent [dsyn]	31
polyphenols [orch, phsu]	31
Histologically [ftcn]	31
Bilateral oophorectomy [topp]	31
Contralateral [spco]	31
Schedule [inpr]	31
Sex Difference [orga]	31
Heart Surgery [topp]	31
Nanoparticles [mnob]	31
Hispanic [popg]	31
cardiac event [dsyn]	31
poor health [fndg]	31
Standing [phsf]	31
Radiation Field [blor]	31
Antidepressant [phsu]	31
dollars [qnco]	31
Lanugo [bpoc]	31
Yearly [tmco]	31
Confounding Variables [ftcn]	31
AD [inpr]	31
Year, Quality-Adjusted Life [tmco]	31
Radiotherapy, Intensity-Modulated [topp]	31
Lymphatic malformation [anab]	31
protein expression [genf]	31
drospirenone [orch, phsu]	31
activating [acty]	31
sildenafil [orch, phsu]	31
Surrogate Markers [qlco]	31
Additional information [tmco]	31
educated [edac]	31
Mammary [bpoc]	31
Atrophy [patf]	31
Frequencies [tmco]	31
in vitro study [resa]	31
Neoplasia [neop]	31
Central Obesity [dsyn]	31
acceptability [qlco]	31
Seizures [sosy]	31
Experiment [resa]	31
Tissue Factor [aapp, imft]	31
Dissemination [spco]	31
Cognition [menp]	31
gene therapy [topp]	31
Dispense [hlca]	31
presentations [idcn]	31
AIDS [dsyn]	31
Haemorrhagic stroke [patf]	31
MU/day [qnco]	32
Adolescence [aggp]	32
Myocarditis [dsyn]	32
Narrative [socb]	32
Half-Life [tmco]	32
Very low density lipoprotein [aapp, bacs, lipd]	32
Specialist [prog]	32
Medial [spco]	32
Transformed [patf]	32
Autologous [qlco]	32
resveratrol [orch, phsu]	32
Atheroma [patf]	32
Indian [popg]	32
high cholesterol level [fndg]	32
Cavernous [spco]	32
Systemic Therapy [topp]	32
Diltiazem [orch, phsu]	32
Mediastinum [blor]	32
Augmented [qnco]	32
Sclerosant [phsu]	32
Lethal [fndg]	32
preventive therapy [inpr]	32
MICRO [lbpr]	32
Mitral Regurgitation [dsyn]	32
Counsel [prog]	32
human studies [resa]	32
prompted [ftcn]	32
Views [spco]	32
Obstruction [patf]	32
Highly significant [qlco]	32
Satisfied [menp]	32
Clinical evaluation [hlca]	32
mg/kg/day [qnco]	32
Phytochemicals [bacs, orch]	32
Primary Outcome Measure [inpr]	32
New Zealand [geoa]	32
Conformal [spco]	32
Acceleration [phpr]	32
Phyto-Estrogen [horm, phsu, strd]	32
aesthetic [ocdi]	32
admissions [hlca]	32
Basic Science [resa]	32
Council [popg]	32
Solutions [sbst]	32
Dissection [topp]	32
Depressive Symptoms [sosy]	32
Paroxysmal [tmco]	32
Cutaneous [spco]	32
Night [tmco]	32
intensive care [hlca]	32
Oral contraceptive [phsu]	32
Mediating [socb]	32
classify [clas]	32
shifted [ftcn]	32
Build [cnce]	32
discussions [topp]	32
Down-Regulation [celf, moft]	32
Facial [blor]	32
Fibrin [aapp, bacs, phsu]	32
sampled [diap]	32
Neonatal [prog]	32
non smokers [fndg]	32
Daytime [tmco]	32
Early Intervention [hlca]	32
progressed [ftcn]	32
Left anterior descending artery [bpoc]	32
Vascular System [bdsy]	32
Axis [bpoc]	32
Oriented [spco]	32
Vision [orgf]	32
Myocardial Revascularization [topp]	32
HMG-CoA reductase inhibitor [orch, phsu]	32
ovarian cancer [neop]	32
Antithrombin [aapp, phsu]	32
.ALPHA.-Tocopherol [lipd, orch, phsu, vita]	32
Pathologic [ftcn]	33
Biologically [qlco]	33
shocks [patf]	33
Drug-induced [ftcn]	33
Consistency [qlco]	33
Thrombolytic Agents [phsu]	33
sbp [diap]	33
Posterior [spco]	33
Sex Hormone-Binding Globulin [aapp, bacs]	33
Expectations [idcn]	33
Imaging Techniques [diap]	33
Rats, Sprague-Dawley [mamm]	33
Lipid Peroxidation [moft]	33
Obstructive sleep apnoea [dsyn]	33
intent [qlco]	33
Atrial Flutter [patf]	33
Sign [fndg]	33
Healthy diet [topp]	33
Intervention Trial [resa]	33
Glycosylated haemoglobin [aapp, bacs]	33
Echocardiogram [diap]	33
Spinal Cord [bpoc]	33
exerted [orgf]	33
Cancer Mortality [qnco]	33
superiority [socb]	33
Every day [tmco]	33
Patient Adherence [inbe]	33
Survey, Health [resa]	33
Nephropathy [dsyn]	33
doubled [ftcn]	33
Chronic inflammation [patf]	33
Diagnosis, clinical [qlco]	33
predisposing [ftcn]	33
Stents [medd]	33
CONSIST [qlco]	33
Probabilities [qnco]	33
deficits [qlco]	33
Anthracyclines [antb, orch]	33
Province [geoa]	33
Pneumonia [dsyn]	33
Hyperhomocysteinemia [dsyn]	33
Explanations [inpr]	33
Animal Model [anim]	33
Phosphorylation [moft]	33
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]	33
Target Population [popg]	33
Folate [orch, phsu, vita]	33
Dizziness [sosy]	33
Reproductive Medicine [bmod]	33
Feeding [hlca]	33
Ischemia-Reperfusion Injury [inpo]	33
Minnesota [geoa]	33
Waist-Hip Ratio [orga]	33
Withdrawn [fndg]	33
doubt [menp]	33
Glycated haemoglobin [aapp, bacs]	33
Thickening [fndg]	33
Aneurysm [dsyn]	33
Adulthood [tmco]	33
Endocarditis, infective NOS [dsyn]	33
equations [cnce]	33
Infant [aggp]	33
AHA [orch, phsu]	33
Lymphoma [neop]	33
Cardiac dysfunction [fndg]	33
Ligation [topp]	33
Nausea [sosy]	33
Genetic Polymorphisms [genf]	33
calcification [ortf]	33
Indexes [inpr]	33
Fatty acid [lipd]	33
ST ELEVATION MYOCARDIAL INFARCTION [fndg]	33
Feedback [phpr]	33
Species [idcn]	34
GO [gngm]	34
Markers, Biochemical [qlco]	34
treatment planning [inpr]	34
Commentary [inpr]	34
Assignment [ftcn]	34
Metastasis [neop]	34
practice guidelines [inpr]	34
Criterion [inpr]	34
etiologies [ftcn]	34
ECHO [topp]	34
Insertion [hlca]	34
Extreme [qlco]	34
Peptides [aapp]	34
Testicular Cancer [neop]	34
Rating [acty]	34
African Americans [popg]	34
Coronary Artery Bypass Surgery [topp]	34
Fetal [emst]	34
Alleles [gngm]	34
Neonates [aggp]	34
Chemopreventive Agent [phsu]	34
laser therapy [topp]	34
hypertension treatment [hlca]	34
Cyclical [tmco]	34
Plasma homocystine level [lbpr]	34
concomitant disease [patf]	34
Drug drug interaction [moft]	34
nmol/L [qnco]	34
General practitioner [prog]	34
Absolute Ethanol [orch]	34
concordance [socb]	34
Space [spco]	34
Comparative Study [inpr]	34
Current state [inpr]	34
occluded [patf]	34
ALCOHOL USE [inbe]	34
Ease [menp]	34
accept [qlco]	34
Pulsatility index [clna]	34
Patch [fndg]	34
Fair [qlco]	34
Standardization [resa]	34
Preservation [lbpr]	34
metropolitan [spco]	34
Variant [qlco]	34
gray [qnco]	34
scenarios [ftcn]	34
recall [menp]	34
Inherited [ftcn]	34
adjunctive therapy [topp]	34
Nitric Oxide Synthase, Endothelial [aapp, enzy]	34
Vitamin C [orch, phsu, vita]	34
Surgical approach [ftcn]	34
Haematology NOS [bmod]	34
Adjustments [inbe]	34
s l [qnco]	34
First Step [bodm]	34
complicate [ftcn]	34
Terminal [tmco]	34
Conventional Treatment [topp]	34
pharmacodynamics [ftcn]	34
Antidepressants [phsu]	34
After [tmco]	34
Cleanse [acty]	34
Closure [topp]	34
Prostate-Specific Antigen [aapp, enzy, imft]	34
Re-admission [idcn]	34
Valvular disease [dsyn]	34
Angiotensin Converting Enzyme [aapp, enzy, imft]	35
Antibiotics [antb]	35
Cholesterol-lowering drug [phsu]	35
Radiosurgery [topp]	35
compatible [idcn]	35
Dropped [acty]	35
SALVAGE [topp]	35
Hyperinsulinaemia [dsyn]	35
Text [inpr]	35
cholesterol level [lbpr]	35
Metabolic Disorders [dsyn]	35
Dyslipidemias [dsyn]	35
Sotalol [orch, phsu]	35
Documents [inpr]	35
Malondialdehyde [orch]	35
Fitness [dora]	35
Replace [idcn]	35
Sampling [diap]	35
Emergency treatment [topp]	35
Selenium [elii, hops]	35
Low-Dose Aspirin [orch, phsu]	35
Arteriovenous malformation [cgab]	35
Bile Acid Sequestrants [phsu]	35
exercise induced [sosy]	35
Limb [bpoc]	35
Intracranial [blor]	35
manifested [ftcn]	35
radiologists [prog]	35
Temporary [tmco]	35
Therapeutic Intervention [topp]	35
Verify [ftcn]	35
oxidant [chvf]	35
g l [qnco]	35
Attenuation [acty]	35
Tobacco use NOS [fndg]	35
Progenitor [famg]	35
Glucose Intolerance [dsyn]	35
Vasoconstriction [ortf]	35
Combination Drug Therapy [topp]	35
initiatives [menp]	35
Bad [qlco]	35
Managed Care [hlca]	35
Isolation [topp]	35
Universal [bodm, carb]	35
Hyperplasia [patf]	35
high triglycerides [fndg]	35
primary treatment [topp]	35
drain [topp]	35
Dimension [qnco]	35
Subpopulation [popg]	35
Vasodilators [phsu]	35
Anti-inflammatory effect [qlco]	35
Body Fat Distribution [fndg]	35
FOAM [topp]	35
Femoral [bpoc]	35
Scanning [diap]	35
Renin-Angiotensin-Aldosterone System [bdsy]	35
differentiate [qlco]	35
Complementary therapies [topp]	35
Hard [qlco]	35
Direction [spco]	35
Massive [qlco]	35
Electrocardiograms [fndg]	35
Older Population [popg]	35
Filled [acty]	35
Gradual [qlco]	35
Bypass Surgery [topp]	35
Colon [bpoc]	35
Resolve [cnce]	35
Advancement [ftcn]	35
Antithrombin III [aapp, phsu]	36
Patient Satisfaction [qlco]	36
Heart Transplantation [topp]	36
Art [ocdi]	36
Frailty [fndg]	36
Parity [fndg]	36
Statistic [qnco]	36
preventive measures [inpr]	36
Enabling [menp]	36
Trial, Multicenter [resa]	36
COLL [inpr]	36
Potassium [elii]	36
Ventricular Function [ortf]	36
mU/mL [qnco]	36
Falls [fndg]	36
blood cholesterol [lbpr]	36
NTproBNP [aapp, bacs]	36
Mitochondrial [celc]	36
Pathogenic [orgm]	36
Mr. [cnce]	36
PRECIPITATE [phpr]	36
Distant [spco]	36
sense [ortf]	36
Anthracycline [antb, orch]	36
tumours [neop]	36
National Health and Nutrition Examination Survey [resa]	36
Exercise, Physical [dora]	36
Conclusive [qlco]	36
radiofrequency ablation [topp]	36
Lupus Erythematosus, Systemic [dsyn]	36
Word [idcn]	36
Unsuccessful [qlco]	36
Between [spco]	36
Transformation [celf]	36
India [geoa]	36
Abstracted [ocac]	36
Tablets [bodm]	36
Vitamin [orch, phsu, vita]	36
Room [spco]	36
Cox Models [inpr, qnco]	36
urogenital [bdsy]	36
Denmark [geoa]	36
stated [geoa]	36
Bradycardia [patf]	36
associated disease [patf]	36
General health [fndg]	36
excision [topp]	36
Once [inpr]	36
terminated [idcn]	36
cognitive function [menp]	36
Vascular surgery [topp]	36
mental health [menp]	37
Walking [dora]	37
Tangentiality [mobd]	37
Carbohydrate Metabolism [moft]	37
Endometrial Hyperplasia [dsyn]	37
Conjugated [spco]	37
Hypertrophy [patf]	37
childhood cancer [neop]	37
cancer prevention [topp]	37
Supplemental [ftcn]	37
Dutch [popg]	37
Adhesion [patf]	37
West [spco]	37
Oophorectomy [topp]	37
High Density Lipoproteins [aapp, bacs, lipd]	37
Levonorgestrel [horm, phsu, strd]	37
Schizophrenia [mobd]	37
Proteinuria [fndg]	37
lines [spco]	37
Osteoporosis, Post-Menopausal [dsyn]	37
Consumer [popg]	37
diagnosing [fndg]	37
Forearm [bpoc]	37
Waist [blor]	37
Judgement [menp]	37
Sole [blor]	37
Ovarian hormone [horm, orch, phsu]	37
Biopsy [diap]	37
Congenital vascular malformation [cgab]	37
Sixth [qnco]	37
Shunt [medd]	37
appropriateness [qlco]	37
soft tissue [tisu]	37
Aortic Valve Replacement [topp]	37
Transport, NOS [celf]	37
Once daily [tmco]	37
Peptide [aapp]	37
North America [geoa]	37
Radiation Exposure [phpr]	37
Bilateral [spco]	37
Titration [lbpr]	37
Coronary Artery Disease Risk [inpr]	37
Belief [idcn]	37
Host [orgm]	37
von Willebrand Factor [aapp, bacs, phsu]	37
Data Analysis [ocac]	37
Tracking [spco]	37
Duplex [spco]	37
Infancy [tmco]	37
early menopause [dsyn]	37
Non-Small Cell Lung Cancer [neop]	37
scenario [ftcn]	37
Digoxin [carb, phsu, strd]	37
serum triglycerides [lbpr]	37
Exclusion Criteria [ftcn]	37
Chagas Disease [dsyn]	37
Whole breast [bdsy]	37
Gamma [npop]	37
plaques [acab]	37
documentation [hlca]	37
CC [neop]	37
skills [inbe]	38
Case Series [resa]	38
Calcium channel blocker [phsu]	38
surgeons [prog]	38
Catheterisation [topp]	38
Rule [idcn]	38
pacemaker [medd]	38
Defibrillator [medd]	38
Therapeutic Efficacy [qlco]	38
Antiplatelet Drugs [phsu]	38
elicit [qlco]	38
stopping [inch, phsu]	38
Connection [inpr]	38
dietary intervention [topp]	38
Synthesized [acty]	38
Fever [fndg]	38
Separated [fndg]	38
Organized [ftcn]	38
Cisplatin [inch, phsu]	38
Courses [tmco]	38
Shock, Cardiogenic [patf]	38
Cardiopulmonary Bypass [topp]	38
Cardiopulmonary [blor]	38
Relations [socb]	38
electrocardiography [fndg]	38
Occasional [tmco]	38
Angina Pectoris, Stable [dsyn]	38
insulin levels [lbpr]	38
High resolution [lbpr]	38
Margin [spco]	38
Coronary care unit [hcro, mnob]	38
Span [cnce]	38
Precursor [idcn]	38
Transcatheter [spco]	38
adaptation [orgf]	38
Systemic disease [dsyn]	38
Pool [geoa]	38
Implantable [medd]	38
Labeled [qlco]	38
Sudden [qlco]	38
Lateral [spco]	38
Work-up [diap]	38
discrepancies [fndg]	38
Edema [patf]	38
Normalize [resa]	38
Solid [qlco]	38
Distributions [spco]	38
Contents [cnce]	38
tnf alpha [aapp, imft]	38
Chain [mnob]	38
Brachial [spco]	38
Finland [geoa]	38
South [spco]	38
Connect [acty]	38
choosing [acty]	38
WWW [mnob]	38
D-dimer [aapp, bacs]	38
learned [menp]	38
Manufacturer [inpr]	38
spanish [popg]	38
Caucasian [popg]	38
Embolism [patf]	38
Carotid Atherosclerosis [dsyn]	38
relieve [ftcn]	38
Mixture [sbst]	38
hospital admissions [hlca]	38
Chart review [hlca]	38
degradation [ftcn]	38
study results [fndg]	38
disease severity [qlco]	38
scoring [qnco]	39
Platelet Function [lbpr]	39
locations [spco]	39
reviewing [inpr]	39
Imbalance [sosy]	39
Clarified [acty]	39
Pump [medd]	39
polidocanol [orch, phsu]	39
Input [cnce]	39
Hydroxy [inch]	39
Hypoglycaemia [dsyn]	39
Osteoarthritis [dsyn]	39
Funding [qnco]	39
Mastectomy [topp]	39
suggestive [ftcn]	39
bibliographies [inpr, mnob]	39
Apo-E [aapp, bacs]	39
Operative procedure [hlca]	39
Eating [orgf]	39
Conduction [ortf]	39
Myopathy [dsyn]	39
Certainty [qlco]	39
Native [ftcn]	39
Verapamil [orch, phsu]	39
Clustering [resa]	39
Clinical Study [resa]	39
Modulated [spco]	39
Breast-Conserving Surgery [topp]	39
Treadmill [mnob]	39
Dwelling [cnce]	39
Aggregation [ftcn]	39
Platelet Activation [ortf]	39
Verified [ftcn]	39
American Society of Clinical Oncology [pros]	39
anomalies [ftcn]	39
Sexual [bhvr]	39
severe symptoms [fndg]	39
Probable [qnco]	39
Sodium Tetradecyl Sulfate [lipd, phsu]	39
fluvastatin [orch, phsu]	39
benefit risk [qlco]	39
QT [qnco]	39
Pacing [inbe]	39
Pre-Menopause [phsf]	39
Cascade [mnob]	39
Endocarditis [dsyn]	39
Cultural [idcn]	39
Amputation [topp]	39
Drop [qnco]	39
exacerbate [fndg]	39
ST elevation [fndg]	39
Formula [inpr]	39
Paroxysmal atrial fibrillation [dsyn]	39
increased activity [fndg]	39
North [spco]	39
Unusual [qlco]	39
wave [npop]	39
risk benefit [qlco]	40
Synergistic [qlco]	40
Angiotensin [aapp, bacs, phsu]	40
Cell Proliferation [celf]	40
Study Participant [grup]	40
Migration [socb]	40
relieving [ftcn]	40
Augmentation [topp]	40
Reperfusion Therapy [topp]	40
natural menopause [orgf]	40
recovered [qlco]	40
Health Care Systems [hcro]	40
predictive factor [inpr]	40
Ventricular arrhythmia [patf]	40
Brazil [geoa]	40
Magnesium [elii]	40
Invasive Breast Cancer [neop]	40
Metabolite [bacs]	40
Common carotid artery [bpoc]	40
Norethisterone [horm, phsu, strd]	40
Phenotypes [orga]	40
Reconstruction [mcha]	40
Silent [qlco]	40
Postoperative Complications [patf]	40
Surgical procedures [hlca]	40
ELISA [lbpr]	40
Morbidities [qnco]	40
Tertiary [qnco]	40
Keyword [inpr]	40
Array [spco]	40
Branch [bpoc]	40
injections [topp]	40
Aortic Stenosis [dsyn]	40
Coronary Artery Bypass Graft Surgery [topp]	40
Cardiac Failure [dsyn]	40
LEFT ANTERIOR DESCENDING CORONARY ARTERY [bpoc]	40
Outpatient Clinic [hcro, mnob]	40
Opposite [spco]	40
Precision [tmco]	40
General Anesthesia [topp]	40
Quality-Adjusted Life Years [tmco]	40
Drainage [bdsu]	40
Strain [inpo]	40
Confusion [mobd]	40
Eye [bpoc]	40
Airway, NOS [medd]	40
Prognostic Marker [qlco]	40
hospital death [fndg]	41
Allocation [acty]	41
Fenofibrate [orch, phsu]	41
Subjective [qlco]	41
experiments [resa]	41
FLUID [bdsu]	41
accessibility [qlco]	41
Delta [inpr]	41
Mutation [genf]	41
Sum [qnco]	41
Carbohydrate [carb]	41
Uterine [bpoc]	41
intralesional [spco]	41
Window [mnob]	41
Low Income [grpa]	41
Freedom [idcn]	41
Chi [inpr]	41
supply [idcn]	41
Adiponectin [aapp, bacs]	41
Atypical [qlco]	41
Inflammatory Response [patf]	41
anatomic [qlco]	41
Transfusion [topp]	41
exposures [inpo]	41
Platform [resd]	41
generic [phsu]	41
Cardiovascular function [ortf]	41
Proportional Hazards Model [inpr, qnco]	41
Propensity Score [qnco]	41
Patient Selection [resa]	41
Mapping [acty]	41
Acetylsalicylic Acid [orch, phsu]	41
Intermediate Risk [cnce]	41
Forward [spco]	41
Offset [qnco]	41
Absent [qnco]	41
Obesity, Abdominal [dsyn]	41
Histological [ftcn]	41
Functional Status [fndg]	41
journals [inpr, mnob]	41
metabolic effects [phsf]	41
Circulatory [phsf]	41
E-Selectin [aapp, imft, rcpt]	41
Surg [tmco]	41
Hip fracture [inpo]	41
antioxidant activity [moft]	41
Healthy Volunteers [popg]	41
Visceral [spco]	41
Manual [inpr, mnob]	41
Real Time [idcn]	41
Arrhythmias, Cardiac [patf]	42
exercise testing [diap]	42
Corticosteroids [horm, phsu, strd]	42
Dogs [mamm]	42
Disease Outcome [fndg]	42
Facility [idcn]	42
Isoflavone [orch, phsu]	42
Transplant [topp]	42
therapeutic agents [inpr]	42
national survey [resa]	42
Top [spco]	42
ST [inpr]	42
Surgical menopause [dsyn]	42
Hypothyroidism [dsyn]	42
early-stage breast cancer [neop]	42
Bind [acty]	42
Intense [qlco]	42
AVM [cgab]	42
Computer [mnob]	42
DNA [bacs, nnon]	42
Adoption [socb]	42
Case Reports [inpr]	42
Emotional [menp]	42
MO [idcn]	42
Cancer Treatment [topp]	42
CG [aapp, enzy]	42
Myocardial Infarctions [dsyn]	42
Telephone [mnob]	42
Behaviors [inbe]	42
Low Grade [qlco]	42
Deposition [ftcn]	42
Collagen [aapp, bacs, bodm]	42
Instrument [medd]	42
Cardioversion [topp]	42
Osteoporotic Fractures [dsyn]	42
Anti-arrhythmic Agent [phsu]	42
TC [geoa]	42
mailed [mnob]	42
Apolipoproteins [aapp, bacs]	42
Hypoxia [patf]	42
Willing [fndg]	42
Actuary [prog]	42
subtypes [clas]	42
Central Nervous System [bdsy]	42
Estrone [horm, phsu, strd]	42
Cardiac Output [clna]	43
Fifth [qnco]	43
Membrane [tisu]	43
Discrimination [menp]	43
Genetics [bmod]	43
coronary angioplasty [topp]	43
ST segment elevation myocardial infarction [dsyn]	43
Time period [tmco]	43
Eliminated [qlco]	43
Checked [acty]	43
Similarity [qlco]	43
Focal [spco]	43
Eligibility [hlca]	43
Smoking Status [clna]	43
Longitudinal Study [resa]	43
Ionising radiation [npop]	43
Left breast [bpoc]	43
Thrombin [aapp, enzy, phsu]	43
diminish [qnco]	43
Registers [inpr]	43
Submitted [ftcn]	43
Blacks [popg]	43
Normal Range [qnco]	43
Section [spco]	43
Approval [qlco]	43
Cross Sectional Analysis [resa]	43
Collection [ftcn]	43
Drug effect [ftcn]	43
Morning [tmco]	43
Difficulty [fndg]	43
Suppressed [ftcn]	43
financial [qnco]	43
intervention trials [resa]	43
Company [mnob, orgt]	43
Lifestyles [socb]	43
Nutrients [food]	43
Clinical Research [resa]	43
Intrinsic [spco]	43
remove [qlco]	43
BY [geoa]	43
Macrophages [cell]	43
viability [qlco]	43
Theoretical [idcn]	43
PurE [moft]	43
Consultation [hlca]	43
late effects [fndg]	43
Health System [gora]	43
striking [ocac]	43
Myocardial perfusion [orga]	44
ENTER [ftcn]	44
Glucose tolerance [phsf]	44
Preventable [inpr]	44
Intraoperative [tmco]	44
Blood sample [bdsu]	44
cover [medd]	44
Quality Improvement [ocac]	44
Back [blor]	44
Growth Hormone [aapp, horm, phsu]	44
Mood [menp]	44
BEAM [topp]	44
arterio-venous [bpoc]	44
Compression [ftcn]	44
Adverse reactions [fndg]	44
Color [npop]	44
Southern [spco]	44
prevention trials [resa]	44
Store [ftcn]	44
Cohort Studies [qnco]	44
menopausal hormone therapy [topp]	44
Loading [acty]	44
Cancer Survivor [podg]	44
Families [famg]	44
Acetylcholine [nsba, orch, phsu]	44
HIV [virs]	44
Translation [inpr]	44
Scheduled [inpr]	44
Pair [qlco]	44
shared [socb]	44
Intermittent Claudication [dsyn]	44
California [geoa]	44
Leptin [aapp, horm]	44
Serious Adverse Event [fndg]	44
End diastolic [clna]	44
Extension [ftcn]	44
Kidney disease [dsyn]	44
prompt [ftcn]	44
Tobacco [hops, orch, phsu]	44
Premedication [topp]	44
century [phsu, vita]	44
Pharmacologic Agent [phsu]	44
Trunk [blor]	44
Spinal [spco]	44
Deep Vein Thrombosis [dsyn]	44
Participant [popg]	44
Pathologies [bmod]	44
Fatigue [sosy]	44
Percentile [qnco]	44
Expand [spco]	44
feel [menp]	44
Genomic [gngm]	44
Projected [inpr]	44
Renal Failure, Chronic [dsyn]	44
Classic [qlco]	44
Water [inch, phsu]	44
thresholds [qlco]	45
Puncture [fndg]	45
Evidence-Based Medicine [bmod]	45
North American [fndg]	45
Mortality, Excess [qnco]	45
Oral use [ftcn]	45
trauma [inpo]	45
Education, Patient [edac]	45
Cardiovascular Disorders [dsyn]	45
Factor VII [aapp, bacs, phsu]	45
Marginal [spco]	45
americans [popg]	45
Anticoagulants [phsu]	45
diagnostic criteria [inpr]	45
Apolipoprotein [aapp, bacs]	45
nonsmokers [fndg]	45
Medroxyprogesterone [horm, phsu, strd]	45
Venous Thrombosis [patf]	45
Treatment Outcomes [qlco]	45
Cancer Risk [qnco]	45
successful treatment [clna]	45
Sent [ftcn]	45
User [idcn]	45
Fiber [food]	45
Northern [spco]	45
Homeostasis model assessment [lbpr]	45
Atherosclerotic Plaques [bdsu]	45
Capillary [bpoc]	45
Colorectal [spco]	45
stenting [medd]	45
Sample Size [qnco]	45
breathing [orgf]	45
determinations [gora]	45
Androgens [horm, phsu]	45
Impaired glucose tolerance [dsyn]	45
Administer [ftcn]	45
Uric Acid [bacs, orch]	45
Blocking [mobd]	45
Discrepancy [fndg]	46
Regular exercise [dora]	46
Fruits [food]	46
Immune [ftcn]	46
Health Benefits [qnco]	46
Streptokinase [aapp, enzy, phsu]	46
Deprivation [qlco]	46
Cardiologist [prog]	46
Hemangiomas [neop]	46
Saturated fat [bacs, food, lipd]	46
Interdisciplinary [ocac]	46
australian [fndg]	46
new therapy [idcn]	46
Task Force [gora]	46
Expanding [spco]	46
Anatomical [qlco]	46
Perceptions [menp]	46
Antihypertensive drug [phsu]	46
Appropriate Treatment [clna]	46
Molecule [sbst]	46
England [geoa]	46
Adverse event [fndg]	46
derivatives [chvs]	46
Policies [inpr]	46
Therapeutic Interventions [topp]	46
Approximate [qlco]	46
Sepsis [dsyn]	46
Pill [phsu]	46
Conference [hcpp]	46
Fruit [food]	46
tumor necrosis factor-alpha [aapp, imft]	46
Mean score [qnco]	46
worsen [qlco]	46
German [popg]	47
proliferative [patf]	47
Asian [popg]	47
institutions [idcn]	47
Cardiovascular Drugs [phsu]	47
LISS [lbpr]	47
Stem [plnt]	47
Diffuse [qlco]	47
Doctor [prog]	47
Erectile dysfunction [dsyn]	47
Defect [ftcn]	47
Taiwan [geoa]	47
Organisation [phsf]	47
Declining [qlco]	47
centered [spco]	47
County [geoa]	47
Rabbit [mamm]	47
Clearance [qlco]	47
Carotid Arteries [bpoc]	47
Markers, Risk [qlco]	47
File [ocac]	47
Adhesion Molecule [aapp, bacs]	47
Intermittent [tmco]	47
Homeostasis [biof]	47
blood lipids [lipd]	47
Vein [bpoc]	47
Localisation [ftcn]	47
Dilation [patf]	47
Adults, Young [aggp]	47
Necrosis [ortf]	47
Mitigate [idcn]	47
Increment [qnco]	47
errors [qlco]	47
Rheumatic Heart Disease [dsyn]	47
Acquisition [acty]	47
drug use [mobd]	47
Communicable Diseases [dsyn]	47
spend [qnco]	47
Put [acty]	47
Preceding [tmco]	47
Veins [bpoc]	47
Theory [idcn]	47
Description [idcn]	47
Mole [neop]	47
Class I [clas]	47
Pre-Existing Disease [rnlw]	48
opinion [menp]	48
Disease Progression [patf]	48
Organizations [orgt]	48
turnover [qnco]	48
Hot Flashes [sosy]	48
linkage [moft]	48
Unaffected [cnce]	48
Preferences [idcn]	48
Beliefs [idcn]	48
Nicotinic Acid [orch, phsu, vita]	48
Abnormality [fndg]	48
Hot flushes [sosy]	48
Ventricular tachyarrhythmia [patf]	48
Tablet [bodm]	48
Nurses [prog]	48
Activate [ftcn]	48
Endothelial cell [cell]	48
expertise [qlco]	48
Acid [chem]	48
Renal insufficiency [dsyn]	48
Plasminogen [aapp, bacs, phsu]	48
Superficial [spco]	48
Renal dysfunction [fndg]	48
Biologic [qlco]	48
Implantable Cardioverter-Defibrillators [medd]	48
mediators [orch, phsu]	48
functioning [ftcn]	48
Simulation [resa]	48
Cardiac Arrest [dsyn]	48
Lungs [bpoc]	48
Viable [qlco]	48
arising [qlco]	48
Ipsilateral [spco]	48
mitral [qlco]	48
Stabilisation [topp]	48
hospitalized patients [podg]	48
general practices [bmod]	49
Kaplan-Meier Analysis [qnco]	49
professionals [prog]	49
Clinical Practice Guidelines [inpr]	49
Revised [topp]	49
Arthritis [dsyn]	49
Risk Management [hlca]	49
mental [menp]	49
Cardiomyopathy, Dilated [dsyn]	49
confirmation [qlco]	49
Plant [plnt]	49
Contraindicated [fndg]	49
Media [inpr]	49
Gemfibrosil [lipd, phsu]	49
Specialists [prog]	49
Short duration [qlco]	49
Vitamin D [orch, phsu, vita]	49
Surgical excision [topp]	49
Data Set [inpr]	49
NM [celf]	49
evolved [ftcn]	49
Share [socb]	49
Details [qlco]	49
Internal Medicine [bmod]	49
Drug Prescriptions [inpr]	49
hormone treatment [topp]	49
purposes [ftcn]	49
Inverse Association [cnce]	49
Estrogens, Conjugated [horm, phsu, strd]	49
interpreted [ftcn]	49
Non Adherence [fndg]	49
Muscle, Smooth, Vascular [tisu]	49
mg/mg [qnco]	49
Bypass [topp]	49
Somewhat [inpr]	49
Health Status [qlco]	49
Intravascular [spco]	49
Clinical Endpoint [clna]	49
Uniform [qlco]	49
Patency [spco]	49
Postprandial [tmco]	49
Well defined [qlco]	49
Idiopathic [ftcn]	49
Electrical [npop]	49
Therapies, Drug [topp]	49
MULTI-DISCIPLINARY TEAM [hlca]	49
Human cells [lbtr]	49
volumes [qnco]	49
Remission [fndg]	49
ETHNIC [popg]	49
Prostacyclin [bacs, eico, phsu]	50
code [ocac]	50
Adjunctive [topp]	50
held [idcn]	50
early stages [tmco]	50
Normalized [resa]	50
Office [mnob]	50
Elevated Cholesterol [dsyn]	50
Clinical examination [hlca]	50
Medical Nutrition Therapy [topp]	50
Environmental Factors [ftcn]	50
Substitution [idcn]	50
Placement [hlca]	50
Long-Term Survivors [podg]	50
Count [acty]	50
Stage I [inpr]	50
Estrogen Receptor alpha [aapp, rcpt]	50
Italy [geoa]	50
Infrequent [tmco]	50
blood lipid [lipd]	50
Profound [qlco]	50
City [geoa]	50
Normalization [resa]	50
Interfere [qlco]	50
Automated [ftcn]	50
Treatment Plan [inpr]	50
displayed [ftcn]	50
Arterial wall [bpoc]	50
Radiology [bmod]	50
Nuclear [spco]	50
Pulse Pressure [orgf]	50
Grade III [qlco]	50
Sustained ventricular tachycardia [dsyn]	50
Primary Care Physicians [prog]	50
glucose levels [lbtr]	50
Cardiomyocytes [cell]	50
Reproducibility [qlco]	50
Histology [bmod]	51
Dydrogesterone [horm, phsu, strd]	51
Bone Density [clna]	51
Ovariectomy [topp]	51
health professionals [prog]	51
Limitation [ftcn]	51
Time Point [tmco]	51
Boost [ftcn]	51
High frequency [tmco]	51
most likely [idcn]	51
Inferior [spco]	51
Table [mnob]	51
incorporation [ftcn]	51
Hip [bpoc]	51
Optimum [qlco]	51
Provisional [idcn]	51
Blood vessel wall [bpoc]	51
Up-Regulation [celf, moft]	51
Incidences [qnco]	51
Dimensions [qnco]	51
At [spco]	51
anti hypertensive [phsu]	51
carriers [fndg]	51
Stop [acty]	51
Transfer [menp]	51
Class III [inpr]	51
Female Gender [fndg]	51
Angiotensin Receptor Blockers [phsu]	51
First myocardial infarction [dsyn]	51
Bear [mamm]	51
Socioeconomic Status [qlco]	51
Angiogenesis [ortf]	51
Therapeutic Effect [hlca]	51
paradigm [resa]	51
Laser [mnob]	51
Portion [spco]	51
presently [idcn]	51
Emergency Department [hcro]	52
refer [ftcn]	52
Salt [chvs]	52
vascular factor [aapp]	52
Mid [spco]	52
Grouped [spco]	52
Blood Vessels [bpoc]	52
Calculation [acty]	52
administrative [ftcn]	52
lipoprotein metabolism [moft]	52
Renin-angiotensin system [bdsy]	52
Therapeutics [topp]	52
Cardiac complications [patf]	52
Borderline [qlco]	52
Kind [qlco]	52
Achievement [bhvr]	52
augment [qnco]	52
Current smoker [clna]	52
particles [chvs]	52
toxicities [inpo]	52
Weight Reduction [fndg]	52
Equation [cnce]	52
Colon Cancer [neop]	52
Unstable [fndg]	52
accelerate [ftcn]	52
Inconclusive [idcn]	53
Scheme [inpr]	53
Attended [ftcn]	53
ARMS [neop]	53
Expert Opinion [cnce]	53
Intra [tmco]	53
Distributed [ftcn]	53
Lipid lowering agents [phsu]	53
pharmacodynamic [biof]	53
Food and Drug Administration [hcro]	53
Database, Electronic [inpr]	53
Missing [idcn]	53
cancer chemoprevention [topp]	53
Magnetic Resonance [npop]	53
Adjacent [spco]	53
Choose [acty]	53
Anti-anginal [phsu]	53
Medicines [phsu]	53
Affinity [npop]	53
female sex [fndg]	53
Predictive Value [qlco]	53
United Kingdom [geoa]	53
HbA [aapp, bacs]	53
Acetate [orch, phsu]	53
Societies [orgt]	53
adherent [ftcn]	53
Endothelium, Vascular [tisu]	53
Thyroid, NOS [bpoc]	53
collaborative [socb]	53
Specialty [bmod]	53
Son [famg]	53
Severely [qlco]	53
Optimization [acty]	53
Computed [lbpr]	53
Dietary intake [orgf]	53
Research Design [resa]	53
Modulating [spco]	53
Anticoagulant [phsu]	53
contraceptive [phsu]	54
Distance [qnco]	54
French [popg]	54
Lymphatic [bpoc]	54
Fourth [qnco]	54
Chance [qlco]	54
Manifest [ftcn]	54
Vasomotor [ftcn]	54
Sequence [nusq]	54
Author [prog]	54
high-risk group [popg]	54
Peri [tmco]	54
Hypotension [fndg]	54
Formed [ftcn]	54
Anterior [spco]	54
Integral [qnco]	54
lower blood pressure [fndg]	54
First-Line Treatment [topp]	54
Reflecting [menp]	54
Government [orgt]	54
GOV [gngm]	54
Differentiation [celf]	54
Software [inpr, mnob]	54
New Agents [clas]	54
Anesthesia [topp]	54
Adopted [fndg]	54
Rose [plnt]	54
Reductase [aapp, enzy]	54
Adipose tissue [tisu]	54
Prominent [qlco]	54
France [geoa]	54
Administration, Oral [topp]	54
diagnose [fndg]	54
ELECTIVE [topp]	54
Market [geoa]	54
Inter- [spco]	54
Culture [idcn]	54
life span [grpa]	54
post treatment [tmco]	54
Pharmacists [prog]	54
Antiplatelet Agents [phsu]	54
Avoidance [menp]	55
Quantification [qnco]	55
Incidence Rate [qnco]	55
MI [idcn]	55
Androgen Deprivation Therapy [topp]	55
Left Atrium [bpoc]	55
Cost Effectiveness Analysis [ocac]	55
Oestradiol valerate [horm, phsu, strd]	55
Perception [menp]	55
Termination [inpr]	55
cytokine [aapp, imft]	55
Calculate [acty]	55
Distal [spco]	55
emergent [idcn]	55
Malignant [qlco]	55
Heart attack [dsyn]	55
Haemoglobin [aapp, bacs]	55
Evaluations [ftcn]	55
Early Detection [diap]	55
Unable [fndg]	55
Geriatric [qlco]	55
Registration [hlca]	55
establishing [qlco]	55
interviews [acty]	55
Charts [inpr]	55
Well-being [idcn]	55
Sedentary [qlco]	55
Long duration [qlco]	55
Chemical [chem]	55
homocysteine levels [lbpr]	55
Prone [spco]	55
Dense [qlco]	55
Child [aggp]	55
Acute phase [tmco]	55
Personalized [qlco]	55
vascular reactivity [clna]	55
British [popg]	55
Fibrillation [dsyn]	55
Waist-to-Hip Ratio [orga]	55
Whites [popg]	55
professional [prog]	55
Quality of life [idcn]	56
estrogen use [fndg]	56
Not available [idcn]	56
Language [lang]	56
Elevated blood pressure [fndg]	56
Pulse Wave Velocity [phsf, qnco]	56
Complement [aapp, imft]	56
Amlodipine [orch, phsu]	56
Headache [sosy]	56
Unlikely [cnce]	56
Attending [prog]	56
Explanation [inpr]	56
Prophylactic [phsu]	56
Cross-Sectional Survey [resa]	56
Haemorrhagic [qlco]	56
Sodium [bacs, elii]	56
Cured [cnce]	56
Iron [bacs, elii, phsu]	56
Sleep [orgf]	56
Oil [lipd]	56
Longevity [tmco]	56
Inducing [ftcn]	56
Monthly [tmco]	56
Pilot [prog]	56
amounts [qnco]	56
Incomplete [qnco]	56
Teaching [edac]	57
Shock [patf]	57
Stable angina [dsyn]	57
ezetimibe [orch, phsu]	57
Promotion [acty]	57
desire [menp]	57
operative procedures [ftcn]	57
Ultrasonography [diap]	57
Block [patf]	57
elevations [spco]	57
Vascular lesions [dsyn]	57
Vasodilatation [phsf]	57
Leg [blor]	57
lives [fndg]	57
Pivot [medd]	57
health care professionals [prog]	57
Transient Ischemic Attack [dsyn]	57
Reviewer [qlco]	57
Active Treatment [topp]	57
The Netherlands [geoa]	57
Normal Tissue [tisu]	57
Developed Countries [qlco]	57
Modulator [mnob]	57
Solution [sbst]	57
Excretion [phsf]	57
rosuvastatin [orch, phsu]	57
combined treatment [topp]	57
Epidemiologic Studies [resa]	57
difficulties [fndg]	57
Elderly woman [aggp]	57
Staff [prog]	58
Essential Hypertension [dsyn]	58
Under [spco]	58
African American [popg]	58
English [lang]	58
technologies [ocdi]	58
Extend [ftcn]	58
.BETA.-Carotene [orch, phsu, vita]	58
Elements [elii]	58
Indirect [qlco]	58
Bleomycin [aapp, antb]	58
Mean Arterial Pressure [fndg]	58
Depth [spco]	58
program treatment [hlca]	58
thromboembolic [ftcn]	58
Total Dose [cnce]	58
Mediate [socb]	58
Cardiac rehabilitation [topp]	58
Patient Compliance [inbe]	58
Mutations [genf]	58
Minority [popg]	58
Mean blood pressure [fndg]	58
HMG-CoA Reductase Inhibitors [orch, phsu]	58
Mandatory [ftcn]	58
Multicenter Study [resa]	58
Episode [tmco]	58
Conversion [ftcn]	58
Twice daily [tmco]	58
Clinical course [tmco]	58
Nitroglycerin [orch, phsu]	59
Foods [food]	59
Lesser [qlco]	59
Repeat [ftcn]	59
Rated [acty]	59
Nurse [prog]	59
Outside [spco]	59
Thromboembolic events [patf]	59
Oncology [bmod]	59
Load [idcn]	59
Drug Delivery Systems [medd]	59
Renal disease [dsyn]	59
Albumin [aapp, bacs]	59
Rigor [sosy]	59
familial [famg]	59
adapted [orch]	59
Safeties [hcpp]	59
italian [lang]	59
contained [ftcn]	59
Task [ocac]	59
illnesses [fndg]	59
etc. [idcn]	59
secretion [biof]	59
Fit [sosy]	59
Chest Wall [bpoc]	59
treatment goals [inpr]	59
Dilatation [topp]	59
Current Therapy [topp]	59
surgical intervention [fndg]	59
Muscle [tisu]	59
animal studies [anim]	60
Hope [menp]	60
Carotid artery [bpoc]	60
standard therapy [topp]	60
steps [cnce]	60
soy [food]	60
Linear Regression [qnco]	60
Environmental [spco]	60
degrees [qnco]	60
unadjusted [ftcn]	60
Estrogen Effects [fndg]	60
Regulated [gora]	60
Neurological [qlco]	60
Fibrosis [patf]	60
popularity [socb]	60
Group A [clas]	60
Anti-Hypertensive Agents [phsu]	60
disease prevention [topp]	60
S-HAM [topp]	60
System, Health Care [hcro]	60
Scope [cnce]	60
Middle [spco]	60
expanded [spco]	60
Substances [sbst]	60
Heavy [qlco]	60
fibrinogen levels [lbpr]	60
Persistence [menp]	60
dying [orgf]	61
Swedish [popg]	61
Restenosis [acab]	61
Satisfaction [menp]	61
Units [qnco]	61
Medication Adherence [fndg]	61
Birth [orgf]	61
Left ventricular mass [fndg]	61
Permit [rnlw]	61
Rhythm [fndg]	61
Cognitive [ftcn]	61
Depressed [fndg]	61
Stages [qlco]	61
Inducible [ftcn]	61
Fear [menp]	61
Syncope [sosy]	61
glucose metabolism [moft]	61
swelling [patf]	61
Stroke risk [inpr]	61
Rural [fndg]	61
Carcinogenesis [neop]	62
Characterization [acty]	62
Stent [medd]	62
Ill [sosy]	62
Intima [tisu]	62
Infected [ftcn]	62
Dyspnea [sosy]	62
Balanced [ftcn]	62
Susceptible [ftcn]	62
Long-Term Effect [phpr]	62
CLIN [inpr]	62
cardiac patients [podg]	62
Ovarian [bpoc]	62
Priority [tmco]	62
plasma cholesterol [lbpr]	62
Lovastatin [orch, phsu]	62
Percutaneous Transluminal Coronary Angioplasty [topp]	62
Asthma [dsyn]	62
Electronic [mnob]	62
specialized [qlco]	62
Cardiac Catheterization [diap, topp]	62
Right Ventricle [bpoc]	62
K+ [elii, phsu]	62
Most Recent [tmco]	62
treatment guidelines [topp]	62
Heterozygous [orga]	62
Educational [inpr]	62
Former [tmco]	63
Stroke, Acute [dsyn]	63
Agonist [phsu]	63
Annually [tmco]	63
Generalized [spco]	63
Inject [ftcn]	63
Algorithms [inpr]	63
Web [mnob]	63
Hearts [bpoc]	63
Pulmonary arterial hypertension [dsyn]	63
Vascular Malformation [anab]	63
centres [spco]	63
Medicare [gora]	63
Restoration [inpr]	63
Exact [qlco]	63
EG [geoa]	63
Inhibitory [acty]	63
Proximal [spco]	63
Outpatients [podg]	63
Fulfill [idcn]	63
Arterial Stiffness [phsf]	63
Chosen [acty]	63
ST segment elevation [fndg]	63
gold standard [qlco]	63
RUPTURE [phpr]	63
Conventional Therapy [topp]	64
Provider [prog]	64
Pharmacist [prog]	64
Adolescents [aggp]	64
Released [ftcn]	64
Switch [mnob]	64
Apo-B [aapp, bacs]	64
Hodgkin Disease [neop]	64
Chest [blor]	64
Angiotensin-converting enzyme inhibitor [phsu]	64
experimental studies [resa]	64
Chelation Therapy [topp]	64
Nitrate [chvs]	64
Advanced age [popg]	64
Instance [idcn]	64
Historical [idcn]	64
Diuretic [phsu]	64
Vitamins [orch, phsu, vita]	64
Cosmetic [mnob]	64
Appearance [orga]	65
External [spco]	65
Endometrial [spco]	65
Prepare [ftcn]	65
choices [inbe]	65
mL/min [qnco]	65
Alive [idcn]	65
Vasodilator [phsu]	65
Resting [dora]	65
Plasma glucose [lbpr]	65
Hemodynamics [ortf]	65
Response Rate [tmco]	65
Estrogenic [horm, orch, phsu]	65
Group I [inpr]	65
Vital [qlco]	65
EXCLUSION [ftcn]	65
manifestation [ftcn]	65
Enrollment [hlca]	65
Quarter [qnco]	65
Core [spco]	65
treatment option [topp]	65
MATCHING [resa]	65
Pharmacology [bmod]	65
Anaemia [dsyn]	65
malignancies [neop]	65
Hospital admission [hlca]	65
Spain [geoa]	65
Oxygen [elii, phsu]	66
doctors [prog]	66
Neutral [qlco]	66
suppress [ftcn]	66
Cross [cnce]	66
Homozygous [orga]	66
Surveys [inpr]	66
Treatment Regimen [topp]	66
Selective Estrogen Receptor Modulator [horm, phsu]	66
Apheresis [topp]	66
regulatory [rnlw]	66
cardiac toxicity [inpo]	66
Judge [prog]	66
Very low [fndg]	66
plasma lipid [lbpr]	66
toxic [inpo]	66
socioeconomic [cnce]	66
Endometrium [bpoc]	66
electrocardiograph [fndg]	66
Velocity [qnco]	66
Hospital Mortality [qlco]	66
Standard deviation [qnco]	66
Reversible [ftcn]	66
Cyclic [tmco]	67
Tissue Plasminogen Activator [aapp, enzy, phsu]	67
Comprise [acty]	67
intensive care unit [hcro, mnob]	67
Reactive Oxygen Species [bacs, elii]	67
Mild to moderate [qlco]	67
Genotypes [orga]	67
MRI [diap]	67
Elimination [phsf]	67
Anthropometry [resa]	67
Follow-up Study [resa]	67
Peripheral vascular disease [dsyn]	67
Working [ocac]	67
Cox Proportional Hazards Models [inpr, qnco]	67
Locally [spco]	67
Accounting [ocac]	67
Vitamin E [lipd, phsu, vita]	67
Clinical Management [hlca]	67
Abstracts [inpr]	67
Eleven [qnco]	67
Weekly [tmco]	67
Developing Countries [qlco]	67
Plaque, Atherosclerotic [bdsu]	67
Risks, Relative [qnco]	67
Urban [geoa]	67
Characteristic [qlco]	67
Psychosocial [ftcn]	67
Body Fat [tisu]	67
CHD [topp]	67
Nitrates [chvs]	67
Gene Expression [genf]	67
Intended [qlco]	67
Stability [qlco]	67
Identical [qlco]	67
Dynamic [ftcn]	67
inpatient [podg]	67
Discontinue [fndg]	68
case control [hlca]	68
Uncommon [qlco]	68
surgical resection [topp]	68
Thousand [qnco]	68
Vascular function [clna]	68
Overcome [acty]	68
Pilot Study [resa]	68
Unrelated [fndg]	68
Early Diagnosis [diap]	68
Smoke [eehu, hops]	68
male patients [orga]	68
Sub- [spco]	68
Diminished [qnco]	68
Valid [qlco]	68
Usage [ftcn]	68
Drug Interactions [moft]	68
Resource [idcn]	68
Non-specific [qlco]	69
transdermal estrogen [horm, phsu, strd]	69
agonists [phsu]	69
Blockade [ftcn]	69
Randomized Clinical Trial [inpr, resa]	69
Clinical Significance [fndg]	69
Electrophysiology [bmod]	69
P-Value [qnco]	69
HEALTHY SUBJECTS [popg]	69
Clinician [prog]	69
Inactive [qlco]	69
World Health Organization [hcro]	69
translate [ocac]	69
Alcohol intake [inbe]	69
Item [enty]	69
mRNA [bacs, nnon]	69
OPEN LABEL [resa]	69
Treatment Effectiveness [qlco]	70
Temporal [spco]	70
Version [ftcn]	70
high cholesterol [fndg]	70
Intention [menp]	70
Australia [geoa]	70
Radiotherapy, Adjuvant [topp]	70
diabetics [fndg]	70
experiences [menp]	70
Sweden [geoa]	70
Reaching [orgf]	70
Recruitment [acty]	70
Aorta [bpoc]	70
Thrombolytic [phsu]	70
Deep [spco]	70
Transplantation [topp]	70
Anatomy [bmod]	70
medication use [fndg]	70
Brachial Artery [bpoc]	70
Healthy Control [qlco]	70
coverage [idcn]	71
{Graft} [bodm]	71
Physical Examination [hlca]	71
Vegetables [food]	71
Hospitalizations [hlca]	71
Apolipoprotein A-I [aapp, bacs]	71
Discontinued [fndg]	71
Norethisterone acetate [horm, phsu, strd]	71
Metformin [orch, phsu]	71
Registries [inpr]	71
Simultaneous [tmco]	71
examinations [hlca]	71
Cancer Patient [podg]	71
Physiologic [ftcn]	71
MS [aapp, enzy]	71
reflected [menp]	71
defects [ftcn]	71
Early Stage [clas]	71
Extract [sbst]	71
Additive [qlco]	71
Pre-existing [qlco]	71
expense [qnco]	71
subcutaneous [spco]	71
SAS [orch]	71
gastrointestinal [spco]	71
Phases [tmco]	71
intracellular [celc]	71
DOI [clas]	71
Clinical Events [idcn]	71
Respondents [popg]	71
Antioxidants [phsu]	71
Validity [qnco]	71
Inverse [qlco]	72
Cluster [idcn]	72
Glomerular Filtration Rate [diap]	72
antiplatelet therapy [topp]	72
Protocols [inpr]	72
Bioavailability [qnco]	72
Agree [inpr]	72
Side Effect [patf]	72
Strokes [dsyn]	72
write [ocdi]	72
adjuvant therapy [topp]	72
synthetic [acty]	72
Live [qlco]	72
product [enty]	72
Statistics [ocdi]	72
Daily Dose [qnco]	72
Qualitative [qlco]	72
Scan [diap]	72
vasculature [bpoc]	72
Functions [ftcn]	73
CVD, NOS [dsyn]	73
Chemopreventive [qlco]	73
Mechanical [ftcn]	73
Corrected [qlco]	73
Infections [dsyn]	73
Permanent [tmco]	73
Discover [acty]	73
Habits [inbe]	73
Atherosclerotic Cardiovascular Disease [dsyn]	73
Current Treatment [topp]	73
Morphology [qlco]	73
General Practitioners [prog]	73
prophylaxis [inpr]	73
case report [inpr]	73
Coupled [ftcn]	73
Enhancement [topp]	73
Channel [spco]	73
Warfarin [hops, orch, phsu]	74
standards [inpr]	74
Phenomenon [phpr]	74
polymorphisms [genf]	74
Sex Hormones [horm, phsu]	74
Reproductive [orgf]	74
Thrombus [patf]	74
Allele [gngm]	74
mU/g [qnco]	74
Nutritional [qlco]	74
Light [npop]	74
Preserved [lbpr]	74
Pulmonary Embolism [dsyn]	74
Health Care Providers [prog]	74
Investigators [prog]	74
Diets [food]	74
Absorption [npop]	74
Continuing [idcn]	75
Keep [ftcn]	75
MMOLE [qnco]	75
Phytoestrogens [horm, phsu, strd]	75
USA [geoa]	75
Demand [topp]	75
Cardiac Death [patf]	75
Internal [spco]	75
Logistic Model [inpr, qnco]	75
Carotid Intima-Media Thickness [clna]	75
Ventricular Fibrillation [dsyn]	75
Reactive [qlco]	75
Pre-clinical [qlco]	75
Niacin [orch, phsu, vita]	75
variants [qlco]	75
Entered [qlco]	75
Substrate [mnob]	75
Interquartile Range [qnco]	75
stopped [qlco]	75
Oestrogens [horm, phsu, strd]	75
breast radiotherapy [topp]	75
Excessive [qlco]	75
Susceptibility [clna]	76
Collaboration [socb]	76
Parameter [spco]	76
PHARMACOKINETIC [resa]	76
Assumed [inpr]	76
U S [geoa]	76
hospital discharge [hlca]	76
Blood Glucose [carb]	76
Withdrawal [acty]	76
Rheumatoid Arthritis [dsyn]	76
Black [popg]	76
serial [inpr, mnob]	77
respiratory [ftcn]	77
operations [ftcn]	77
Creatinine [bacs, orch]	77
Survival Rates [qnco]	77
limiting [ftcn]	77
Relapse [phpr]	77
Entity [enty]	77
Isoflavones [orch, phsu]	77
Academic [orgt]	77
Thromboembolism [dsyn]	77
medical care [fndg]	77
Near [fndg]	77
Restriction [ftcn]	77
Controlled Clinical Trial [inpr]	77
Papers [mnob]	77
Surface [spco]	77
Attractive [qlco]	77
Left Ventricular Hypertrophy [dsyn]	77
binding [ftcn]	78
FAVOR [orch, phsu, vita]	78
FED [dsyn]	78
Co-morbid conditions [fndg]	78
right sided [spco]	78
pg/mL [qnco]	78
estimating [qnco]	78
complaints [fndg]	78
Endocrine [bdsy]	78
Curative [cnce]	78
English Language [lang]	78
Intervention Group [popg]	78
allowing [socb]	78
statistical analysis [resa]	78
Relaxation [acty]	78
In the Field [spco]	78
coronary revascularisation [topp]	78
Survival Rate [qnco]	78
indicator [irda]	79
pharmacologic therapy [ftcn]	79
Attitudes [menp]	79
Japan [geoa]	79
Abdominal [blor]	79
Hodgkin Lymphoma [neop]	79
Heterogeneous [qlco]	79
Train [mnob]	79
Dosimetry [lbpr]	79
Slight [qlco]	79
Bone Loss [patf]	79
Fracture [inpo]	79
Inappropriate [qlco]	79
Peripheral Vascular Diseases [dsyn]	79
applicable [qlco]	79
lymphatic malformations [anab]	79
Dual [inpr]	80
Contractile [phsf]	80
Responsive [ftcn]	80
Steroid [strd]	80
Clinical setting [spco]	80
Statistical Significance [qnco]	80
Oxidation [moft]	80
Signal [phpr]	80
Platelet aggregation [celf]	80
specialised [qlco]	80
Treatment Effect [fndg]	80
Prostate [bpoc]	80
serum lipid [lbpr]	80
Recipient [humn]	80
antagonists [chvf]	80
Microvascular [ftcn]	80
Deterioration [phpr]	80
Catheter [medd]	80
Hyperglycaemia [dsyn]	80
Communities [geoa]	80
Sometimes [tmco]	80
calcium antagonist [phsu]	80
Control Groups [grup]	81
Plasma lipids [lbpr]	81
Removed [qlco]	81
Pharmaceutical [bodm]	81
Weak [sosy]	81
Platelets [cell]	81
Pharmacy [hcro]	81
Dosages [qnco]	81
Technical [ftcn]	81
Participation [ftcn]	81
radiation disease [dsyn]	81
assessments [hlca]	81
structures [spco]	81
Coronary Atherosclerosis [dsyn]	81
Infusion [topp]	81
Advocate [ocdi]	81
Varies [inpr]	81
Medium [inpr]	81
possess [mobd]	81
estimation [menp]	81
Localized [spco]	81
Deficient [ftcn]	81
pay [qnco]	81
Heparin [bacs, carb, phsu]	81
DELIVER [orch, phsu]	81
weighted [orga]	82
concepts [idcn]	82
Service [ocac]	82
recurrences [phpr]	82
cross over [genf]	82
Agreement [socb]	82
Suppression [patf]	82
Demographics [idcn]	82
Strength [qnco]	82
Carry [acty]	82
ineffective [idcn]	82
Ventricular Dysfunction, Left [patf]	82
Environment [spco]	82
Easily [qlco]	82
Catheter Ablation [topp]	82
Classical [qlco]	82
Changing [ftcn]	82
Natural History [ocdi]	83
Satisfactory [inpr]	83
Vasodilation [phsf]	83
Case-Control Study [resa]	83
Created [acty]	83
Uncontrolled [qlco]	83
Renal Failure [dsyn]	83
Biology [bmod]	83
Evolving [ftcn]	83
F- [inch, phsu]	83
Animal [anim]	83
Implantable Cardioverter-Defibrillator [medd]	83
providers [prog]	83
Estrogen Receptors [aapp, rcpt]	83
Progestogens [horm, phsu, strd]	83
Accelerated [ftcn]	83
cardiologists [prog]	84
anticoagulation [topp]	84
literature review [inpr]	84
Tolerance [fndg]	84
algorithm [inpr]	84
Communication [socb]	84
Mediastinal [blor]	84
Adverse Effect [fndg]	84
Enzyme [enzy, orch]	84
First-Line Therapy [topp]	84
mU/L [qnco]	84
Planned [ftcn]	84
clopidogrel [orch, phsu]	84
Benign [qlco]	84
Removal [topp]	84
Metabolites [bacs]	84
Blinded [resa]	84
Fractures [inpo]	85
Cytokines [aapp, imft]	85
Completion [qlco]	85
Germany [geoa]	85
Easy [qlco]	85
Body Composition [orga]	85
adiposity [dsyn]	85
Definite [qlco]	85
Cardiotoxicity [inpo]	85
Discovery [acty]	85
Urgent [tmco]	85
Descriptive [idcn]	85
Pharmacological Treatment [topp]	85
Infants [aggp]	85
Surrounding [spco]	85
Create [acty]	85
Sex Differences [orga]	85
Very high [fndg]	85
Reaction [ftcn]	85
Efficiency [qnco]	86
Coronary Artery Bypass Grafting [topp]	86
From [qlco]	86
Medical History [fndg]	86
yr [tmco]	86
examining [fndg]	86
tailored [prog]	86
Implanted [medd]	86
reviews [inpr]	86
Rehabilitation [topp]	86
Syndromes [dsyn]	86
Meaning [idcn]	87
Low density lipoprotein cholesterol level [lbpr]	87
Behavioral [inbe]	87
cigarette smoking [hops]	87
Restricted [ftcn]	87
Cutoff [ftcn]	87
Uncertainty [idcn]	87
Resolved [idcn]	87
Resolution [idcn]	87
Worsening [qlco]	87
placebo controlled study [inpr, resa]	87
Diagnoses [fndg]	88
Age Groups [aggp]	88
Trigger [clna]	88
canadian [fndg]	88
Chronic heart failure [dsyn]	88
Records [inpr]	88
Inhibiting [acty]	88
Directions [spco]	88
Save [mcha]	88
simultaneously [tmco]	88
urinary [qlco]	88
General Practice [bmod]	88
Receptors [aapp, rcpt]	88
Intima media thickness [clna]	89
Precise [phsu]	89
Activated [acty]	89
Signaling [celf]	89
Contraceptives, Oral [phsu]	89
vasomotor symptom [sosy]	89
Pulmonary Hypertension [dsyn]	89
Endometrial Cancer [neop]	89
Income [qnco]	90
Proliferation [patf]	90
Estrogen receptor [aapp, rcpt]	90
Construct [clas]	90
Principal [qlco]	90
absolute risk [qnco]	90
Twelve [qnco]	90
Vascular anomalies [cgab]	90
origin [clas]	90
base [inch]	90
Uptake [phsf]	90
Weight Gain [fndg]	90
Anxiety [menp]	91
Exogenous [spco]	91
Multivariate Analyses [qnco]	91
Without [qlco]	91
Hospital Stay [tmco]	91
soluble [celc]	91
Renal Disease, End-Stage [dsyn]	91
D NOS [aapp, imft]	91
Surgically [hlca]	91
Haemostasis [ortf]	91
allowed [socb]	91
Malformation [cgab]	91
Malignancy [neop]	91
clinics [hcro, mnob]	91
Country [geoa]	92
Circulation [phsf]	92
document [inpr]	92
Polymorphism [genf]	92
Epidemic [phpr]	92
female patients [orga]	92
dementia [mobd]	92
Retrospective Cohort Study [resa]	92
Variance [qlco]	92
Journal [inpr, mnob]	92
Phenotype [orga]	92
Antagonist [ortf]	92
suffered [mobd]	93
Data Extraction [resa]	93
Smoking Cessation [inbe]	93
Tachycardia [fndg]	93
Renal function [ortf]	93
Fractions [qnco]	93
Food [food]	93
Conjugated Equine Estrogens [horm, phsu, strd]	93
endovascular [blor]	93
intervals [tmco]	93
Basal [spco]	93
Disturbance [qlco]	93
Since [tmco]	94
Height [orga]	94
Quartile [qlco]	94
Practitioner [prog]	94
Controlled Study [resa]	94
Pharmacokinetics [phsf]	94
causality [ftcn]	94
Clinical presentation [inpr]	94
Emergency [phpr]	94
Menopausal Status [clna]	94
Haemorrhage [patf]	94
Odds Ratios [qnco]	95
Moderately [qlco]	95
Health Outcomes [inpr]	95
blood samples [bdsu]	95
Network [prog]	95
Typical [qlco]	95
DE [geoa]	95
Researchers [prog]	95
Risk Assessment [hlca]	95
Arteriovenous Malformations [cgab]	95
Suboptimal [qlco]	95
Pathological [bmod]	95
Acquired [tmco]	95
Occlusion [ortf]	95
educational program [edac]	95
Pulmonary Disease, Chronic Obstructive [dsyn]	95
Psychological [ftcn]	95
Europe [geoa]	96
Valvular heart disease [dsyn]	96
Validation [resa]	96
Prescriptions [hlca]	96
exception [idcn]	96
Canada [geoa]	96
Insight [menp]	96
Bone Mineral Density [clna]	96
perioperative [tmco]	96
Apoptosis [celf]	96
Normotensive [fndg]	96
Anti-inflammatory [phsu]	96
Randomization [resa]	96
Perfusion [topp]	96
Antiarrhythmic Drugs [phsu]	96
insights [menp]	96
Oxidative [ftcn]	96
Multifactorial [fndg]	96
fail [ftcn]	96
Extended [ftcn]	97
Today [antb, orch]	97
Epidemiologic [bmod]	97
older adult [popg]	97
assist [socb]	97
Perimenopausal [tmco]	97
mg/L [qnco]	97
Modeling [inpr, resa]	97
Rat [mamm]	97
Uterus [bpoc]	97
Angina Pectoris [sosy]	97
chinese [lang]	98
self reported [resa]	98
ACE Inhibitors [phsu]	98
In-Hospital Mortality [qlco]	98
Advice [hlca]	98
Visits [bhvr]	98
Twice [inpr]	98
suffer [mobd]	98
outcome measure [qnco]	98
Category [inpr]	98
Robust [qlco]	98
Risk Ratio [qnco]	98
Hold [idcn]	98
Pravastatin [orch, phsu]	98
Physiology [bmod]	98
Policy [inpr]	98
Upper [spco]	99
fibrinolytic [topp]	99
Drive [menp]	99
Accuracy [qlco]	99
Detail [qlco]	99
Thickness [qlco]	99
Insulin Sensitivity [patf]	99
Entry [inpr]	99
categorized [acty]	99
Publications [inpr, mnob]	99
Original [idcn]	99
Guidance [hlca]	99
Specificity [qnco]	99
Joint [bsoj]	99
Hour [tmco]	99
sequelae [patf]	99
Sinus rhythm [fndg]	99
tibolone [phsu, strd]	99
Kidney [bpoc]	100
Informed [qlco]	100
Shift [ftcn]	100
Premature [tmco]	100
peripheral arterial disease [dsyn]	100
Team [grup]	100
Proteins [aapp, bacs]	100
Actual [qlco]	100
Heart Diseases [dsyn]	100
co-morbidity [idcn]	100
Social [ftcn]	100
Repair, NOS [orgf]	101
Calcium Channel Blockers [phsu]	101
Fibrates [orch, phsu]	101
For [qlco]	101
Services [ocac]	101
Cardiovascular event [fndg]	101
controversy [socb]	101
Operative [tmco]	101
Step [cnce]	101
Androgen [horm, phsu]	101
Aid [socb]	101
Before [tmco]	101
Always [tmco]	102
measuring [qlco]	102
conflicting [inbe]	102
enable [menp]	102
On [ftcn]	102
China [geoa]	102
operate [ftcn]	102
Hypertriglyceridaemia [fndg]	102
investigating [ftcn]	102
Expired [orgf]	102
Referral [hlca]	103
arterial hypertension [dsyn]	103
Resident [prog]	103
ECG NOS [diap]	103
Infarct [patf]	103
Energy [fndg]	103
Arm [blor]	103
therapy, hormonal [topp]	103
Concurrent [tmco]	103
Ethnicity [popg]	103
Disorder [dsyn]	103
Cardiac function [ortf]	104
Spontaneous [ftcn]	104
justify [ftcn]	104
Domain [ftcn]	104
Electrocardiogram [fndg]	104
Lipid lowering drug [phsu]	104
logistic [ocac]	104
haemostatic [ortf]	104
Interventional [topp]	104
VALVE [medd]	104
Hepatic [blor]	104
CT [gngm]	104
Personal [orga]	104
Fraction [qnco]	105
compromise [fndg]	105
American Heart Association [hcro]	105
True [qlco]	105
Capability [qlco]	105
Statistical [ocdi]	105
Haemodialysis [topp]	105
Dose-dependent [qnco]	105
Biomarker [clna]	105
DEVICES [medd]	105
Inform [aapp, imft, phsu]	105
Double [ftcn]	105
Ablation [topp]	105
Selective Estrogen Receptor Modulators [horm, phsu]	106
Immediately [tmco]	106
Mu [inpr]	106
Recommendation [idcn]	106
inhibited [qlco]	106
Rank [inpr]	106
{Non-patient} [clna]	106
Cardiac Diseases [dsyn]	106
Above [spco]	107
Ratios [qnco]	107
centers [spco]	107
Age Group [aggp]	107
Ambulatory [ftcn]	107
Doppler [diap]	107
Testosterone [horm, phsu, strd]	107
Inconsistent [qlco]	107
Employed [fndg]	107
university hospital [hcro, mnob]	107
Regression Analyses [inpr]	107
Models, Animal [anim]	108
Left Ventricular Function [ortf]	108
Skin [bdsu]	108
long-term treatment [hlca]	108
Pathology [bmod]	108
Cerebrovascular disease [patf]	108
Long-Term Effects [phpr]	108
determination [lbpr]	108
Intact [qlco]	108
Behavior [inbe]	108
Indicators [irda]	108
Pregnancy [orgf]	108
molecules [sbst]	108
Counseling [hlca]	108
Colorectal Cancer [neop]	109
Publication [inpr, mnob]	109
Cardiac Surgery [topp]	109
Cessation [acty]	109
Covered [ftcn]	109
reveal [qlco]	109
Cure [cnce]	109
Library [mnob, orgt]	109
Lost [ftcn]	109
Double-Blind Study [resa]	109
Sudden Cardiac Death [patf]	109
Return [qlco]	109
Offered [fndg]	109
Composition [clna]	109
Hysterectomy [topp]	109
mg kg [qnco]	109
Products [enty]	109
Amiodarone [orch, phsu]	109
CORRECTION [inpr]	110
contraindications [qlco]	110
ng/mL [qnco]	110
Fast [fndg]	110
TOPIC [ftcn]	110
Timing [tmco]	110
Reticular [spco]	110
Middle Aged [aggp]	111
Meeting [hlca]	111
hours [tmco]	111
Registered [hlca]	111
Entire [qnco]	111
Separate [spco]	111
Cohort Study [qnco]	111
BARRIER [medd]	112
Beta-blocker [phsu]	112
variations [qlco]	112
Subclinical [qlco]	112
Needs [qlco]	112
Poor prognosis [fndg]	112
Deficiency [ftcn]	112
Source [fndg]	112
gender differences [orga]	112
Self [idcn]	112
Western [spco]	112
Statement [idcn]	113
Draw [inpr]	113
Composite [qlco]	113
Adjuvant [chvf]	113
Requirement [ftcn]	113
Find [fndg]	113
Atrial [bpoc]	113
Tamoxifen [orch, phsu]	113
Incremental [qnco]	113
Steroids [strd]	113
Platelet [cell]	114
RE [idcn]	114
modulate [spco]	114
Alcohol consumption [inbe]	114
Clinical Trials, Randomized [inpr, resa]	114
Stimulation [topp]	114
Dialysis [npop]	114
univariate analysis [resa]	114
Participating [ftcn]	114
Committee [grup]	114
Evolution [genf]	114
surgical treatment [hlca]	115
Attributable [menp]	115
cardiovascular complications [patf]	115
Angioplasty [topp]	115
Intravenous [spco]	115
Tumors [neop]	115
Medical therapy [topp]	115
Complicated [ftcn]	115
organs [bpoc]	115
Impairment [patf]	115
Blood flow [orgf]	116
congenital [qlco]	116
basel [hcro]	116
Answer [inpr]	117
ROUTE [ftcn]	117
Anti-arrhythmic [phsu]	117
Waist Circumference [clna]	117
Representative [acty]	117
Enzymes [enzy, orch]	117
KG [geoa]	117
Causing [ftcn]	117
Lifestyle changes [socb]	118
myocardial ischaemia [dsyn]	118
Vessels [bpoc]	118
Data Sources [qnco]	118
Transient [popg]	118
Ideal [qlco]	118
Discontinuation [hlca]	118
Stimulated [npop]	118
Chest Pain [sosy]	118
Promoting [acty]	118
Unit [qnco]	119
Modulation [spco]	119
Resistant [ftcn]	119
Anti-Hypertensive Drugs [phsu]	119
mg/d [qnco]	119
Prognoses [hlca]	119
Home [cnce]	119
Fibrinolysis [phsf]	119
Clarify [acty]	119
Preferred [idcn]	119
endpoints [qlco]	119
atorvastatin [orch, phsu]	119
Pretreatment [sbst]	120
Roles [socb]	120
Illness [fndg]	120
Familial hypercholesterolaemia [dsyn]	120
Cardiomyopathy [dsyn]	120
Antiarrhythmic drug [phsu]	120
Combined therapy [topp]	120
Minimum [qlco]	120
Threshold [qlco]	120
Vascular Diseases [dsyn]	120
Fixed [fndg]	120
institute [orgt]	120
Pathway [moft]	120
Reperfusion [topp]	121
Contributing [acty]	122
Questionnaires [inpr]	122
Patient Outcome [idcn]	122
Perceived [menp]	122
Regression Analysis [inpr]	122
Differential [qlco]	122
Position [spco]	122
Climacteric [orgf]	122
Recognition [menp]	122
Together [qlco]	123
Obtain [ftcn]	123
Orally [spco]	123
Family [famg]	123
Ethanol [orch]	123
Angiographies [diap]	123
estrogen deficiency [dsyn]	123
Japanese [popg]	123
Definitive [tmco]	123
Exclude [ftcn]	123
Induction [ftcn]	124
Framingham [inpr]	124
Subset [clas]	124
Device [medd]	124
Attenuated [qlco]	124
effectiveness treatment [qlco]	124
Alpha [inpr]	124
Lacking [qlco]	124
Refractory [ftcn]	124
resection [topp]	125
Sequential [idcn]	125
Serum lipids NOS [lbpr]	125
Interview [acty]	125
Coronary Arteries [bpoc]	125
Heterogeneity [qlco]	126
Apolipoprotein B [aapp, bacs]	126
Pharmacologic [bmod]	126
focusing [clna]	126
treatment options [topp]	126
Rich [qlco]	126
Prospective Cohort Study [resa]	126
Childhood [tmco]	126
Perform [ftcn]	126
Ultrasound [diap]	126
homocysteine [aapp, bacs]	126
Suspected [idcn]	126
Aware [menp]	126
Real [qlco]	126
Consequence [ftcn]	127
Pharmacotherapy [topp]	127
Rarely [qlco]	127
Close [ftcn]	127
debate [acty]	127
Brain [bpoc]	127
Inclusion Criteria [qlco]	127
Lung Cancer [neop]	127
Myocardium [tisu]	127
Quantify [qnco]	128
cohorts [popg]	128
decreases [qnco]	128
cardiac events [dsyn]	128
Nutrition [bmod]	128
Project [cnce]	128
Planning [menp]	128
density [qnco]	128
Interpretation [inpr]	128
Widespread [spco]	128
clinical characteristics [clna]	128
serum concentration [qnco]	129
Largest [qnco]	129
Pro [aapp, bacs]	129
Plaque [dsyn]	129
Medical Records [inpr]	129
Suffering [mobd]	129
Stenosis [patf]	129
Immediate [tmco]	129
Endothelial Cells [cell]	130
serum cholesterol [lbpr]	130
cross sections [spco]	130
Modality [idcn]	130
Cerebrovascular [qlco]	130
Mode [ftcn]	130
Relief [fndg]	130
Cell [cell]	130
Genotype [orga]	130
Progestins [horm, phsu, strd]	130
Resistance [menp]	131
practices [menp]	131
Generated [acty]	131
Diverse [qlco]	131
Nitric Oxide [bacs, inch, phsu]	131
Heart study [diap]	131
Image [inpr]	131
White [popg]	131
Rest [dora]	132
Longitudinal [spco]	132
Tests [lbpr]	132
Lp(a) [aapp, bacs]	132
meta-analyses [resa]	132
WHI [inpr]	133
contact [ftcn]	133
Delayed [tmco]	133
Rationale [idcn]	133
Sites [spco]	133
Exposed [clna]	134
Efficient [qlco]	134
Aortic [bpoc]	134
Resources [idcn]	134
Irradiated [ftcn]	134
Preliminary [tmco]	134
Long-term Follow-up [hlca]	134
Attenuate [acty]	134
Artery [bpoc]	134
Linear [spco]	134
Individualized [qlco]	134
Availability [ftcn]	134
Residual [qlco]	134
Segment [spco]	135
regional [spco]	135
Angiography [diap]	135
Sudden death [patf]	135
High sensitivity [lbpr]	136
Beginning [tmco]	136
injection [topp]	136
Multidisciplinary [ocac]	136
Lipid Metabolism [moft]	136
Cl - [elii]	136
observations [resa]	136
Correct [qlco]	137
Investigations [hlca]	137
Vascular disease [dsyn]	137
ALCOHOL [orch]	137
C-reactive protein level [lbpr]	137
Pooled [cnce]	137
kg-m [qnco]	137
Likelihood [qnco]	137
encounter [hlca]	137
Log [inpr]	138
manifestations [ftcn]	138
Life Expectancy [grpa]	138
Unfavorable [qlco]	138
Side [spco]	139
Angina, Unstable [dsyn]	139
lowered [spco]	139
Structure [spco]	139
Peak [qnco]	139
Retrospective Study [resa]	139
Transition [comd]	140
mice [mamm]	140
left sided [spco]	140
Insufficient [qlco]	140
Guideline [inpr]	140
Arteries [bpoc]	140
Parallel [qlco]	140
Prospective Studies [resa]	140
Supported [cnce]	140
Weight Loss [fndg]	140
Lipid level [lbtr]	141
Maximal [qlco]	141
Venous Thromboembolism [patf]	141
computed tomography [diap]	141
Curve [spco]	141
Operation [hlca]	141
Spectrum [qnco]	141
Persistent [tmco]	141
Bone [bpoc]	141
Genes [gngm]	142
Intensity [qlco]	142
Visit [bhvr]	142
Replacement therapy [topp]	142
Probability [qnco]	142
Prostate Cancer [neop]	143
Tachycardia, Ventricular [patf]	143
introduce [ftcn]	143
Disability [fndg]	143
Economic [ocdi]	143
Pressure [phpr]	144
Elevation [topp]	144
Out-patient [podg]	144
Confidence Intervals [qnco]	145
Scores [qnco]	145
Completely [qlco]	145
Technology [ocdi]	145
multiple regression [qlco]	145
Epidemiological Studies [resa]	145
Uncertain [idcn]	145
Wall [mnob]	145
Carotid [bpoc]	146
Percutaneous Coronary Intervention [topp]	146
Primary Endpoint [irda]	146
Apply [hlca]	146
Partial [qnco]	146
Ventricular arrhythmias [patf]	146
Life threatening [idcn]	146
Inadequate [qlco]	147
Raloxifene [orch, phsu]	147
Recovery [acty]	147
Poorly [qlco]	147
Embolisation [topp]	147
Pathways [moft]	147
Ischaemic stroke [dsyn]	148
Simvastatin [orch, phsu]	148
Reason [idcn]	148
Diameter [qnco]	148
Risk Reduction [inbe]	148
Foundation [orgt]	148
Inhibitor [qlco]	148
newly [idcn]	148
Syndromes, Acute Coronary [dsyn]	149
High density lipoprotein cholesterol level [lbpr]	149
Combine [mnob]	149
Progressive [ftcn]	150
HRT [topp]	150
Race [popg]	150
considerations [fndg]	150
Disease, Cardiac [dsyn]	150
utility [orgt]	151
Equine [mamm]	151
Location [spco]	151
sources [fndg]	151
Managed [ocac]	152
University [mnob, orgt]	152
Episodes [tmco]	152
Regulation [gora]	152
Right [spco]	152
Delivered [acty]	152
Managing [ocac]	152
Neck [blor]	153
Acceptable [qlco]	153
Preparation [ftcn]	153
endothelial dysfunction [dsyn]	153
Interval [tmco]	153
Diuretics [phsu]	154
Mixed [ftcn]	154
Quantitative [qnco]	154
Conjugated estrogen [horm, phsu, strd]	154
Department [orgt]	154
SURVIVE [phsu]	154
definition [idcn]	154
Grade [clas]	154
ejection fraction [diap]	154
Open [spco]	155
Intermediate [spco]	155
Programs [inpr]	155
screen [hlca]	155
Coagulation [ortf]	155
Treatment Efficacy [qlco]	156
Contribution [acty]	156
Person [popg]	156
Basic [ftcn]	156
glycemia [carb]	157
Face [blor]	157
Implantation [topp]	157
Decision Making [menp]	157
Site [spco]	157
utilization [ftcn]	157
systematic [ftcn]	157
Multi [qnco]	158
Chronic disease [dsyn]	158
Thrombolysis [clna]	158
Fall [fndg]	158
Overweight [sosy]	158
Integration [genf]	158
Line [spco]	158
Blood Pressure, High [dsyn]	158
untreated [fndg]	158
Usual [qlco]	159
smokers [fndg]	159
Calcium [bacs, elii, phsu]	159
Gene [gngm]	159
minute [tmco]	160
Bias [idcn]	160
TOLERABILITY [resa]	160
Accurate [qlco]	160
Ensure [food]	161
Mass [fndg]	161
Tissues [tisu]	161
Combinations [mnob]	161
Vessel [bpoc]	161
Begin [tmco]	161
Slow [qlco]	161
Animals [anim]	161
Clinical Data [inpr]	161
Equivalent [qlco]	162
Smaller [qlco]	162
Proportional [qlco]	162
Approved [qlco]	162
magnitude [qnco]	162
limit [ftcn]	163
Estrogen Replacement [topp]	163
Reporting [hlca]	163
Absolute [qlco]	163
Coronary artery [bpoc]	163
cholesterol levels [lbpr]	163
Balance [orgf]	163
Maintained [ftcn]	163
Supplementation [topp]	163
receptor [aapp, rcpt]	163
Organ [bpoc]	163
malformations [ftcn]	164
Chronic kidney disease [dsyn]	164
Head [blor]	164
Access [spco]	164
Raised [qnco]	165
Family history [fndg]	165
Minor [popg]	165
concept [idcn]	165
PubMed [inpr]	165
Nature [idcn]	165
Selection Criteria [qlco]	165
plasma concentration [qnco]	165
Comorbidity [idcn]	165
Repeated [ftcn]	165
Coronary angiography [diap]	166
challenges [hlca]	166
surveillance [ftcn]	166
Sufficient [qlco]	166
Panel [idcn]	167
exert [orgf]	168
Stratified [qlco]	168
Coronary Disease [dsyn]	168
pulmonary [bpoc]	168
Reliability [qnco]	168
Sustained [ftcn]	169
Slightly [idcn]	169
Clinical Trial [resa]	169
Lowest [qlco]	169
Arrhythmias [patf]	169
prescribing [hlca]	170
Awareness [menp]	170
Superior [spco]	170
Annual [tmco]	170
Changed [ftcn]	170
Greatest [qnco]	170
Peripheral [spco]	170
Hazard [qlco]	171
Left Ventricle [bpoc]	171
Liver [bpoc]	172
rats [mamm]	172
Training [edac]	172
Hormone Replacement Therapy, Post-Menopausal [topp]	172
Maintenance [acty]	172
modalities [idcn]	173
Thought [menp]	173
forms [qlco]	173
Targeting [ftcn]	173
Invasive [qlco]	173
In Vivo [spco]	174
Old age [fndg]	174
Living [idcn]	174
Chronic Diseases [dsyn]	174
Presentation [idcn]	175
applications [hlca]	175
Prediction [idcn]	175
Detailed [qlco]	175
establish [qlco]	175
Formulation [resa]	175
mortality rates [qnco]	176
Relate [orch]	176
Cholesterol, HDL [bacs, lipd]	176
PLAN [dsyn]	176
Hand [bpoc]	176
Diastolic [clna]	177
Left ventricular ejection fraction [clna]	177
Endogenous [ftcn]	177
hormone replacement [topp]	178
Protocol [inpr]	178
ADD [mobd]	178
Fold [spco]	178
Acute Coronary Syndrome [dsyn]	178
Coronary heart disease risk [inpr]	178
Initially [tmco]	179
High Prevalence [qnco]	179
Injury [inpo]	179
Observation [resa]	179
Delay [tmco]	179
Session [evnt]	179
Concerns [idcn]	179
Syndrome [dsyn]	179
signs [ftcn]	179
Symptom [sosy]	180
Dosage [qnco]	180
indication [idcn]	180
apparent [idcn]	180
Full [qlco]	180
Rapidly [qlco]	180
Study Population [popg]	180
ventricular [bpoc]	180
Categories [inpr]	181
Accepted [qlco]	181
Inclusion [qlco]	181
Broad [spco]	181
Assay [lbpr]	181
Biomarkers [clna]	181
Cellular [cell]	182
dysfunction [ftcn]	182
Activities [acty]	182
Content [menp]	182
Magnetic Resonance Imaging [diap]	183
Abnormal [qlco]	183
Angina [sosy]	183
Pre-operative [tmco]	183
View [spco]	183
hospitalized [fndg]	184
Sensitive [ftcn]	184
estimates [qnco]	184
Combination Therapy [topp]	184
Mortality rate [qnco]	184
Progesterone [horm, phsu, strd]	184
Laboratory [mnob, orgt]	184
Disorders [dsyn]	185
incident [idcn]	186
Final [tmco]	186
progress [ftcn]	186
Means [cnce]	186
Cardiovascular system [bdsy]	186
Natural [ftcn]	187
Finding [sosy]	188
Chemoprevention [topp]	188
Stratification [resa]	188
Consumption [acty]	188
synthesis [biof]	188
Oxidative Stress [comd]	188
Unchanged [fndg]	189
Supplement [food]	189
Great [qnco]	189
High density lipoprotein [aapp, bacs, lipd]	189
Antihypertensive therapy [topp]	189
Institution [hcro, mnob]	189
Whole [qnco]	190
Arrhythmia [patf]	190
Attribute [idcn]	190
Power [hcpp]	190
Impaired [ftcn]	190
Triglyceride level [lbtr]	190
Relationships [qlco]	191
Infection, NOS [dsyn]	191
Reverse [idcn]	191
Prolonged [tmco]	191
TEN [dsyn]	191
Failed [ftcn]	192
Primary Care [hlca]	192
Data Collection [resa]	192
Never [tmco]	192
Targeted [ftcn]	193
Not significant [fndg]	193
body [humn]	193
Option [ftcn]	193
Relevance [qlco]	194
Scientific [ocdi]	194
Isolated [ftcn]	194
Metabolism [orgf]	194
reflect [menp]	194
Started [qlco]	194
Affecting [ftcn]	195
Renal [bpoc]	195
decisions [menp]	195
Hospitals [hcro, mnob]	195
Delivery [topp]	195
Body Weight [orga]	195
Biochemical [ftcn]	195
Capacity [qnco]	196
Epidemiology [bmod]	196
referred [ftcn]	196
Release [hlca]	196
Regular [qlco]	197
Registry [inpr]	197
Amount [qnco]	197
Pain [sosy]	197
therapeutic use [topp]	198
Antioxidant [phsu]	198
Stress [fndg]	198
follow [tmco]	199
Variation [qlco]	199
Intake [ftcn]	199
Markedly [qlco]	199
Minimal [qlco]	199
Performance [inbe]	199
Cumulative [qlco]	200
Non-invasive [ftcn]	200
Clinic [hcro, mnob]	200
Mild [qlco]	200
Databases [inpr]	200
Protein [aapp, bacs]	201
actions [ftcn]	201
overview [inpr]	202
Hormonal [qlco]	202
Excess [qlco]	202
Beta [plnt]	203
Special [qlco]	203
Concomitant [tmco]	204
Goals [inpr]	204
Alteration [idcn]	204
subgroups [virs]	204
Material [sbst]	204
Molecular [qlco]	204
Polypharmacy [fndg]	204
Medicine [phsu]	205
Maximum [qnco]	205
consideration [fndg]	205
Obese [dsyn]	205
Involvement [ftcn]	205
Progestagen [horm, phsu, strd]	205
Cycle [tmco]	205
Classification [clas]	206
Lung [bpoc]	206
Generation [tmco]	206
radiation therapy [inpr]	206
Unique [qlco]	206
Aims [idcn]	206
detect [fndg]	207
Remaining [qlco]	207
List [cnce]	207
Humans [humn]	208
Others [fndg]	208
Statistically [ocdi]	208
Testing [ftcn]	208
In Vitro [inpr]	208
Outcome Measures [qnco]	208
Decreasing [qlco]	208
Hormones [horm]	208
Thrombosis [patf]	209
Transdermal [ftcn]	209
Relation [famg]	211
Tumor [neop]	211
inhibitors [chvf]	212
Hemodynamic [ortf]	212
Percutaneous [spco]	212
aetiology [ftcn]	213
thi [euka]	213
worse [qlco]	213
estrogen therapy [topp]	213
Variability [cnce]	214
Able [orga]	214
arrested [dsyn]	214
Gain [qnco]	215
predictive [qlco]	215
Added [ftcn]	216
Physiological [ftcn]	216
Significance [qnco]	216
Population Based Study [resa]	217
medroxyprogesterone acetate [horm, phsu, strd]	218
Example [cnce]	218
Extracted [topp]	218
toxicity [qlco]	218
controlling [ftcn]	219
Implementation [acty]	219
recommend [idcn]	220
Simple [qlco]	220
Variable [qlco]	220
Consensus [socb]	221
Attempt [evnt]	221
Epidemiological [bmod]	221
reasons [idcn]	221
Endothelium [tisu]	222
Length [qnco]	222
SD [fndg]	222
Triglyceride [bacs, lipd]	222
paediatric [bmod]	223
confirm [qlco]	223
placebo-controlled [resa]	223
Pattern [spco]	223
Over [spco]	223
aggressive [mobd]	223
Lipid-lowering therapy [topp]	223
trends [tmco]	223
Million [qnco]	224
randomized controlled trial [inpr, resa]	224
Study Design [resa]	224
Directly [qlco]	224
Marked [qlco]	224
Sensitivity [qnco]	225
Rapid [qlco]	225
Lipoprotein (a) [aapp, bacs]	225
Modified [ftcn]	225
Copyright [inpr]	225
Loss [qnco]	225
Decision [menp]	225
Excellent [qlco]	226
Public Health [bmod]	226
GENETIC [topp]	227
Ischaemia [dsyn]	227
Angiotensin-Converting Enzyme Inhibitors [phsu]	227
Persons [popg]	227
Call [menp]	227
Extensive [qlco]	227
Post-Menopause [orgf]	228
Asymptomatic [fndg]	228
Detection [topp]	229
RANDOM [resa]	229
Failure [ftcn]	229
Physician [prog]	230
Infarction [patf]	230
Pre [tmco]	231
Cardiovascular morbidity [dsyn]	231
Component [mnob]	231
World [popg]	231
Set [menp]	231
eligible [idcn]	231
Give [ftcn]	233
Options [ftcn]	233
College [mnob]	233
Presenting [idcn]	234
Lipoproteins [aapp, bacs]	234
Depression [mobd]	234
Antihypertensive [phsu]	235
mg day [qnco]	236
Venous malformation [anab]	237
Physical [hlca]	237
Health Care [hlca]	237
menopausal symptoms [sosy]	237
Postoperative [tmco]	237
Exhibit [inpr]	237
Includes [ftcn]	238
Probably [idcn]	238
monitor [hlca]	238
Reports [inpr]	238
Cross-Sectional Study [resa]	238
Responsible [fndg]	238
Clinical Studies [resa]	238
Possibly [qlco]	238
Experimental [qlco]	239
randomized controlled trials [inpr, resa]	239
Routine [qlco]	240
mmol/L [qnco]	240
At risk [qlco]	240
heart rate [clna]	241
Recurrent [tmco]	241
Success [socb]	242
Compliance [qnco]	242
production [ocac]	243
Circulating [ftcn]	243
Hyperlipidaemia [dsyn]	243
Determinant [ftcn]	243
Meet [idcn]	245
Congestive heart failure [dsyn]	245
Series [qnco]	246
premenopausal [tmco]	246
preventive [ftcn]	247
subgroup [virs]	247
Phase [tmco]	248
distribution [idcn]	248
limitations [ftcn]	248
methodology [inpr]	248
SO [geoa]	248
Containing [ftcn]	249
Discussion [topp]	249
Venous [bpoc]	249
Numerous [qnco]	249
Diastolic blood pressure [clna]	249
formation [biof]	250
Fibrinogen [aapp, bacs, phsu]	250
Term [tmco]	250
Woman [popg]	251
Abnormalities [cgab]	252
Left [spco]	252
Promote [acty]	252
clinicians [prog]	252
GY [geoa]	252
Biological [bmod]	252
Prior [tmco]	252
Traditional [ftcn]	253
Adequate [qlco]	254
Revascularisation [topp]	254
Meta-Analysis [inpr]	255
Basis [ftcn]	255
responses [orga]	256
consequences [ftcn]	256
Problems [idcn]	256
Insulin Resistance [patf]	257
Identification [menp]	257
Predicted [idcn]	257
Models [inpr]	258
Enhanced [acty]	258
Focused [spco]	259
Bleeding [patf]	259
Complication [patf]	259
Cells [cell]	259
Prescription [hlca]	260
Classified [clas]	260
Compound [qlco]	261
Estrogen Replacement Therapy [topp]	261
Structural [spco]	261
Global [spco]	262
Congenital heart disease [cgab, dsyn]	263
Inhibition [menp]	264
Excluded [idcn]	264
Rare [tmco]	265
summary [inpr]	265
demographic [ocdi]	265
Advanced [qlco]	267
Region [geoa]	267
Initiative [menp]	268
Degree [qlco]	268
ACT [topp]	268
Induce [ftcn]	268
Continued [idcn]	268
Reach [orgf]	269
Patterns [spco]	270
PROPOSED [idcn]	271
Logistic Regression [resa]	271
Place [spco]	272
Lipoprotein [aapp, bacs]	272
OBSERVATIONAL [resa]	272
Fatal [qlco]	273
Activation [acty]	273
MODIFY [ftcn]	273
Atherogenesis [patf]	273
larger [qnco]	273
Aspect [qnco]	274
times [tmco]	274
carried [acty]	274
Countries [geoa]	274
Characterized [acty]	274
Components [mnob]	275
ONGOING [idcn]	276
Detected [fndg]	276
Technique [ftcn]	276
Replacement [topp]	277
Costs [qnco]	278
M NOS [aapp, imft]	278
Scale [medd]	279
Essential [qlco]	279
Searched [acty]	279
Review, Systematic [inpr]	279
Cost Effectiveness [qnco]	281
pathogenesis [ftcn]	281
Irradiation [npop]	282
Work [ocac]	282
Proven [qlco]	282
Of [spco]	283
Half [qnco]	283
End Point [qlco]	284
Hormone Therapy [topp]	284
Maintain [acty]	284
Pharmacological [bmod]	284
Highest [qlco]	285
Date [tmco]	286
admitted [hlca]	287
Course [tmco]	287
Adherence [ftcn]	287
Note [clna]	287
Ageing [orgf]	288
Measurement [ftcn]	288
Ability [orga]	289
Initiation [menp]	290
High dose [qnco]	290
Vascular Malformations [anab]	291
Study, Prospective [resa]	292
Metabolic syndrome [dsyn]	292
i e [diap, inpr]	293
Stable [qlco]	293
Regimen [topp]	294
Tissue [tisu]	294
Imaging [diap]	294
Relative Risk [qnco]	295
Survey [inpr]	295
Reference [idcn]	296
admission [hlca]	296
Conventional [qlco]	296
Discharge [bdsu]	297
tested [inpr]	298
State [geoa]	299
Investigation [hlca]	299
Involving [ftcn]	300
Systolic blood pressure [clna]	300
Glucose [bacs, carb, phsu]	300
Ii [aapp]	300
controversies [socb]	301
trend [tmco]	301
Systemic [ftcn]	301
III [inpr]	301
European [popg]	302
Systolic [tmco]	302
Variety [cnce]	302
Consistent [idcn]	302
Guide [prog]	303
Certain [qlco]	303
Attention [menp]	303
Physical activity [dora]	304
Chemotherapy [topp]	305
increases [ftcn]	305
Arterial [bpoc]	306
weight [orga]	306
Exposure NOS [inpo]	306
Insulin [aapp, horm, phsu]	307
Dietary [food]	307
Procedure [diap, topp]	308
Survivors [podg]	309
Indications [idcn]	310
Problem [fndg]	310
Thrombolytic Therapy [topp]	310
Comprehensive [qlco]	312
Difficult [qlco]	312
Males [fndg]	312
H+ [elii]	312
Females [fndg]	312
Menopausal [phsf]	313
Community [geoa]	314
Questionnaire [inpr]	314
International [idcn]	314
Lipids [lipd]	314
Local [spco]	315
Understand [menp]	315
LED [mnob]	316
Start [tmco]	316
Atrial Fibrillation [patf]	316
Low dose [qnco]	318
Critical [qlco]	319
Echocardiography [diap]	319
Context [fndg]	320
Serious [qlco]	320
Successful [qlco]	320
Unknown [qlco]	320
diabetic [fndg]	321
Interest [menp]	321
Percentage [qnco]	322
Recurrence [phpr]	322
General Population [popg]	323
Types [qlco]	325
frequency [qnco]	325
DOUBLE BLIND [resa]	326
atherosclerotic [ftcn]	326
Continue [idcn]	328
Hospitalization [hlca]	328
Stage [tmco]	329
short [qlco]	329
Protection [fndg]	330
Assigned [ftcn]	331
Paper [mnob]	332
Percent [qnco]	334
COMPLETED [qlco]	334
Event [evnt]	334
Low Risk [fndg]	334
United States [geoa]	335
Documented [hlca]	335
Application [hlca]	335
Flow [npop]	336
Update [tmco]	336
Enhance [acty]	336
Derived [qlco]	337
Active [ftcn]	337
Education [edac]	338
Burden [idcn]	338
Progestin [horm, phsu, strd]	338
Inflammatory [ftcn]	338
Concentration [menp]	338
regimens [inpr]	338
Feature [qlco]	339
Screening [hlca]	340
conclude [bodm, orch]	341
pathophysiology [ftcn]	343
Primary Prevention [topp]	344
promise [idcn]	345
occurrence [ftcn]	345
Hypothesis [idcn]	345
techniques [inpr]	346
Comorbidities [idcn]	346
Diagnostic [fndg]	346
Center [spco]	346
Expression [topp]	348
Fasting [fndg]	348
Lesion [fndg]	350
Applied [hlca]	350
Contrast [qlco]	350
Subsequent [tmco]	351
Tool [mnob]	352
Short-term [tmco]	355
Beta-Blockers [phsu]	356
Goal [inpr]	356
reductions [npop]	357
Effort [orgf]	357
retrospective [resa]	358
Severity [qlco]	359
Introduction [hlca]	359
Nine [qnco]	360
Taken [cnce]	360
Wide [spco]	361
Class [inpr]	362
Symptomatic [ftcn]	362
adverse events [fndg]	363
Expected [idcn]	363
Program [cnce]	363
Breast [bpoc]	363
Hypercholesterolaemia [dsyn]	364
Monitoring [hlca]	364
procedures [inpr]	364
Complete [qlco]	365
Sclerotherapy [topp]	365
Hormone [horm]	366
Low density lipoprotein [aapp, bacs, lipd]	367
absence [qnco]	368
twenty [orch, phsu]	368
Continuous [idcn]	368
divided [ftcn]	371
Initiate [idcn]	373
size [spco]	375
Damage [inpo]	375
Cholesterol, LDL [bacs, strd]	377
Myocardial [spco]	377
Control Group [grup]	377
Observational Study [resa]	378
Estrogens [horm, phsu, strd]	378
Aspirin [orch, phsu]	379
depend [medd]	379
Point [qnco]	379
Affected [ftcn]	379
Blood [tisu]	380
Modification [ftcn]	380
Materials [sbst]	381
free [ftcn]	381
prognostic [inpr]	381
Multivariate Analysis [qnco]	381
American [popg]	382
Highly [qlco]	383
Central [spco]	383
Approaches [spco]	384
Extent [spco]	384
lesions [fndg]	384
Approximately [qlco]	385
Best [qlco]	388
Clear [qlco]	388
Negative [qlco]	389
matched [resa]	389
Challenge [clna]	389
Estimate [qnco]	389
Inflammation [patf]	389
Correlation [qlco]	390
Altered [ftcn]	391
MEDLINE [inpr]	392
Third [qnco]	392
Plus [qlco]	394
Database [inpr]	395
Frequent [tmco]	395
Area [geoa]	397
Estradiol [horm, phsu, strd]	397
Improving [qlco]	397
statistically significant [qnco]	399
Endothelial [tisu]	399
hypertensive [fndg]	399
Form [qlco]	400
Users [humn]	400
Age-Years [tmco]	401
Question [inpr]	401
treating [topp]	403
Surgical [hlca]	404
mediated [socb]	404
Advance [medd]	405
properties [qlco]	405
confirmed [qlco]	406
Doses [qnco]	407
Then [tmco]	407
Metabolic [ftcn]	408
Cost [qnco]	409
choice [inbe]	410
Calculated [ftcn]	412
mmHg [qnco]	412
Human [humn]	415
Onset [qlco]	415
Score [qnco]	416
Ischaemic [ftcn]	416
Moderate [qlco]	416
C-reactive protein [aapp, imft]	416
Associations [menp]	417
Correlated [qlco]	419
mg dl [qnco]	420
General [spco]	421
Adult [aggp]	422
criteria [inpr]	423
prescribed [hlca]	423
Post [tmco]	423
Very [qlco]	423
majority [socb]	424
Measures [qnco]	425
Good [qlco]	426
Therapies [topp]	428
Link [inpr]	428
Equal [qlco]	428
Radiation [npop]	429
Died [orgf]	429
Cardiology [bmod]	430
Gender [orga]	430
R- [spco]	436
account [idcn]	437
Seven [qnco]	438
End [spco]	438
Little NOS [cgab, dsyn]	439
Adults [aggp]	442
Second [qnco]	443
Adjustment [inbe]	443
Order [inpr]	444
Past [tmco]	444
Science [ocdi]	444
adverse effects [ftcn]	445
Eight [qnco]	446
Children [aggp]	446
Provided [acty]	449
Interaction [ftcn]	450
Statin [orch, phsu]	451
g% [qnco]	451
Functional [ftcn]	451
lack [qlco]	452
Dyslipidaemia [dsyn]	453
Exist [cnce]	454
Collected [idcn]	458
Decade [qnco]	458
measurements [ftcn]	459
Exercise [dora]	459
Physicians [prog]	460
Record [inpr]	460
society [orgt]	463
Favorable [qlco]	464
Authors [prog]	466
Cardiovascular Diseases [dsyn]	468
People [popg]	470
Mechanism [ftcn]	470
deaths [orgf]	472
Standard [qlco]	473
Odds Ratio [qnco]	473
Alternative [cnce]	474
Administered [ftcn]	474
If [qlco]	477
Proportion [qnco]	479
Relative [famg]	480
Medication [phsu]	480
Frequently [tmco]	482
Regression [patf]	484
Test [lbpr]	484
Out [spco]	486
side effects [ftcn]	486
Indicated [fndg]	488
Action [ftcn]	489
With [qlco]	490
Novel [tmco]	494
recommendations [idcn]	495
Presented [idcn]	495
High Density Lipoprotein Cholesterol [bacs, lipd]	497
Now [tmco]	498
Measure [qnco]	498
Male [fndg]	499
Consecutive [qlco]	501
Osteoporosis [dsyn]	502
Sample [sbst]	502
Low Density Lipoprotein Cholesterol [bacs, strd]	504
Triglycerides [bacs, lipd]	504
Medications [phsu]	506
Dependent [qlco]	506
Optimal [qlco]	507
TREAT [ftcn]	512
Life Style [socb]	512
Diabetes Mellitus [dsyn]	513
Value [qnco]	514
Direct [qlco]	517
Hazard Ratio [qnco]	517
chronic [tmco]	517
Revealed [qlco]	517
Address [inpr]	519
Diet [food]	519
Secondary Prevention [topp]	521
Obesity [dsyn]	521
Knowledge [inpr]	522
strategy [menp]	523
Play [dora]	523
Normal [qlco]	526
Poor [grpa]	526
Process [bpoc]	527
Last [qlco]	530
Status [qlco]	533
Elderly [popg]	534
progression [patf]	535
influential [idcn]	536
Strong [qlco]	537
month [tmco]	539
Female [fndg]	541
Represent [acty]	546
Understanding [menp]	546
Ratio [qnco]	546
Involved [ftcn]	550
Concentrations [menp]	551
secondary [neop]	553
search [inpr]	553
Occurred [acty]	554
patient care [hlca]	555
Few [qnco]	556
variables [qlco]	557
Relevant [qlco]	558
Seen [qlco]	558
Diagnosed [fndg]	559
Index [inpr]	561
Focus [spco]	564
Six [qnco]	564
Ireland [geoa]	565
Daily [tmco]	566
Late [tmco]	568
Acute myocardial infarction [dsyn]	568
Elevated [qlco]	568
I- [inch]	570
Case [ftcn]	572
activity [dora]	572
Treatments [topp]	576
Serum [bdsu]	576
weeks [tmco]	579
Leading [tmco]	583
Estimated [qnco]	585
Same [qlco]	585
Small [qnco]	586
prospective [resa]	586
Concern [idcn]	590
System [ftcn]	591
Prognosis [hlca]	591
Total Cholesterol [lbpr]	591
Type [qlco]	594
Initial [tmco]	596
Body Mass Index [diap]	596
Complex [qlco]	599
Diseases [dsyn]	603
Statins [orch, phsu]	607
Help [socb]	607
Controlled [ftcn]	612
Risks [qlco]	614
Administration [ocac]	614
Appropriate [qlco]	626
cardiovascular risk factor [dsyn]	626
Recently [tmco]	628
Duration [tmco]	628
Marker [clna]	628
???lead [elii, hops]	628
cardiovascular events [fndg]	629
Heart failure [dsyn]	633
Method [inpr]	639
Issue [fndg]	640
Contribute [acty]	641
Part [spco]	642
Hospital [hcro, mnob]	642
Comparison [acty]	642
Currently [tmco]	642
Effectiveness [qlco]	643
Required [ftcn]	651
national [inpr]	653
reviewed [inpr]	655
interventions [hlca]	657
Recommended [idcn]	657
Sex [orgf]	659
Single [popg]	665
Multiple [qnco]	666
Smoking [inbe]	670
days [tmco]	670
Defined [cnce]	670
Report [inpr]	674
Values [qlco]	675
Analyzed [resa]	680
investigate [ftcn]	680
Severe [qlco]	685
Clinical Trials [resa]	686
In [qnco]	686
Obtained [ftcn]	689
Assessment [hlca]	690
Average [qnco]	692
Long [qlco]	694
Young [tmco]	696
Adjusted [ftcn]	696
Agent [chvf]	697
Previous [tmco]	698
Plasma [bdsu]	699
lowering [spco]	700
Reducing [qlco]	702
vascular [bpoc]	703
Surgery [bmod]	713
Oral [spco]	718
mg% [qnco]	719
Parameters [fndg]	723
Risk factor [qnco]	728
ischaemic heart disease [dsyn]	730
Additional [ftcn]	731
Take [hlca]	732
Relationship [qlco]	733
History [ocdi]	733
Five [qnco]	735
Characteristics [qlco]	737
Alone [qnco]	740
Occur [acty]	740
Guidelines [inpr]	748
function [phsf]	748
Response [orga]	751
Evaluation [ftcn]	752
radiotherapy [inpr]	753
Cohort [popg]	757
acute [tmco]	764
Predictor [idcn]	764
Literature [inpr]	764
GIVEN [cnce]	766
Cholesterol [bacs, strd]	766
investigated [ftcn]	766
Limited [ftcn]	767
Presence [topp]	769
Affect [menp]	771
Target [ftcn]	777
placebo [topp]	789
Breast Cancer [neop]	790
Select [acty]	792
Atherosclerosis [dsyn]	792
Compare [acty]	792
practice [menp]	793
Various [irda]	794
Established [qlco]	795
Safety [hcpp]	802
Future [tmco]	810
Mechanisms [ftcn]	814
Support [medd]	815
intervention [hlca]	819
coronary artery disease [dsyn]	821
strategies [menp]	823
Examined [fndg]	825
Needed [qlco]	831
Events [evnt]	832
Model [inpr]	835
Better [qlco]	839
Null [qnco]	840
coronary [bpoc]	850
Likely [qlco]	853
Benefits [qnco]	858
Article [inpr]	859
Life [idcn]	863
Prognostic Factor [clna]	866
Addition [ftcn]	869
experience [menp]	869
Increasing [ftcn]	875
Morbidity [qnco]	876
Combination [qlco]	882
Often [tmco]	882
median [spco]	885
Menopause [phsf]	887
Survival [acty]	888
Information [idcn]	895
participants [popg]	895
Induced [ftcn]	896
Four [qnco]	901
setting [ftcn]	903
symptoms [ftcn]	904
Medical [ftcn]	905
Known [qlco]	922
LTD [ortf]	922
objectives [inpr]	923
Make [ftcn]	924
Quality [qlco]	926
Care [acty]	926
Confidence Interval [qnco]	939
Independent [idcn]	944
APPEAR [qlco]	947
Cancer [neop]	948
Blood Pressure [orgf]	951
Approach [spco]	953
Improvement [cnce]	957
Profile [lbpr]	958
Complications [patf]	974
Stroke [dsyn]	976
Dose [qnco]	979
Aged [orga]	986
Conduct [inbe]	989
Published [ocac]	994
Heart [bpoc]	994
Combined [qlco]	995
Lipid [lipd]	998
Heart disease [dsyn]	999
condition [dsyn]	1000
Drugs [phsu]	1005
Primary [qlco]	1013
Prevalence [qnco]	1035
Diagnosis [fndg]	1036
Possible [qlco]	1041
Cardiac [bpoc]	1046
Therapeutic [topp]	1050
Following [tmco]	1069
Well [qlco]	1070
Improved [qlco]	1083
Need [qlco]	1090
Main [qlco]	1092
Myocardial Infarction [dsyn]	1093
Range [qnco]	1102
Large [qnco]	1105
Cases [ftcn]	1112
Identified [qlco]	1136
Several [qnco]	1137
Change [ftcn]	1138
Provide [acty]	1149
considered [idcn]	1153
PREVENT [phsu]	1155
Available [ftcn]	1168
Received [qlco]	1169
High Risk [qlco]	1175
Purpose [ftcn]	1179
low [qlco]	1184
randomized [resa]	1186
Decrease [qlco]	1192
Drug [phsu]	1203
Diabetes [dsyn]	1208
Reported [inpr]	1212
Measured [qlco]	1216
Recent [tmco]	1224
Evaluated [ftcn]	1228
IMPACT [gngm]	1231
Decreased [qnco]	1231
Specific [qlco]	1232
Estrogen [horm, phsu, strd]	1239
Non [ftcn]	1241
findings [ftcn]	1243
Subject [grup]	1254
Overall [inpr]	1259
Drug Therapy [topp]	1259
Assessed [acty]	1265
Early [tmco]	1274
Incidence [qnco]	1280
Association [menp]	1288
Receive [qlco]	1289
development [phsf]	1304
Men [popg]	1312
Benefit [qnco]	1331
Old [tmco]	1331
Current [tmco]	1335
Assess [acty]	1336
N NOS [aapp, imft]	1337
Similar [qlco]	1347
Individual [popg]	1353
Common [qnco]	1355
Death [orgf]	1357
